<!DOCTYPE html><html lang="en"><head><script src="https://cdnjs.cloudflare.com/ajax/libs/js-polyfills/0.1.42/polyfill.min.js"></script><link href="https://www.hindawi.com/static/themes/hindawi/base.css" rel="stylesheet"/><meta charSet="utf-8" class="next-head"/><meta name="viewport" content="width=device-width, initial-scale=1" class="next-head"/><title class="next-head">Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways</title><link rel="canonical" href="https://www.hindawi.com/journals/ecam/2012/378415/" class="next-head"/><link rel="shortcut icon" type="image/x-icon" href="https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/favicon.ico" class="next-head"/><meta name="title" content="Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways"/><meta rel="canonical" href="https://www.hindawi.com/journals/ecam/2012/378415/"/><meta name="description" content="Cancer metastasis is a primary cause of cancer death. &lt;i&gt;Antrodia cinnamomea&lt;/i&gt; (&lt;i&gt;A. cinnamomea&lt;/i&gt;), a medicinal mushroom in Taiwan, has shown antioxidant and anticancer activities. In this study, we first observed that ethanol extract of fruiting bodies of &lt;i&gt;A. cinnamomea&lt;/i&gt; (EEAC) exerted a concentration-dependent inhibitory effect on migration and motility of the highly metastatic CL1-5 cells in the absence of cytotoxicity. The results of a gelatin zymography assay showed that &lt;i&gt;A. cinnamomea&lt;/i&gt; suppressed the activities of matrix metalloproteinase-(MMP-) 2 and MMP-9 in a concentration-dependent manner. Western blot results demonstrated that treatment with &lt;i&gt;A. cinnamomea&lt;/i&gt; decreased the expression of MMP-9 and MMP-2; while the expression of the endogenous inhibitors of these proteins, that is, tissue inhibitors of MMP (TIMP-1 and TIMP-2) increased. Further investigation revealed that &lt;i&gt;A. cinnamomea&lt;/i&gt; suppressed the phosphorylation of ERK1/2, p38, and JNK1/2. &lt;i&gt;A. cinnamomea&lt;/i&gt; also suppressed the expressions of PI3K and phosphorylation of Akt. Furthermore, treatment of CL1-5 cells with inhibitors specific for PI3K (LY 294002), ERK1/2 (PD98059), JNK (SP600125), and p38 MAPK (SB203580) decreased the expression of MMP-2 and MMP-9. This is the first paper confirming the antimigration activity of this potentially beneficial mushroom against human lung adenocarcinoma CL1-5 cancer cells."/><meta property="og:url" content="https://www.hindawi.com/journals/ecam/2012/378415/"/><meta property="og:type" content="website"/><meta property="og:image" content="https://images.hindawi.com/journals/ecam/ecam.banner.jpg"/><meta property="og:image:type" content="image/jpeg"/><meta property="og:image:width" content="600"/><meta property="og:image:height" content="315"/><meta property="og:title" content="Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways"/><meta name="twitter:site" content="website"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:image" content="https://images.hindawi.com/journals/ecam/ecam.banner.jpg"/><meta name="twitter:title" content="Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways"/><meta property="og:description" content="Cancer metastasis is a primary cause of cancer death. &lt;i&gt;Antrodia cinnamomea&lt;/i&gt; (&lt;i&gt;A. cinnamomea&lt;/i&gt;), a medicinal mushroom in Taiwan, has shown antioxidant and anticancer activities. In this study, we first observed that ethanol extract of fruiting bodies of &lt;i&gt;A. cinnamomea&lt;/i&gt; (EEAC) exerted a concentration-dependent inhibitory effect on migration and motility of the highly metastatic CL1-5 cells in the absence of cytotoxicity. The results of a gelatin zymography assay showed that &lt;i&gt;A. cinnamomea&lt;/i&gt; suppressed the activities of matrix metalloproteinase-(MMP-) 2 and MMP-9 in a concentration-dependent manner. Western blot results demonstrated that treatment with &lt;i&gt;A. cinnamomea&lt;/i&gt; decreased the expression of MMP-9 and MMP-2; while the expression of the endogenous inhibitors of these proteins, that is, tissue inhibitors of MMP (TIMP-1 and TIMP-2) increased. Further investigation revealed that &lt;i&gt;A. cinnamomea&lt;/i&gt; suppressed the phosphorylation of ERK1/2, p38, and JNK1/2. &lt;i&gt;A. cinnamomea&lt;/i&gt; also suppressed the expressions of PI3K and phosphorylation of Akt. Furthermore, treatment of CL1-5 cells with inhibitors specific for PI3K (LY 294002), ERK1/2 (PD98059), JNK (SP600125), and p38 MAPK (SB203580) decreased the expression of MMP-2 and MMP-9. This is the first paper confirming the antimigration activity of this potentially beneficial mushroom against human lung adenocarcinoma CL1-5 cancer cells."/><meta name="twitter:description" content="Cancer metastasis is a primary cause of cancer death. &lt;i&gt;Antrodia cinnamomea&lt;/i&gt; (&lt;i&gt;A. cinnamomea&lt;/i&gt;), a medicinal mushroom in Taiwan, has shown antioxidant and anticancer activities. In this study, we first observed that ethanol extract of fruiting bodies of &lt;i&gt;A. cinnamomea&lt;/i&gt; (EEAC) exerted a concentration-dependent inhibitory effect on migration and motility of the highly metastatic CL1-5 cells in the absence of cytotoxicity. The results of a gelatin zymography assay showed that &lt;i&gt;A. cinnamomea&lt;/i&gt; suppressed the activities of matrix metalloproteinase-(MMP-) 2 and MMP-9 in a concentration-dependent manner. Western blot results demonstrated that treatment with &lt;i&gt;A. cinnamomea&lt;/i&gt; decreased the expression of MMP-9 and MMP-2; while the expression of the endogenous inhibitors of these proteins, that is, tissue inhibitors of MMP (TIMP-1 and TIMP-2) increased. Further investigation revealed that &lt;i&gt;A. cinnamomea&lt;/i&gt; suppressed the phosphorylation of ERK1/2, p38, and JNK1/2. &lt;i&gt;A. cinnamomea&lt;/i&gt; also suppressed the expressions of PI3K and phosphorylation of Akt. Furthermore, treatment of CL1-5 cells with inhibitors specific for PI3K (LY 294002), ERK1/2 (PD98059), JNK (SP600125), and p38 MAPK (SB203580) decreased the expression of MMP-2 and MMP-9. This is the first paper confirming the antimigration activity of this potentially beneficial mushroom against human lung adenocarcinoma CL1-5 cancer cells."/><meta name="citation_title" content="Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways"/><meta name="citation_author" content="Chen, Ying-Yi"/><meta name="citation_author" content="Liu, Fon-Chang"/><meta name="citation_author" content="Chou, Pei-Yu"/><meta name="citation_author" content="Chien, Yi-Chung"/><meta name="citation_author" content="Chang, Wun-Shaing Wayne"/><meta name="citation_author" content="Huang, Guang-Jhong"/><meta name="citation_author" content="Wu, Chieh-Hsi"/><meta name="citation_author" content="Sheu, Ming-Jyh"/><meta name="citation_journal_title" content="Evidence-Based Complementary and Alternative Medicine"/><meta name="citation_publisher" content="Hindawi"/><meta name="citation_volume" content="2012"/><meta name="citation_year" content="2012"/><meta name="citation_date" content="2012/02/21"/><meta name="citation_online_date" content="2012/02/21"/><meta name="citation_doi" content="https://doi.org/10.1155/2012/378415"/><meta name="citation_issn" content="1741-427X"/><meta name="citation_abstract" content="Cancer metastasis is a primary cause of cancer death. &lt;i&gt;Antrodia cinnamomea&lt;/i&gt; (&lt;i&gt;A. cinnamomea&lt;/i&gt;), a medicinal mushroom in Taiwan, has shown antioxidant and anticancer activities. In this study, we first observed that ethanol extract of fruiting bodies of &lt;i&gt;A. cinnamomea&lt;/i&gt; (EEAC) exerted a concentration-dependent inhibitory effect on migration and motility of the highly metastatic CL1-5 cells in the absence of cytotoxicity. The results of a gelatin zymography assay showed that &lt;i&gt;A. cinnamomea&lt;/i&gt; suppressed the activities of matrix metalloproteinase-(MMP-) 2 and MMP-9 in a concentration-dependent manner. Western blot results demonstrated that treatment with &lt;i&gt;A. cinnamomea&lt;/i&gt; decreased the expression of MMP-9 and MMP-2; while the expression of the endogenous inhibitors of these proteins, that is, tissue inhibitors of MMP (TIMP-1 and TIMP-2) increased. Further investigation revealed that &lt;i&gt;A. cinnamomea&lt;/i&gt; suppressed the phosphorylation of ERK1/2, p38, and JNK1/2. &lt;i&gt;A. cinnamomea&lt;/i&gt; also suppressed the expressions of PI3K and phosphorylation of Akt. Furthermore, treatment of CL1-5 cells with inhibitors specific for PI3K (LY 294002), ERK1/2 (PD98059), JNK (SP600125), and p38 MAPK (SB203580) decreased the expression of MMP-2 and MMP-9. This is the first paper confirming the antimigration activity of this potentially beneficial mushroom against human lung adenocarcinoma CL1-5 cancer cells."/><meta name="citation_fulltext_html_url" content="https://www.hindawi.com/journals/ecam/2012/378415/"/><meta name="citation_pdf_url" content="https://downloads.hindawi.com/journals/ecam/2012/378415.pdf"/><meta name="citation_xml_url" content="https://downloads.hindawi.com/journals/ecam/2012/378415.xml"/><meta name="dc.creator" content="Chen, Ying-Yi"/><meta name="dc.creator" content="Liu, Fon-Chang"/><meta name="dc.creator" content="Chou, Pei-Yu"/><meta name="dc.creator" content="Chien, Yi-Chung"/><meta name="dc.creator" content="Chang, Wun-Shaing Wayne"/><meta name="dc.creator" content="Huang, Guang-Jhong"/><meta name="dc.creator" content="Wu, Chieh-Hsi"/><meta name="dc.creator" content="Sheu, Ming-Jyh"/><meta name="dc.title" content="Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways"/><meta name="dc.description" content="Cancer metastasis is a primary cause of cancer death. &lt;i&gt;Antrodia cinnamomea&lt;/i&gt; (&lt;i&gt;A. cinnamomea&lt;/i&gt;), a medicinal mushroom in Taiwan, has shown antioxidant and anticancer activities. In this study, we first observed that ethanol extract of fruiting bodies of &lt;i&gt;A. cinnamomea&lt;/i&gt; (EEAC) exerted a concentration-dependent inhibitory effect on migration and motility of the highly metastatic CL1-5 cells in the absence of cytotoxicity. The results of a gelatin zymography assay showed that &lt;i&gt;A. cinnamomea&lt;/i&gt; suppressed the activities of matrix metalloproteinase-(MMP-) 2 and MMP-9 in a concentration-dependent manner. Western blot results demonstrated that treatment with &lt;i&gt;A. cinnamomea&lt;/i&gt; decreased the expression of MMP-9 and MMP-2; while the expression of the endogenous inhibitors of these proteins, that is, tissue inhibitors of MMP (TIMP-1 and TIMP-2) increased. Further investigation revealed that &lt;i&gt;A. cinnamomea&lt;/i&gt; suppressed the phosphorylation of ERK1/2, p38, and JNK1/2. &lt;i&gt;A. cinnamomea&lt;/i&gt; also suppressed the expressions of PI3K and phosphorylation of Akt. Furthermore, treatment of CL1-5 cells with inhibitors specific for PI3K (LY 294002), ERK1/2 (PD98059), JNK (SP600125), and p38 MAPK (SB203580) decreased the expression of MMP-2 and MMP-9. This is the first paper confirming the antimigration activity of this potentially beneficial mushroom against human lung adenocarcinoma CL1-5 cancer cells."/><meta name="dc.publisher" content="Hindawi"/><meta name="dc.format" content="text/html"/><meta name="dc.language" content="en"/><meta name="dc.identifier" content="https://doi.org/10.1155/2012/378415"/><meta name="dc.type" content="Research Article"/><meta name="dc.date" content="2012/02/21"/><meta name="dcterms.issued" content="2012/02/21"/><meta name="prism.publicationDate" content="2012/02/21"/><meta name="prism.volume" content="2012"/><meta name="prism.section" content="Research Article"/><meta name="prism.doi" content="https://doi.org/10.1155/2012/378415"/><meta name="prism.issn" content="1741-427X"/><meta name="dc.source" content="Evidence-Based Complementary and Alternative Medicine"/><meta name="prism.publicationName" content="Evidence-Based Complementary and Alternative Medicine"/><meta name="authors" content="Ying-Yi Chen | Fon-Chang Liu | ... | Ming-Jyh Sheu"/><meta name="Author" content="Hindawi"/><meta name="robots" content="index"/><meta name="google-site-verification" content="AxEuDsL7vXGOxRe53-uFhOk2ODN0bbXMeuBy6Pfq4ww"/><script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="fbafd62a-0a4e-4f7b-a04d-56f57fa3d716"></script><link href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/basictable.css" rel="stylesheet" media="none" class="next-head"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/owl.carousel.min.css" media="none" class="next-head"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/owl.theme.default.min.css" media="none" class="next-head"/><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/jquery.js" class="next-head"></script><link rel="preload" type="text/css" href="https://cdn.bibblio.org/rcm/4.24/bib-related-content.min.css" as="style" class="next-head"/><link rel="preload" type="text/css" href="https://cdn.bibblio.org/rcm/4.24/bib-related-content.min.css" as="style" class="next-head"/><script class="next-head">
        (function(w,d,s,l,i){w[l]=w[l]||[];
            w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js', });
            var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';
            j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl
            ;
            f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-MQ4MGW');</script><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/journal_article.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/webpack-8ed9452df514b4d17d80.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/common.833c76e043bbff9f1f05.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_error.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/basic_page.j~be281a1b.25833a967f60c50378e5.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/main-87fc3e527b54e364ead2.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/login.js~stati~9d879864.8fb864f66b07cdcdf10f.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/content_alerts~fb8dc725.93e0b4fc708693fdbfaa.js" as="script"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/css/common.19957fe3.chunk.css"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/css/static/cpr9K8AjZYaP4CWVbtn5c/pages/journal_article.js.bf2397b9.chunk.css"/><style data-styled="NQpXC gnduKR jzXSTA bNmdOy epRoim bUhGXt gjctdt jGJLow kAzjOl ivbKJD fopjOz hbVEoI khbeDd gvAGTV kNoiZu diutvq bqeMOy bMdQcY ldSkVQ cmzomn fJLQxX kuxTps prcY bJcSpM elhyhe fTkdCR jCfZqq EwsTm mkXor dULvrJ dfaOeH jOLhQl TsaZF iiusBg cqhPZs gaRePw dEfJbW eBepOs fSPaCp bVEEaH etauus ctePXh gCIfTO OGgkt dUABlg jUTgTa eujois cQgXqt ewCAZX kdvWPs hAFFGk lkWWFY ehYbwJ legory epgILe kCfRMJ bjwAQR byflLi jXeALb UVThf dDyxFF fkVFlF dzZrgS jLUVhb dVCLgr bBmZJZ ewHMLz bbzREB jknsZc eSvjPB jntdRu iySbrx bCmGAV TdHTO bmMPie fClRDD iomKnj fexZtq eGVCps mBGSe bkiEfx ztvYg cUsFHx duuwge lcOiDF gsmOCv kPshFw kRoxOt jZOxOO eHMFfo XkrFe irNWJI dMuGGA kfDwZY evMkvU fYrLtk fjviok hgKieC cIribm khHUcu exFqMv dbAANp eyHfWh cBTaXT becpDt kbSZJl jzTMLK gbrQxi hRnXob hymroZ cbcyj hmDWcT isgRZA ihmyEq itFKcQ cGuwDn jrsDZP gWTCXQ jGPvPL etzuBr gWgCNb WHkfb ibWUzs kdRRST cHatnS kxdGAZ jHPgUP fXBKFa hNPrIr bnbfTS cYsVdk inBNwS dkutRV hlGpbO filPdg ecHxGW gCiATD eEFYIL dsXEHZ iXKuYd" data-styled-version="4.4.1">
/* sc-component-id: sc-bdVaJa */
.EwsTm{height:200vh;width:100%;position:fixed;z-index:1;background:rgba(255,255,255,0.8);} .EwsTm.isHide{display:none;} @media (min-width:768px) and (max-width:991px){} @media (min-width:992px){.EwsTm{display:none;}}
/* sc-component-id: sc-htpNat */
.bUhGXt{color:black;-webkit-text-decoration:none;text-decoration:none;border-radius:5px;font-size:16px;} .bUhGXt:focus-visible{outline-width:3px;outline-color:#8fc9ff;outline-style:solid;}
/* sc-component-id: sc-bxivhb */
.ivbKJD{display:inline-block;}
/* sc-component-id: sc-ifAKCX */
.fopjOz{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-flex:wrap;-ms-flex:wrap;flex:wrap;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;list-style-type:none;margin:0;padding:0;} .fopjOz li{padding:0 10px;} .fopjOz li a{padding:0;} .fopjOz a{-webkit-transition:border .25s ease-in-out 0s;transition:border .25s ease-in-out 0s;border-bottom:2px solid #fff;border-radius:0;} .fopjOz a:hover{border-bottom:2px solid #9b9b9b;padding-bottom:4px;} .fopjOz .active{border-bottom:2px solid #57a61e;}
/* sc-component-id: sc-EHOje */
.jOLhQl{vertical-align:middle;height:24px;}.TsaZF{vertical-align:middle;height:40px;}.iiusBg{vertical-align:middle;height:16px;}
/* sc-component-id: sc-bZQynM */
.bNmdOy{max-width:1440px;margin:0 auto;width:100%;}
/* sc-component-id: sc-htoDjs */
.khbeDd{vertical-align:middle;font-size:24px;}.gvAGTV{vertical-align:middle;font-size:9px;}.kNoiZu{vertical-align:middle;font-size:16px;}.diutvq{vertical-align:middle;font-size:22px;}.bqeMOy{vertical-align:middle;font-size:20px;}.bMdQcY{vertical-align:middle;font-size:11px;}
/* sc-component-id: sc-fjdhpX */
.jzXSTA{position:fixed;top:0;left:0;right:0;z-index:1000;background:#fff;height:70px;font-size:16px;font-weight:500;border-bottom:1px solid #e3e3e3;-webkit-transition:all 0.5s;transition:all 0.5s;} @media (max-width:991px){.jzXSTA{border-bottom:1px solid #e3e3e3;}} @media (max-width:767px){.jzXSTA{margin-bottom:70px;height:60px;}} .jzXSTA .header__padding{padding:0 20px;box-sizing:border-box;} @media (max-width:991px){.jzXSTA .header__padding{padding:0 0 0 20px;}} .jzXSTA .menu{position:fixed;top:60px;right:0;width:100%;background:white;} @media (max-width:991px){.jzXSTA .menu{z-index:2;}} @media (min-width:768px){.jzXSTA .menu{width:500px;top:70px;}} @media (min-width:991.5px){.jzXSTA .menu{display:none;}} .jzXSTA .menu ul{list-style-type:none;text-align:center;padding:0;margin:0;} @media (min-width:768px){.jzXSTA .menu ul{padding:0;border-left:1px solid #e3e3e3;}} .jzXSTA .menu ul li a{color:#4a4a4a;padding:10px;-webkit-text-decoration:none;text-decoration:none;display:block;border-bottom:1px solid #e3e3e3;} .jzXSTA .menu .button_wrap{width:90%;margin:10px auto;border-radius:5px;border-style:solid;border-width:1px;} @media (min-width:768px){.jzXSTA .menu .button_wrap{display:none;}} .jzXSTA .menu .button__publishing{background-color:#6ba439;color:#fff;border-color:#6ba439;} .jzXSTA .menu .button__login{display:none;background-color:#fff;color:#4D8A17;border-color:#e3e3e3;} .jzXSTA.headerUp{-webkit-transform:translateY(-100%);-ms-transform:translateY(-100%);transform:translateY(-100%);}
/* sc-component-id: sc-jzJRlG */
.jGJLow{-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;} .jGJLow a{padding:10px;} .jGJLow nav{-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} @media (max-width:991px){.jGJLow nav{display:none;}} .jGJLow nav ul{margin-right:16px;} .jGJLow nav ul li a{color:#4a4a4a;padding:10px 0px 4px;margin:0 6px;} @media (max-width:991px){.jGJLow .icon-themeable{border-left:1px solid #e3e3e3;padding:23px 20px;}} @media (max-width:767px){.jGJLow .icon-themeable{padding:18px 20px;}} @media (max-width:767.5px){.jGJLow.mobileButtonFlex{-ms-flex:0 0 51%;-webkit-flex:0 0 51%;-ms-flex:0 0 51%;flex:0 0 51%;max-width:51%;}}
/* sc-component-id: sc-cSHVUG */
.ldSkVQ{display:none;padding:0;background-color:#fff;border:none;height:59px;} @media (min-width:768px){.ldSkVQ{height:69px;}} .ldSkVQ img{box-sizing:content-box;width:28px;padding:17px 20px;} @media (min-width:768px){.ldSkVQ img{padding:22px 20px;}} @media (max-width:991px){.ldSkVQ{display:inline-block;}}
/* sc-component-id: sc-kAzzGY */
.epRoim a{display:inline-block;padding:15px 0;} @media (max-width:767px){.epRoim a{padding:10px 0;}} @media (max-width:767.5px){.epRoim.mobileLogoFlex{-ms-flex:0 0 49%;-webkit-flex:0 0 49%;-ms-flex:0 0 49%;flex:0 0 49%;max-width:49%;}}
/* sc-component-id: sc-chPdSV */
.hbVEoI{border:none;height:50px;background-color:#fff;margin:10px 0 0 17px;position:relative;} @media (max-width:991.5px){.hbVEoI{margin:0 3px 0 16px;padding:0;height:69px;}} @media (max-width:767.5px){.hbVEoI{height:59px;}} .hbVEoI img{box-sizing:content-box;} .hbVEoI .icon__cross{width:24px;height:24px;} @media (min-width:768px){.hbVEoI .icon__cross{padding:23px 20px;}} @media (min-width:992px){.hbVEoI .icon__cross{padding:0px;}}
/* sc-component-id: sc-ckVGcZ */
.gjctdt{vertical-align:middle;height:39px;} @media (max-width:401px){.gjctdt{max-width:100%;}}
/* sc-component-id: sc-jKJlTe */
.inBNwS{background-color:#0d2934;font-size:16px;position:relative;z-index:3;} @media (max-width:991px){.inBNwS{z-index:0;}}
/* sc-component-id: sc-eNQAEJ */
.dkutRV{border-bottom :1px solid;border-color:#828282;padding:29px 40px 30px 40px;} @media (min-width:992px){.dkutRV{padding:40px 40px 40px 35px;}} .dkutRV .primary__footer .mobile{display:block;} .dkutRV .primary__footer .desktop{display:none;} @media (min-width:992px){.dkutRV .primary__footer{-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;}.dkutRV .primary__footer .mobile{display:none;}.dkutRV .primary__footer .desktop{display:block;}} @media (min-width:992px){.dkutRV .col5{-webkit-flex:0 0 18%;-ms-flex:0 0 18%;flex:0 0 18%;max-width:18%;}} .dkutRV address{font-style:inherit;line-height:1.5;font-size:16px;display:none;border-right:1px solid #EBEBEB;} @media (max-width:767px){.dkutRV address{border-bottom:1px solid #E3E3E3;padding-bottom:20px;}} @media (min-width:992px){.dkutRV address{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;margin-right:50px;}} @media (min-width:1200px){.dkutRV address{margin-right:70px;}} .dkutRV address p{margin:0;font-size:14px;} @media (max-width:767px){.dkutRV address p{text-align:center;}} @media (min-width:1200px){.dkutRV address p{font-size:16px;}} .dkutRV nav ul{list-style:none;padding:0;line-height:2;font-size:16px;margin:18px 0 0 0;} .dkutRV nav ul:first-child{margin:0;} @media (min-width:992px){.dkutRV nav ul{margin:0;}} .dkutRV nav ul li{line-height:22px;padding:5px;} .dkutRV nav ul li a{color:#d8d8d8;font-weight:500;display:block;font-size:16px;} .dkutRV nav ul li img{padding:2.5px 0 0 10px;box-sizing:content-box;-webkit-transform:rotate(180deg);-ms-transform:rotate(180deg);transform:rotate(180deg);}
/* sc-component-id: sc-hMqMXs */
.hlGpbO{padding-top:6px;color:#FFFFFF;font-weight:500;margin-bottom:29px;} @media (min-width:992px){.hlGpbO{-webkit-flex:0 0 25%;-ms-flex:0 0 25%;flex:0 0 25%;max-width:-webkit-fit-content;max-width:-moz-fit-content;max-width:fit-content;}}
/* sc-component-id: sc-kEYyzF */
.ecHxGW{margin-right:20px;} .ecHxGW:last-child{margin-right:0;}
/* sc-component-id: sc-kkGfuU */
.filPdg{margin-top:15px;}
/* sc-component-id: sc-iAyFgw */
.gCiATD{line-height:30px;font-size:11px;padding:10px 20px;text-align:center;} .gCiATD .textright{text-align:right;font-weight:500;} @media (max-width:767px){.gCiATD .textright{text-align:center;}} @media (min-width:992px){.gCiATD .textright{font-weight:100;}} .gCiATD a{font-size:13px;color:#fff;}
/* sc-component-id: sc-hSdWYo */
.etauus{display:inline-block;background-color:#fff;color:#4D8A17;border-color:#E3E3E3;width:auto;border-radius:5px;font-size:16px;border-width:1px;border-style:solid;} .etauus:focus-visible{outline-width:3px;outline-color:#8fc9ff;outline-style:solid;}
/* sc-component-id: sc-eHgmQL */
.fTkdCR{font-size:22px;color:#000;} @media (min-width:767.5px){.fTkdCR{font-size:24px;}} @media (min-width:991.5px){.fTkdCR{font-size:25px;}} .fTkdCR:after{content:'';display:inline-block;margin-top:0.2em;margin-left:0.5em;}
/* sc-component-id: sc-iRbamj */
.jZOxOO{font-size:30px;font-weight:500;-webkit-letter-spacing:1px;-moz-letter-spacing:1px;-ms-letter-spacing:1px;letter-spacing:1px;line-height:1;margin-top:0;} @media (min-width:767.5px){.jZOxOO{font-size:40px;}} @media (min-width:991.5px){.jZOxOO{font-size:40px;}} .jZOxOO sup,.jZOxOO sub{vertical-align:baseline;position:relative;top:-10px;} .jZOxOO sub{top:10px;}
/* sc-component-id: sc-Rmtcm */
.hNPrIr{font-size:20px;font-weight:500;margin-top:0;margin-bottom:15px;}
/* sc-component-id: sc-bRBYWo */
.fXBKFa{display:inline-block;} @media (max-width:991.5px){.fXBKFa{width:100%;}} @media (min-width:991.5px){.fXBKFa.hide{display:none !important;}}
/* sc-component-id: sc-hzDkRC */
.bnbfTS{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-flex:wrap;-ms-flex:wrap;flex:wrap;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;list-style-type:none;margin:0;width:100%;padding:0 !important;border-top:1px solid #fff;} .bnbfTS li{width:100%;text-align:center;box-sizing:border-box;padding:17px 0px;min-height:48px;} .bnbfTS li a{display:block;} .bnbfTS .iconBorder{border-right:1px solid #fff;} .bnbfTS img{width:23px;} .bnbfTS img.socialLinkedin{width:28px;} .bnbfTS .wechat-container{position:relative;} .bnbfTS .wechat-container .addthis_inline_share_toolbox{position:absolute;top:0;left:0;width:100%;height:100%;opacity:0 !important;}
/* sc-component-id: sc-jtRfpW */
.OGgkt{background-color:#6BA439;color:#fff;padding:20px;line-height:22px !important;border-radius:0;border-top:1px solid #fff;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;min-height:60px;} .OGgkt img{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .OGgkt span{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .OGgkt span.text{padding-left:20px;font-weight:500;} @media (max-width:360px){.OGgkt span.text{padding-left:5px;font-size:14px;}} @media (min-width:320px) and (max-width:767.5px){.OGgkt span.text{padding-left:20px;}}.dUABlg{background-color:#F2F2F2;color:#4A4A4A;padding:20px;line-height:22px !important;border-radius:0;border-top:1px solid #E3E3E3;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;min-height:60px;} .dUABlg img{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .dUABlg span{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .dUABlg span.text{padding-left:20px;font-weight:500;} @media (max-width:360px){.dUABlg span.text{padding-left:5px;font-size:14px;}} @media (min-width:320px) and (max-width:767.5px){.dUABlg span.text{padding-left:20px;}}
/* sc-component-id: sc-kTUwUJ */
.eujois{width:20px;}
/* sc-component-id: sc-dqBHgY */
.cQgXqt{width:20px;height:16px;color:#6ba439;}
/* sc-component-id: sc-cbkKFq */
.kuxTps{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;position:fixed;top:60px;} @media (min-width:767.5px){.kuxTps{position:fixed;top:70px;}} @media (min-width:991.5px){.kuxTps{position:fixed;top:70px;}}.prcY{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;top:0px;} @media (min-width:767.5px){.prcY{top:0px;}} @media (min-width:991.5px){.prcY{position:fixed;top:241px;}}
/* sc-component-id: sc-hGoxap */
.dEfJbW{position:relative;background:#007d8d;} @media (max-width:991px){.dEfJbW{z-index:2;}} @media (min-width:767.5px) and (max-width:991.5px){.dEfJbW{width:50%;}} @media (min-width:991.5px){.dEfJbW{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;border-top:1px solid white;}} .dEfJbW.isHide{display:none;} @media (min-width:991.5px){.dEfJbW.isHide{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}} .dEfJbW .submit__button{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;box-shadow:0 2px 4px rgba(0,0,0,.5);padding:0 20px;min-height:45px;} .dEfJbW .submit__button span.text{font-size:16px;} .dEfJbW .submit__button img{width:20px;} @media (min-width:767.5px){.dEfJbW .submit__button{min-height:58px;}.dEfJbW .submit__button img{width:22px;}} @media (min-width:991.5px){.dEfJbW .submit__button{display:none;}}
/* sc-component-id: sc-fjmCvl */
.fSPaCp{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;font-size:16px;font-weight:500;color:#fff;background-color:#007d8d;line-height:20px;padding:10px 20px;border:0;border-radius:0;border-top:1px solid #fff;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;margin:0;} @media (min-width:767.5px){.fSPaCp{padding:16px 20px;}} @media (min-width:991.5px){.fSPaCp{border-top:none;border-right:1px solid #fff;padding:14.5px 15px;font-size:14px;}} @media (min-width:1200px){.fSPaCp{padding:14.5px 20px;font-size:16px;}} .fSPaCp .icon__inactive{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.fSPaCp .icon__inactive{-webkit-transform:rotateZ(0);-ms-transform:rotateZ(0);transform:rotateZ(0);}} .fSPaCp.button__active{background:#fff;color:#4A4A4A;} @media (min-width:767.5px) and (max-width:991.5px){.fSPaCp.button__active{border-right:1px solid #007f8f;}} .fSPaCp .icon__active{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.fSPaCp .icon__active{-webkit-transform:rotate(0);-ms-transform:rotate(0);transform:rotate(0);}} .fSPaCp .icon__hidden{display:none;}.bVEEaH{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;font-size:16px;font-weight:500;color:#fff;background-color:#007d8d;line-height:20px;padding:10px 20px;border:0;border-radius:0;border-top:1px solid #fff;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;margin:0;} @media (min-width:767.5px){.bVEEaH{padding:16px 20px;}} @media (min-width:991.5px){.bVEEaH{border-top:none;border-right:0;padding:14.5px 15px;font-size:14px;}} @media (min-width:1200px){.bVEEaH{padding:14.5px 20px;font-size:16px;}} .bVEEaH .icon__inactive{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.bVEEaH .icon__inactive{-webkit-transform:rotateZ(0);-ms-transform:rotateZ(0);transform:rotateZ(0);}} .bVEEaH.button__active{background:#fff;color:#4A4A4A;} @media (min-width:767.5px) and (max-width:991.5px){.bVEEaH.button__active{border-right:1px solid #007f8f;}} .bVEEaH .icon__active{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.bVEEaH .icon__active{-webkit-transform:rotate(0);-ms-transform:rotate(0);transform:rotate(0);}} .bVEEaH .icon__hidden{display:none;}
/* sc-component-id: sc-TFwJa */
.gCIfTO{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;font-size:16px;font-weight:500;color:#fff;background-color:#007d8d;line-height:20px;padding:10px 20px;border:0;border-radius:0;border-top:1px solid #fff;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;} @media (min-width:767.5px){.gCIfTO{padding:16px 20px;}} @media (min-width:991.5px){.gCIfTO{-webkit-transition:all 0.25s;transition:all 0.25s;border-top:none;border-right:1px solid #fff;border-left:0;padding:14.5px 30px 14.5px 20px;width:calc(100% / 6);font-size:14px;}.gCIfTO:hover{background:#fff;color:#4A4A4A;}} @media (min-width:1200px){.gCIfTO{font-size:16px;}}
/* sc-component-id: sc-bHwgHz */
.ctePXh{width:18px;margin-right:-4px;} @media (min-width:991.5px){.ctePXh{width:7px;font-size:7px;}} @media (min-width:1200px){.ctePXh{width:18px;}}
/* sc-component-id: sc-krDsej */
.ewCAZX{position:absolute;top:0;width:calc(100% - 20px);right:0;bottom:0;background:#fff;-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;min-height:290px;box-shadow:0 2px 4px rgba(0,0,0,0.5);} .ewCAZX.hide__submenu{-webkit-transform:translateX(100%);-ms-transform:translateX(100%);transform:translateX(100%);} @media (min-width:767.5px){.ewCAZX.hide__submenu{-webkit-transform:translateX(-200%);-ms-transform:translateX(-200%);transform:translateX(-200%);}} @media (min-width:767.5px){.ewCAZX{left:100%;width:100%;padding-top:20px;z-index:-1;min-height:375px;}} @media (min-width:991.5px){.ewCAZX{display:none;}}
/* sc-component-id: sc-dTdPqK */
.lkWWFY{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;display:none;} @media (min-width:991.5px){.lkWWFY.hide__submenu{-webkit-transform:translateY(-300%);-ms-transform:translateY(-300%);transform:translateY(-300%);}} @media (min-width:991.5px){.lkWWFY{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;height:186px;top:49px;left:0;position:absolute;right:0;background:#fff;z-index:-1;box-shadow:0 4px 6px rgba(0,0,0,0.21);}}
/* sc-component-id: sc-itybZL */
.kdvWPs{font-weight:700;border:0;color:#4A4A4A;padding:10px 0;background-color:#fff;font-size:16px;line-height:20px;} .kdvWPs:focus-visible{outline-width:3px;outline-color:#8fc9ff;outline-style:solid;} @media (min-width:767.5px){.kdvWPs{display:none;}}
/* sc-component-id: sc-fzsDOv */
.hAFFGk{margin:0px 10px 2px 20px;-webkit-transform:rotate(90deg);-ms-transform:rotate(90deg);transform:rotate(90deg);display:inline-block;}
/* sc-component-id: sc-gPWkxV */
.legory{width:50%;}
/* sc-component-id: sc-jVODtj */
.epgILe{color:#007B8B;width:50%;font-size:16px;line-height:26px;margin:auto;padding:0 6%;}
/* sc-component-id: sc-kUaPvJ */
.ehYbwJ{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:50%;padding:24.5px 2% 0;-webkit-order:0;-ms-flex-order:0;order:0;} @media (min-width:1024px){.ehYbwJ{padding:24.5px 3% 0;}}
/* sc-component-id: sc-giadOv */
.eBepOs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;} @media (min-width:991.5px){.eBepOs{width:calc(100% / 6);}.eBepOs:first-child{border-left:none;}}
/* sc-component-id: sc-fONwsr */
.kCfRMJ{background-color:#D8D8D8;position:absolute;left:50%;display:inline-block;height:121px;width:2px;top:33px;}
/* sc-component-id: sc-LKuAh */
.lcOiDF{padding:0;margin:10px 0 25px 0;}
/* sc-component-id: sc-iBEsjs */
.kPshFw{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;border:none;font-size:12px;font-weight:500;margin-top:7px;padding:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .kPshFw:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media (min-width:767.5px){.kPshFw{margin-top:10px;}}
/* sc-component-id: sc-hzNEM */
.gsmOCv{overflow-y:hidden;height:auto;max-height:100%;-webkit-transition:all .5s;transition:all .5s;background-color:#F2F2F2;padding:0 16px;} .gsmOCv.isHide{max-height:0;-webkit-transition:all .5s;transition:all .5s;} .gsmOCv p{font-size:14px;line-height:22px;} .gsmOCv sup{margin-top:-5px;}
/* sc-component-id: sc-chbbiW */
.mBGSe{padding:0;}
/* sc-component-id: sc-kZmsYB */
.bkiEfx{font-size:14px;font-weight:700;line-height:16px;-webkit-letter-spacing:0.58px;-moz-letter-spacing:0.58px;-ms-letter-spacing:0.58px;letter-spacing:0.58px;margin:23px 0 0px !important;} @media (min-width:767.5px){.bkiEfx{margin:34px 0 0px !important;}} @media (min-width:991.5px){.bkiEfx{margin:-4px 0 0 !important;}}
/* sc-component-id: sc-RcBXQ */
.ztvYg{font-size:14px;line-height:22px;} .ztvYg a{color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .ztvYg a:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: sc-iSDuPN */
@font-face{font-family:'STIXGeneral-Bold';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Bold.otf');font-weight:normal;font-style:normal;} .kRoxOt{font-weight:700;font-family:STIXGeneral-Bold;margin:19px 0 22px;font-size:25px;line-height:28px;-webkit-letter-spacing:normal;-moz-letter-spacing:normal;-ms-letter-spacing:normal;letter-spacing:normal;} @media (min-width:767.5px){.kRoxOt{font-size:25px;margin:20px 0 23px;}} @media (min-width:991.5px){.kRoxOt{font-size:30px;line-height:34px;margin:19px 0 22px;}} .kRoxOt p{margin:0;}
/* sc-component-id: sc-fZwumE */
.cUsFHx{padding:0 3px;}
/* sc-component-id: sc-fQejPQ */
.duuwge{font-size:14px;} .duuwge:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: sc-jtRlXQ */
@font-face{font-family:'STIXGeneral-Regular';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Regular.otf');font-weight:normal;font-style:normal;} @font-face{src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Regular.otf');font-weight:normal;font-style:normal;} @font-face{font-family:'STIXGeneral-Regular';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Regular.otf');font-weight:normal;font-style:normal;} .exFqMv{font-family:STIXGeneral-Regular;text-align:justify;} .exFqMv a{word-break:break-all;} .exFqMv h4:first-of-type{border-top:0px solid #E3E3E3;padding-top:0;} .exFqMv h4{font-size:20px;font-family:"IBM Plex Sans",sans-serif;border-top:1px solid #E3E3E3;padding-top:23px;margin-top:15px;margin-bottom:-3px;} .exFqMv h4#abstract{margin-top:-7px;margin-bottom:-3px;} @media (min-width:767.5){.exFqMv h4#abstract{margin-top:-6px;}} @media (min-width:991.5px){.exFqMv h4#abstract{margin-top:34px;}} .exFqMv h4.references,.exFqMv h4.copyright{border-top:1px solid #E3E3E3;padding-top:23px;} .exFqMv h4.references{margin-bottom:-8px;} .exFqMv h5,.exFqMv h6{margin:22px 0;font-size:16px;word-break:break-word;} .exFqMv h6{margin:25px 0;text-align:left;} .exFqMv p{font-size:16px;word-break:break-word;} .exFqMv .floats-partial-section{border:1px solid #E3E3E3;margin:25px auto;} @media (max-width:767px){.exFqMv .floats-partial-section{margin:0 auto;overflow-x:hidden;}} .exFqMv .floats-partial-section .floats-partial-content{padding:19px 0px 19px 0px;height:254px;width:96%;overflow:hidden;margin:0 auto;position:relative;cursor:pointer;} .exFqMv .floats-partial-section .floats-partial-content table{margin:0 auto;} .exFqMv .floats-partial-section .floats-partial-content .table-group{width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;} .exFqMv .floats-partial-section .floats-partial-content .table-group table{width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;} .exFqMv .floats-partial-section .floats-partial-content .table-group table object{z-index:-1;position:relative;} .exFqMv .floats-partial-section .floats-partial-content .table-group table td{padding:4px 7px;} .exFqMv .floats-partial-section .floats-partial-content .table-group table td.align_left{text-align:left;} .exFqMv .floats-partial-section .floats-partial-content .table-group table td.align_center{text-align:center;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-content{padding:22px 0px 0 0px;height:197px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-content{padding:23px 0px 13px 0px;height:215px;}} .exFqMv .floats-partial-section .floats-partial-content:after{content:"";height:20%;position:absolute;bottom:0;right:0;left:0;background:-moz-linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);background:-webkit-gradient(linear,left top,right top,color-stop(0%,rgba(255,255,255,.7)),color-stop(56%,rgba(255,255,255,.7)),color-stop(100%,rgba(255,255,255,.7)));background:-webkit-linear-gradient(rgba(255,255,255,0) 0%,rgba(255,255,255,0.5) 30%,rgba(255,255,255,0.7) 56%,rgba(255,255,255,0.9) 75%,rgba(255,255,255,1) 100%);background:-o-linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);background:-ms-linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);background:linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);-webkit-filter:progid:DXImageTransform.Microsoft.gradient( startColorstr='#00ffffff',endColorstr='#ffffff',GradientType=1 );filter:progid:DXImageTransform.Microsoft.gradient( startColorstr='#00ffffff',endColorstr='#ffffff',GradientType=1 );} .exFqMv .floats-partial-section .floats-partial-footer{background-color:#F2F2F2;border-top:1px solid #E3E3E3;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .minimize_btn{-webkit-flex:1;-ms-flex:1;flex:1;background:url('data:image/svg+xml;base64,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') no-repeat 6px;background-position:center;margin-top:10px;min-width:55px;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .minimize_btn{display:none;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .expand_btn{-webkit-flex:1;-ms-flex:1;flex:1;background:url('data:image/svg+xml;base64,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') no-repeat 6px;background-position:center;margin-top:10px;min-width:55px;display:none;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .expand_btn{display:none;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-text{-webkit-flex:9;-ms-flex:9;flex:9;text-align:left;padding:21px 37px 10px 0px;font-size:16px;font-weight:700;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-text{padding:19px 18px 10px 18px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-text{padding:19px 21px 10px 21px;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{-webkit-flex:1;-ms-flex:1;flex:1;background:url('data:image/svg+xml;base64,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') no-repeat 6px;background-position:center;padding:16px 0 16px 0;min-width:62px;max-width:62px;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{padding:16px 0 17px 0;min-width:52px;max-width:52px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{padding:15px 0 17px 0;min-width:60px;max-width:60px;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url:hover{-webkit-text-decoration:none;text-decoration:none;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text{font-size:14px;padding:0px 18px 17px 22px;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text{padding:0px 15px 15px 18px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text{padding:0px 18px 19px 21px;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text figcaption{margin:0;padding:0;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text svg{max-width:100%;} .exFqMv ol{font-size:16px;padding-left:32px;font-family:STIXGeneral-Regular;line-height:24px;margin:15px 0;} .exFqMv ol li{margin:10px 0;padding-left:10px;word-break:normal;} .exFqMv ol li a{word-break:break-all;} .exFqMv ol li .reflinks{display:block;} .exFqMv ol li .reflinks a{color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .exFqMv ol li .reflinks a:hover{-webkit-text-decoration:underline;text-decoration:underline;} .exFqMv ol li .reflinks .sep{color:#000000;} .exFqMv .table-wrapper{width:auto;overflow-x:auto;} .exFqMv .table-wrapper::-webkit-scrollbar{-webkit-appearance:none;width:5px;height:5px;} .exFqMv .table-wrapper::-webkit-scrollbar-thumb{border-radius:5px;background-color:rgba(0,0,0,.5);-webkit-box-shadow:0 0 1px rgba(255,255,255,.5);} @media (min-width:768px){.exFqMv .table-wrapper{overflow-x:auto;width:auto;-webkit-break-word:word-break;break-word:word-break;margin:0 auto;}} @media (min-width:992px){.exFqMv .table-wrapper{width:auto;}} @media (min-width:1324px){.exFqMv .table-wrapper{width:auto;}} @media (min-width:320px){.exFqMv{margin-bottom:33px;padding:0;}} @media (min-width:992px){.exFqMv{padding:0;margin-bottom:100px;}} @media (min-width:1325px){.exFqMv{margin-bottom:100px;}} .exFqMv .owl-stage{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;} .exFqMv .floats-partial-middle--thumbs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot svg{fill:#4D8A17;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot strong{color:#4D8A17;font-weight:500;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot.active strong{color:#007B8B;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot.active svg{fill:#007B8B;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot .nowrap{white-space:nowrap;} .exFqMv .partial-carousel-dot{text-align:center;cursor:pointer;border:0;width:100px;padding-bottom:20px;background-color:#fff;display:table-cell;} .exFqMv .partial-carousel-dot:focus-visible{outline-offset:-3px;} .exFqMv .partial-carousel-dot strong{font-size:11px;padding-top:12px;} @media (min-width:767.5px){.exFqMv .partial-carousel-dot strong{font-size:16px;}} .exFqMv .partial-carousel-dot img{width:90px;height:90px;border:1px solid #979797;margin:10px 0;} .exFqMv .partial-carousel-wrapper .floats-partial-middle{border-top:1px solid #e3e3e3;display:block;margin-bottom:50px;padding-top:1px;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-middle{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;margin-bottom:0;}} .exFqMv .partial-carousel--single-image{overflow:hidden;text-align:center;} .exFqMv .partial-carousel--single-image img{width:100%;max-height:239px;height:auto;} @media (min-width:767.5px){.exFqMv .partial-carousel--single-image img{max-height:357px;}} @media (min-width:991.5px){.exFqMv .partial-carousel--single-image img{max-height:417px;}} .exFqMv .partial-carousel--single-image strong{font-size:11px;padding-top:12px;} @media (min-width:767.5px){.exFqMv .partial-carousel--single-image strong{font-size:16px;}} .exFqMv .owl-nav,.exFqMv .owl-dots{display:none;} .exFqMv .partial-carousel-wrapper .owl-loaded{position:relative;height:auto;max-height:287px;} @media (min-width:767.6px){.exFqMv .partial-carousel-wrapper .owl-loaded{max-height:414px;}} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .owl-loaded{max-height:477px;}} .exFqMv .partial-carousel-wrapper .floats-partial-content,.exFqMv .owl-stage-outer,.exFqMv .owl-stage{max-height:287px;height:auto;} @media (min-width:767.6px){.exFqMv .partial-carousel-wrapper .floats-partial-content,.exFqMv .owl-stage-outer,.exFqMv .owl-stage{max-height:414px;}} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-content,.exFqMv .owl-stage-outer,.exFqMv .owl-stage{max-height:477px;}} .exFqMv .partial-carousel-wrapper .floats-partial-content::after,.exFqMv .owl-stage-outer::after,.exFqMv .owl-stage::after{background:transparent;} .exFqMv .partial-carousel-wrapper .floats-partial-middle--thumbs{width:100%;overflow-x:auto;-webkit-align-items:self-start;-webkit-box-align:self-start;-ms-flex-align:self-start;align-items:self-start;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-middle--thumbs{width:calc(100% - 110px);}} .exFqMv .partial-carousel-wrapper .floats-partial-middle--nav{width:100%;position:relative;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-middle--nav{width:20%;}} .exFqMv .floats-partial-middle{position:relative;} .exFqMv .partial-carousel-wrapper .carousel-prev{background:url('data:image/svg+xml;base64,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') no-repeat 17.5px;height:50px;width:61px;display:inline-block;border:0;border-right:1px solid #E3E3E3;padding:0;cursor:pointer;background-position-y:54.35%;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .carousel-prev{width:51px;background-position-x:8px;}} @media (min-width:991.5px){.exFqMv .partial-carousel-wrapper .carousel-prev{width:59px;background-position-x:16px;}} .exFqMv .partial-carousel-wrapper .carousel-next{background:url('data:image/svg+xml;base64,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') no-repeat 18.5px;height:52px;width:61px;display:inline-block;padding:0px;cursor:pointer;border:0;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .carousel-next{width:51px;}} @media (min-width:991.5px){.exFqMv .partial-carousel-wrapper .carousel-next{width:59px;}} .exFqMv .partial-carousel-wrapper .partial-carousel-next-prev{position:absolute;right:0;bottom:-50px;height:50px;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .partial-carousel-next-prev{bottom:0;}} .exFqMv .partial-carousel-wrapper .floats-partial-content{padding:12px;} .exFqMv .partial-carousel-wrapper .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{border-left:none;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-content{display:none;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer{background-image:url(https://w2o-xhtml-parsed-preprod.s3-eu-west-1.amazonaws.com/table_thumb.svg);background-repeat:no-repeat;background-position:17px 17px;background-size:100px 70px;border-top:none;min-height:110px;position:relative;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .table-thumb-overlay{cursor:pointer;position:absolute;left:17px;top:17px;height:70px;width:100px;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text{padding-left:137px;padding-right:0px;position:relative;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text .caption-text-overlay{cursor:pointer;position:absolute;top:20px;left:135px;height:20px;width:60px;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .floats-partial-caption-text{color:black;display:block !important;-webkit-text-decoration:none;text-decoration:none;width:auto;margin-left:140px;margin-right:20px;padding:0px 0px 15px 0px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .minimize_btn{display:none !important;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .expand_btn{display:none !important;} @media (max-width:567px){.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer{background-size:60px 45px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .table-thumb-overlay{height:45px;width:60px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text{padding:30px 0px 15px 95px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text .caption-text-overlay{top:30px;left:95px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .floats-partial-caption-text{margin:0px 20px;}} .exFqMv .owl-item{overflow-y:hidden;margin-bottom:0;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;} .exFqMv .supplementary--docs{display:-ms-flexbox;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-ms-flex-wrap:wrap;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;padding-left:2em;} @media (min-width:767.5px){.exFqMv .supplementary--docs{padding-left:1em;}} .exFqMv .supplementary--docs li{-ms-flex:0 0 100%;-webkit-flex:0 0 100%;-ms-flex:0 0 100%;flex:0 0 100%;max-width:100%;} @media (min-width:991.5px){.exFqMv .supplementary--docs li{-ms-flex:0 0 50%;-webkit-flex:0 0 50%;-ms-flex:0 0 50%;flex:0 0 50%;max-width:50%;}} .exFqMv .supplementary--docs li a::after{content:'';background :url(data:image/svg+xml;base64,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) no-repeat 5px;padding-right:35px;background-size:14px;} .exFqMv .dataset-section .supplementary--dpis-desc{padding-left:19px;} .exFqMv .dataset-section .supplementary--dpis-desc p{margin:10px 0;} .exFqMv .table-group.fixed-width,.exFqMv .table-group.sidewaystable{min-width:auto;} .exFqMv .noliststyle{padding-left:1em;} .exFqMv .noliststyle li{padding-left:0;} .exFqMv .xml-content > hr{display:none;} .exFqMv sup,.exFqMv sub{vertical-align:baseline;position:relative;top:5px;} .exFqMv sup{top:-5px;} @media (min-width:767.5px){.exFqMv a{position:relative;}} .exFqMv a div.tooltip{cursor:auto;position:absolute;width:280px;background:#fff;border:1px solid #adadad;padding:20px;margin:0;display:none;z-index:2;color:#000;} @media (min-width:767.5px){.exFqMv a div.tooltip{width:400px;}} @media (min-width:991.5px){.exFqMv a div.tooltip{width:572px;}} .exFqMv a div.tooltip .cross{position:absolute;right:10px;top:10px;display:block;height:14px;width:14px;cursor:pointer;} .exFqMv a div.tooltip ol{margin:0;padding:0 0 10px 20px;} .exFqMv a div.tooltip ol li{text-align:left;margin:0;} .exFqMv a div.tooltip.left{left:20px;} @media (min-width:767.5px){.exFqMv a div.tooltip.left{left:-20px;}} @media (min-width:991.5px){.exFqMv a div.tooltip.left{left:-100px;}} .exFqMv a div.tooltip.right{right:20px;} @media (min-width:767.5px){.exFqMv a div.tooltip.right{right:-20px;}} @media (min-width:991.5px){.exFqMv a div.tooltip.right{right:-100px;}} .exFqMv a div.tooltip a.seeRef{padding-left:30px;} .exFqMv .gloss-abbr tr td:first-child{white-space:nowrap;} .exFqMv table.algorithm td{word-break:keep-all;} .exFqMv h4#copyright + p a{word-break:break-word;}
/* sc-component-id: sc-bGbJRg */
.dVCLgr{width:100%;} @media (min-width:991.5px){.dVCLgr{width:19%;}} @media (min-width:1280px){.dVCLgr{width:24%;max-width:350px;}} .dVCLgr p{border:1px solid #E3E3E3;}
/* sc-component-id: sc-bEjcJn */
.jLUVhb{-webkit-flex:1 0 30%;-ms-flex:1 0 30%;flex:1 0 30%;list-style:none;padding:0;-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;} @media (min-width:320px) and (max-width:991.5px){.jLUVhb{position:fixed;width:100%;z-index:2;margin:0;margin-top:50px;top:169px;max-height:calc(100vh - 165px);overflow-y:auto;}} @media (min-width:767.5px) and (max-width:991.5px){.jLUVhb{top:179px;}} @media (min-width:991.5px) and (max-width:1200px){.jLUVhb{max-width:354px;-webkit-flex:1 0 20%;-ms-flex:1 0 20%;flex:1 0 20%;}} @media (min-width:1200px){.jLUVhb{-webkit-flex:1 0 25%;-ms-flex:1 0 25%;flex:1 0 25%;max-width:354px;}} .jLUVhb p{margin:0;padding:10px 0;font-size:16px;font-weight:700;line-height:24px;display:none;} @media (min-width:991.5px){.jLUVhb p{display:block;padding:10px 20px;border:1px solid #E3E3E3;border-bottom:0;}} .jLUVhb.links__hidden{display:none;} @media (min-width:991.5px){.jLUVhb.links__hidden{display:block;}} .jLUVhb.translate{-webkit-transform :translateY(-120px);-ms-transform :translateY(-120px);transform :translateY(-120px);} @media (min-width:768px){.jLUVhb.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}} @media (min-width:991.5px){.jLUVhb.translate{-webkit-transform:none;-ms-transform:none;transform:none;}.jLUVhb.translate #leftSectionMenu{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}}
/* sc-component-id: sc-ePZHVD */
.ewHMLz{color:#4A4A4A;}
/* sc-component-id: sc-likbZx */
.bBmZJZ{font-size:16px;font-weight:500;line-height:20px;color:#4A4A4A;border:1px solid #E3E3E3;border-bottom:0;background-color:#f2f2f2;display:list-item;} @media (min-width:991px){.bBmZJZ{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.bBmZJZ:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} .bBmZJZ:last-child{border-bottom:1px solid #E3E3E3;} .bBmZJZ a{display:block;padding:10px 20px;}
/* sc-component-id: sc-eKZiaR */
.dzZrgS{position:fixed;width:100%;height:50px;color:#4D8A17;background-color:#F2F2F2;border:none;font-size:16px;line-height:18px;font-weight:500;z-index:2;top:170px;-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;text-align:left;border-top:1px solid #FFFFFF;} @media (min-width:320px) and (max-width:991.5px){.dzZrgS{padding-left:15px;border-bottom:4px solid #FFFFFF;}.dzZrgS.is-open{border-bottom:4px solid #F2F2F2;}} @media (min-width:767.5px){.dzZrgS{top:179px;}} @media (min-width:991.5px){.dzZrgS{display:none;}} .dzZrgS .icon__dots{cursor:pointer;-webkit-transform:rotate(90deg) translateY(8px);-ms-transform:rotate(90deg) translateY(8px);transform:rotate(90deg) translateY(8px);margin-right:15px;} @media (min-width:991.5px){.dzZrgS .icon__dots{padding-right:20px;margin-bottom:2px;-webkit-transform:none;-ms-transform:none;transform:none;}} .dzZrgS.translate{-webkit-transform :translateY(-120px);-ms-transform :translateY(-120px);transform :translateY(-120px);top:170px;} @media(min-width:991.5px){.dzZrgS.translate{-webkit-transform :translateY(-130px) rotate(90deg);-ms-transform :translateY(-130px) rotate(90deg);transform :translateY(-130px) rotate(90deg);}}
/* sc-component-id: sc-jrIrqw */
.eHMFfo{padding:0;margin:20px 0;} .eHMFfo span{font-size:14px;} .eHMFfo span.isHide{display:none;} .eHMFfo span i{font-style:italic;} .eHMFfo span i.isHide{display:none;}
/* sc-component-id: sc-hjRWVT */
.irNWJI{width:16px;margin:0 2px 2px;}
/* sc-component-id: sc-iQtOjA */
.kfDwZY{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;border:none;font-size:12px;font-weight:500;margin-top:7px;padding:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .kfDwZY:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media (min-width:767.5px){.kfDwZY{margin-top:5px;}}
/* sc-component-id: sc-fHxwqH */
.dMuGGA{overflow-y:hidden;height:auto;max-height:100%;-webkit-transition:all .5s;transition:all .5s;} .dMuGGA.isHide{max-height:0;-webkit-transition:all .5s;transition:all .5s;} .dMuGGA p:first-child{margin-top:15px;} .dMuGGA p{font-size:14px;line-height:23px;display:block;} .dMuGGA sup{margin-top:-5px;}
/* sc-component-id: sc-cEvuZC */
.XkrFe{border:none;border-top:1px solid #E3E3E3;height:2px;margin:15px 0;} .XkrFe.hr__author{margin-bottom:12px;}
/* sc-component-id: sc-cBdUnI */
@media (min-width:320px) and (max-width:991.5px){.hRnXob{display:none;}} @media (min-width:991.5px){.hRnXob{z-index:1;}}
/* sc-component-id: sc-exkUMo */
.hymroZ{background-color:#6ba339;color:#ffffff;display:none;} .hymroZ span.text{padding-left:20px;} @media (min-width:991px){.hymroZ{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.hymroZ:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}}
/* sc-component-id: sc-kcDeIU */
.cbcyj{background-color:#f2f2f2;color:#4a4a4a;display:none;} .cbcyj span.text{padding-left:20px;} @media (min-width:991.5px) and (max-width:1279.5px){.cbcyj{display:none !important;}} @media (min-width:991px){.cbcyj{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.cbcyj:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.cbcyj.hide{display:none !important;}}
/* sc-component-id: sc-BngTV */
.hmDWcT{background-color:#f2f2f2;color:#4a4a4a;display:none;} .hmDWcT span.text{padding-left:20px;} @media (min-width:1279.5px){.hmDWcT{display:none !important;}} @media (min-width:991px){.hmDWcT{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.hmDWcT:hover{background-color :#5D9230;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.hmDWcT.hide{display:none !important;}}
/* sc-component-id: sc-hBbWxd */
.kdRRST{background-color:#f2f2f2;border-top:1px solid #ffffff;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;font-size:14px;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;padding:20px 55px 20px 25px;} @media (max-width:1279.5px){.kdRRST{padding-right:20px;}} @media (max-width:991.5px){.kdRRST{display:none;}}
/* sc-component-id: sc-dyGzUR */
.cHatnS div{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;} .cHatnS div:last-of-type{padding-top:20px;} .cHatnS span{color:#4F4F4F;font-size:20px;font-weight:700;line-height:26px;}
/* sc-component-id: sc-drKuOJ */
.kxdGAZ{-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column-reverse;-ms-flex-direction:column-reverse;flex-direction:column-reverse;height:100%;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;} .kxdGAZ span{padding-top:15px;}
/* sc-component-id: sc-cTjmhe */
@media (min-width:991.5px){.ihmyEq{width:100%;z-index:1;}}
/* sc-component-id: sc-cugefK */
.itFKcQ{background-color:#F2F2F2;color:#4A4A4A;border-top:1px solid #FFFFFF;font-size:16px;font-weight:500;padding:20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;cursor:pointer;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;} @media (min-width:991px){.itFKcQ{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.itFKcQ:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.itFKcQ.hide{display:none !important;}} .itFKcQ.active .icon-themeable{-webkit-transform:rotate(180deg);-ms-transform:rotate(180deg);transform:rotate(180deg);}
/* sc-component-id: sc-fnwBNb */
.etzuBr{display:none;}
/* sc-component-id: sc-iNhVCk */
.gWgCNb{background-color:#f2f2f2;border-radius:0;border-top:1px solid #e3e3e3;font-size:16px;color:#4a4a4a;font-weight:500;padding:11px 20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;} @media (min-width:991px){.gWgCNb{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.gWgCNb:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}}
/* sc-component-id: sc-eAKXzc */
.WHkfb{-webkit-flex:1 0 90%;-ms-flex:1 0 90%;flex:1 0 90%;padding-left:50px;} @media (min-width:767.5px){.WHkfb{padding-left:93px;}} @media (min-width:991.5px){.WHkfb{padding-left:50px;}}
/* sc-component-id: sc-bfYoXt */
.cGuwDn{width:20px;height:24px;}
/* sc-component-id: sc-gbOuXE */
.jGPvPL{width:22px;height:21px;padding:2px;}
/* sc-component-id: sc-dRFtgE */
.jrsDZP{-webkit-flex:1 0 80%;-ms-flex:1 0 80%;flex:1 0 80%;padding-left:26px;} @media (min-width:767.5px){.jrsDZP{padding-left:69px;}} @media (min-width:991.5px){.jrsDZP{padding-left:20px;}} @media (min-width:991.5px) and (max-width:1279.5px){.jrsDZP{display:none;}}
/* sc-component-id: sc-gkFcWv */
.gWTCXQ{display:none;} @media (min-width:991.5px){.gWTCXQ{padding-left:20px;max-width:100px;display:inline;}} @media (min-width:1279.5px){.gWTCXQ{display:none;}}
/* sc-component-id: sc-hUfwpO */
.jHPgUP{width:100%;border-left:1px solid #f2f2f2;border-right:1px solid #f2f2f2;border-bottom:none;cursor:pointer;} .jHPgUP li{background-color:#f2f2f2;} @media (min-width:991px){.jHPgUP li{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.jHPgUP li:hover{background-color :#ffffff;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} .jHPgUP h3{display:none;}
/* sc-component-id: sc-imABML */
.ibWUzs{background-color:#f2f2f2;color:#4a4a4a;display:block;border-top:1px solid #ffffff;border-radius:0;font-size:16px;font-weight:500;padding:20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;cursor:pointer;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;} .ibWUzs .right__icon{padding:0;height:16px;width:20px;} @media (min-width:991px){.ibWUzs{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.ibWUzs:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.ibWUzs.hide{display:none !important;}}
/* sc-component-id: sc-cjHlYL */
.mkXor{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:25%;float:right;margin-top:-49px;} @media (max-width:374px){.mkXor{width:26.5%;}} @media (min-width:992px){.mkXor{display:none;}}
/* sc-component-id: sc-dRaagA */
.dULvrJ{background-color:#6ba339;color:white;-webkit-flex:1 0 25%;-ms-flex:1 0 25%;flex:1 0 25%;z-index:100;padding:14px 16px 10px 19px;border-radius:0px;border-bottom:1px solid #ffffff;} @media (min-width:320px) and (max-width:767px){.dULvrJ{border-bottom:none;padding:16px 16px 14px 16px;font-size:14px;}.dULvrJ .article_toolbar_icon{display:none;}}
/* sc-component-id: sc-fEUNkw */
.dfaOeH{margin-right:16px;width:24px;height:24px;}
/* sc-component-id: sc-dREXXX */
.cqhPZs{width:16px;height:auto;float:right;} @media (min-width:767.5px){.cqhPZs{width:24px;height:24px;}}
/* sc-component-id: sc-nrwXf */
.byflLi{font-size:14px;padding:16px 20px 24px;} @media (max-width:991px){.byflLi{display:none;}}
/* sc-component-id: sc-eitiEO */
.jXeALb{font-size:14px;} .jXeALb:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: sc-bhlBdH */
.UVThf{font-size:14px;font-weight:bold;}
/* sc-component-id: sc-kDhYZr */
.iySbrx{margin:35px 0 0;display:none;} @media(max-width:767px){.iySbrx.mobile_tabs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}.iySbrx.row2{margin:15px 0 0;}} @media(min-width:768px){.iySbrx.desktop_tabs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}} @media (min-width:991.5px){.iySbrx{margin:0;}}
/* sc-component-id: sc-sPYgB */
.bCmGAV{width:15px;border-bottom:1px solid #E0E0E0;} @media(max-width:767px){.bCmGAV.row2_edge_left{-webkit-flex-basis:10%;-ms-flex-preferred-size:10%;flex-basis:10%;}.bCmGAV.row2_edge_right{-webkit-flex-basis:30%;-ms-flex-preferred-size:30%;flex-basis:30%;}}
/* sc-component-id: sc-dHIava */
.TdHTO{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;padding:0 10px;width:190px;min-height:40px;-webkit-flex:auto;-ms-flex:auto;flex:auto;border:1px solid #E0E0E0;border-radius:0;border-right:0;border-bottom:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;color:#4D8A17 !important;} .TdHTO:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media(min-width:768px){.TdHTO{width:215px;}} .TdHTO:last-of-type{border-right:1px solid #E0E0E0;border-top:1px solid #E0E0E0;}.bmMPie{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;padding:0 10px;width:190px;min-height:40px;-webkit-flex:auto;-ms-flex:auto;flex:auto;border:1px solid #E0E0E0;border-radius:0;border-right:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;color:#4A4A4A !important;} .bmMPie:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media(min-width:768px){.bmMPie{width:215px;}} .bmMPie:last-of-type{border-right:1px solid #E0E0E0;border-top:1px solid #E0E0E0;}
/* sc-component-id: sc-bSbAYC */
.fClRDD{border-width:1px;border-style:solid;border-color:#007B8B;background:rgba(0,123,139,0.05);padding:25px 20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;margin-top:30px;}
/* sc-component-id: sc-guztPN */
.fexZtq{display:block;margin-left:15px;} @media(min-width:768px){.fexZtq{margin-left:30px;}} .fexZtq br{content:"";display:block;margin-bottom:16px;}
/* sc-component-id: sc-cFlXAS */
.iomKnj{font-family:STIXGeneral;font-size:30px;width:37px;height:37px;-webkit-flex:1 0 37px;-ms-flex:1 0 37px;flex:1 0 37px;border-radius:50%;background:#3396A3;color:#FFFFFF;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;font-weight:bold;} @media(min-width:768px){.iomKnj{font-size:40px;width:48px;height:48px;-webkit-flex:1 0 48px;-ms-flex:1 0 48px;flex:1 0 48px;}}
/* sc-component-id: sc-OxbzP */
.eEFYIL{width:100%;height:auto;background-color:#4A4A4A;font-family:'IBM Plex Sans',sans-serif;font-size:14px;font-weight:500;color:#fff;padding:15px 20px;line-height:20px;position:fixed;bottom:0px;z-index:3;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;-webkit-transition:-webkit-transform .25s;-webkit-transition:transform .25s;transition:transform .25s;} .eEFYIL a{color:#7ED321;} .eEFYIL p{display:inline;margin:0;} .eEFYIL.hideBanner{-webkit-transform:translateY(100%);-ms-transform:translateY(100%);transform:translateY(100%);}
/* sc-component-id: sc-bYnzgO */
.dsXEHZ{background:transparent;border:none;height:20px;width:20px;margin-left:20px;padding:0;cursor:pointer;}
/* sc-component-id: sc-cPuPxo */
.iXKuYd{min-width:20px;height:20px;}
/* sc-component-id: baseContent__Main-sc-134g3di-2 */
.cmzomn{margin-top:140px;} @media (min-width:767.5px){.cmzomn{margin-top:85px;}} @media (min-width:991.5px){.cmzomn{margin-top:70px;min-height:calc(100vh - 334px);}}
/* sc-component-id: threeColumn__ThreeColumnWrapper-sc-1bf4078-0 */
.dDyxFF{width:100%;} @media only screen and (min-width:992px){.dDyxFF{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-flow:row wrap;-ms-flex-flow:row wrap;flex-flow:row wrap;padding:0 20px;max-width:1440px;margin:0 auto;}} @media (min-width:991.5px) and (max-width:1100.5px){.dDyxFF .partenership__collabText{font-size:12px;}} @media (min-width:1100.5px) and (max-width:1200.5px){.dDyxFF .partenership__collabText{font-size:14px;}} @media (min-width:991.5px) and (max-width:1071.5px){.dDyxFF .partenership__logoWrapper img{margin-left:20px;margin-bottom:10px;}.dDyxFF .partenership__logoWrapper img:last-child{margin-left:0;margin-bottom:0;}} @media (max-width:1150px){.dDyxFF .journal-metrics-container{display:none;}.dDyxFF .journal_report_link-border-helper{display:none;}}
/* sc-component-id: threeColumn__LeftWrapper-sc-1bf4078-1 */
@media only screen and (min-width:992px){.fkVFlF{width:20%;}} @media only screen and (min-width:1280px){.fkVFlF{width:25%;}}
/* sc-component-id: threeColumn__RightWrapper-sc-1bf4078-2 */
.jzTMLK{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;} @media only screen and (min-width:992px){.jzTMLK{width:20%;margin-bottom:60px;}.jzTMLK.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}} @media only screen and (min-width:1280px){.jzTMLK{width:25%;}}
/* sc-component-id: threeColumn__ContentWrapper-sc-1bf4078-3 */
.bbzREB{margin:0 20px;overflow:hidden;} @media only screen and (min-width:992px){.bbzREB{width:calc(60% - 40px);}} @media only screen and (min-width:1280px){.bbzREB{width:calc(50% - 40px);}}
/* sc-component-id: threeColumn__Content-sc-1bf4078-4 */
.jknsZc{margin:0 auto;overflow:hidden;} @media only screen and (min-width:768px){.jknsZc{max-width:688px;}} @media only screen and (min-width:992px){.jknsZc{max-width:100%;}} @media only screen and (min-width:1075px){.jknsZc{max-width:572px;}}
/* sc-component-id: article__BaseStyle-sc-10qhnp8-0 */
.gnduKR{width:100%;margin-top:170px;} @media (min-width:767.5px){.gnduKR{margin-top:179px;}} @media (min-width:991.5px){.gnduKR{margin-top:180px;min-height:840px;}}
/* sc-component-id: article__StickyStyle-sc-10qhnp8-1 */
.fJLQxX{width:100%;max-width:1440px;z-index:3;-webkit-transition:all 0.5s;transition:all 0.5s;} .fJLQxX.translate{-webkit-transform:translateY(-120px);-ms-transform:translateY(-120px);transform:translateY(-120px);} @media (min-width:767.5px){.fJLQxX.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}} @media (min-width:991.5px){.fJLQxX.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}}
/* sc-component-id: article__SubtitleStyled-sc-10qhnp8-2 */
.elhyhe{background-color:#007b8b;opacity:0.8;color:#fff;margin-bottom:0;margin-top:0;padding:17px 0 17px 20px;line-height:23px;height:60px;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;font-size:20px;font-weight:500;} @media (min-width:767.5px){.elhyhe{line-height:26px;}} @media (min-width:991.5px){.elhyhe{line-height:50px;padding:5px 0 5px 20px;height:60px;}}
/* sc-component-id: article__JournalMenuTitle-sc-10qhnp8-3 */
.jCfZqq{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;font-size:16px;font-weight:500;line-height:20px;height:50px;width:100%;background-color:#007b8b;color:#fff;text-align:left;padding-left:14px;padding-right:0;border:0;border-top:1px solid #fff;} .jCfZqq span{font-size:24px;padding-right:14px;} @media (min-width:991.5px){.jCfZqq{display:none;}}
/* sc-component-id: article__WhiteWrapper-sc-10qhnp8-5 */
.bJcSpM{background-color:#fff;display:block;position:relative;} .bJcSpM h1,.bJcSpM h2{color:#fff;} .bJcSpM h2{font-size:20px;} @media (min-width:767.5px){.bJcSpM h2{font-size:25px;}} .bJcSpM h1{font-size:20px;} @media (min-width:767.5px){.bJcSpM h1{font-size:24px;}} @media (min-width:991.5px){.bJcSpM h1{font-size:40px;}}
/* sc-component-id: articleContent__ArticleContentsWrapper-sc-2yl9jy-0 */
.eSvjPB{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;} .eSvjPB .author__editor--hr{display:block;}
/* sc-component-id: articleContent__ArticleContentsSectionsWrapper-sc-2yl9jy-1 */
.jntdRu{width:100%;} @media (max-width:991.5px){.jntdRu{margin-top:52px;}} .jntdRu p{margin:12px 0;line-height:20px;} .jntdRu .articlecontent__alignment{width:100%;min-width:306px;padding-left:7px;padding-right:7px;} @media (min-width:346px){.jntdRu .articlecontent__alignment{padding-left:20px;padding-right:20px;}} @media (min-width:767.5px){.jntdRu .articlecontent__alignment{width:543px;margin:auto;padding-left:0px;padding-right:0px;}} @media (min-width:991.5px){.jntdRu .articlecontent__alignment{max-width:612px;width:75%;margin:inherit;margin-left:50px;padding-left:20px;padding-right:20px;}} @media (min-width:1100px){.jntdRu .articlecontent__alignment{margin-left:118px;}} .jntdRu .article__title{padding-bottom:12px;} @media (min-width:767.5px){.jntdRu .article__title{padding-bottom:15px;}} .jntdRu .article__summary{padding-bottom:65px;} @media (min-width:991.5px){.jntdRu .article__summary{padding-bottom:75px;}} @media (min-width:767.5px){.jntdRu #vjs_video_3 button{-webkit-transform:none;-ms-transform:none;transform:none;left:40%;margin-top:0;}} .jntdRu .video-js .vjs-big-play-button{top:calc(50% - 22.5px);left:calc(50% - 50px);} .jntdRu .video-js{margin:20px 0;} .jntdRu a{color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .jntdRu a:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: articleContent__ArticleWrapper-sc-2yl9jy-2 */
.eGVCps{background-position:0px 0px;background-origin:content-box;background-size:99%;margin-top:50px;}
/* sc-component-id: articleContent__EditorWrapper-sc-2yl9jy-3 */
.evMkvU{padding:0;}
/* sc-component-id: articleContent__PublicationTimeLineWrapper-sc-2yl9jy-4 */
.fjviok{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;margin:15px 0 30px;border-bottom:1px solid #E3E3E3;} @media (min-width:767.5px){.fjviok{border-top:1px solid #E3E3E3;margin:20px 0 30px;}}
/* sc-component-id: articleContent__PublcationCol-sc-2yl9jy-5 */
.hgKieC{-webkit-flex-basis:0;-ms-flex-preferred-size:0;flex-basis:0;-webkit-box-flex:1;-webkit-flex-grow:1;-ms-flex-positive:1;flex-grow:1;max-width:100%;border-right:1px solid #E3E3E3;padding:5px 0 15px;} @media (min-width:767.5px){.hgKieC{padding:5px 0;}} .hgKieC.notPublished{display:none;} @media (min-width:767.5px){.hgKieC.notPublished{display:block;}} @media (max-width:767.5px){.hgKieC.isPublished{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}.hgKieC.isPublished span:first-child::after{content:':';padding-right:3px;}} .hgKieC:last-child{border-right:none;}
/* sc-component-id: articleContent__PublicationField-sc-2yl9jy-6 */
.cIribm{display:block;text-align:center;font-size:14px;font-weight:700;}
/* sc-component-id: articleContent__PublicationValue-sc-2yl9jy-7 */
.khHUcu{display:block;text-align:center;font-size:14px;}
/* sc-component-id: articleContent__TextWrapper-sc-2yl9jy-8 */
.fYrLtk{margin:-7px 0 -5px;font-size:14px;}
/* sc-component-id: biblio__Wrapper-sc-1nou1lz-0 */
.eyHfWh{position:relative;} .eyHfWh.hide{display:none;} .eyHfWh hr{position:absolute;left:0;right:0;top:-30px;border-top:1px solid #E3E3E3;border-bottom:0;}.cBTaXT.hide{display:none;} .cBTaXT hr{display:none;}
/* sc-component-id: biblio__BiblioWrapper-sc-1nou1lz-1 */
@font-face{font-family:'STIXGeneral-Bold';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/_/hindawi-ui/fonts/STIXGeneral-Regular.otf');} .kbSZJl{padding:0 20px 20px;} .kbSZJl .bib__image{display:none;} .kbSZJl .bib__title{font-size:20px;} .kbSZJl .bib__name{font-size:18px;font-family:'STIXGeneral-Bold',serif !important;color:rgb(74,74,74);font-weight:700;} .kbSZJl .bib--split .bib__link .bib__info,.kbSZJl .bib--split .bib__link.bib__link--image .bib__info,.kbSZJl [class*='bib--txt'] .bib__link .bib__info,.kbSZJl [class*='bib--txt'] .bib__link.bib__link--image .bib__info{padding:10px 0 !important;} .kbSZJl .bib__author{font-size:14px;line-height:22px;color:rgb(132,132,132);margin-top:3px;margin-bottom:0px;margin-right:20px;opacity:1;font-family:'IBM Plex Sans',sans-serif;font-weight:500;} .kbSZJl #biblio_sidebar .bib__link{border-top:1px solid rgb(227,227,227) !important;padding-top:5px !important;padding-bottom:5px !important;} .kbSZJl #biblio_sidebar .bib__link:first-child{border-top:0 !important;padding-top:0 !important;} .kbSZJl #biblio_sidebar .bib__link:first-child .bib__info{padding-top:0 !important;} .kbSZJl #biblio_widget .bib--split .bib__link .bib__info,.kbSZJl #biblio_widget .bib--split .bib__link.bib__link--image .bib__info{padding:10px 15px 10px 0 !important;} @media (min-width:767.5px){.kbSZJl{padding:0 40px 20px;}} @media (min-width:991.5px){.kbSZJl{padding:0 20px;}}
/* sc-component-id: biblio__H4-sc-1nou1lz-2 */
.becpDt{font-size:20px;font-family:'IBM Plex Sans';color:#000;font-weight:600;margin-top:34px;margin-bottom:18px;padding:0 20px;}
/* sc-component-id: journal_article__ArticleStickyTopToolbar-sc-12fk6zy-0 */
.gbrQxi{display:none;} @media (min-width:991.5px){.gbrQxi{display:block;}.gbrQxi .article_top_toolbar{top:110px;z-index:-100;}.gbrQxi .article_top_toolbar .pdf_desktop{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}.gbrQxi .article_top_toolbar .ref_desktop{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}} .gbrQxi .article_toolbar_views{margin-top:-58px;display:block;text-align:right;}
/* sc-component-id: journal_article__ArticleStickyBottomToolbar-sc-12fk6zy-1 */
@media (min-width:991.5px){.isgRZA .article_bottom_toolbar{top:292px;z-index:-10;}}
/* sc-component-id: journal_article__BreadCrumbStyle-sc-12fk6zy-2 */
@media (min-width:991.5px){.bjwAQR{padding:16px 20px 24px;height:60px;}}
/* sc-component-id: journal_article__ArticleBaseStyle-sc-12fk6zy-3 */
.NQpXC .content,.NQpXC .contentWrapper{overflow:visible;}
/* sc-component-id: journal_article__BiblioIntegratorSidebar-sc-12fk6zy-4 */
.cYsVdk{max-width:350px;} @media (max-width:991.5px){.cYsVdk{display:none !important;}}
/* sc-component-id: journal_article__BiblioIntegratorWidget-sc-12fk6zy-5 */
.dbAANp{background-color:#f5f5f5;padding:15px 20px 24px 20px;margin-top:2px;margin-bottom:20px;} @media (min-width:991.5px){.dbAANp{margin-top:-64px;margin-bottom:40px;}} .dbAANp .hrTitleRef{padding:0;margin-top:0;font-family:'IBM Plex Sans',sans-serif;} .dbAANp #biblio_widget{padding:0;}</style></head><body style="margin:0;box-sizing:border-box"><div id="__next"><div class="static_page"><div class="page no__focus__outline"><header class="sc-fjdhpX jzXSTA"><div class="sc-bZQynM bNmdOy E_HUmlU2Hj3PpkDmWzKPd header__padding"><div class="sc-kAzzGY epRoim mobileLogoFlex _1fpqArXPCxgnlv2rXZC2sl _1SoDWGr_FVsil9klRfjnhb"><a class="sc-htpNat bUhGXt link" href="/" aria-label="Home"><img alt="logo" src="https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/logo.svg" class="sc-ckVGcZ gjctdt"/></a></div><div class="sc-jzJRlG jGJLow mobileButtonFlex _2v1j-tLx3hx0tgKcpPzH6B _3wm8FgzqRuRWouJG31YgKx E_HUmlU2Hj3PpkDmWzKPd"><nav class="sc-bxivhb ivbKJD"><ul class="sc-ifAKCX fopjOz sc-kpOJdX kAzjOl"><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/journals/" aria-label="Journals">Journals</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/publish-research/" aria-label="Publish with us">Publish with us</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/publishing-partnerships/" aria-label="Publishing partnerships">Publishing partnerships</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/about/" aria-label="About us">About us</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/blog/" aria-label="Blog">Blog</a></li></ul></nav><button class="sc-chPdSV hbVEoI icon__search" aria-label="Search"><span class="sc-htoDjs khbeDd icon__search icon-colored _3hSk3ArgsWMFh5QJIGblNr icon-themeable" title="" font-size="24"></span></button><button aria-label="Hamburger Menu" class="sc-cSHVUG ldSkVQ"><span class="sc-htoDjs khbeDd hamburger icon-colored _20YUA8q5mREEBfJm8VsdXV icon-themeable" title="" font-size="24"></span></button></div></div></header><div class="sc-bZQynM bNmdOy"></div><main class="baseContent__Main-sc-134g3di-2 cmzomn  article__BaseStyle-sc-10qhnp8-0 gnduKR DADtd11SJ4KyWZ2l6zAnr base_style journal_article__ArticleBaseStyle-sc-12fk6zy-3 NQpXC"><div class="sc-bZQynM bNmdOy width_wrapper"><div id="journal__navigation" class="sc-cbkKFq kuxTps article__StickyStyle-sc-10qhnp8-1 fJLQxX"><a class="sc-htpNat bUhGXt link article__WhiteWrapper-sc-10qhnp8-5 bJcSpM" href="/journals/ecam/" aria-label=""><h2 class="sc-eHgmQL fTkdCR article__SubtitleStyled-sc-10qhnp8-2 elhyhe _1ZrXcsbATVL_kHOpFAan9k">Evidence-Based Complementary and Alternative Medicine</h2></a><button class="article__JournalMenuTitle-sc-10qhnp8-3 jCfZqq journalNavCheck" id="journalMenuTitle"><span>+</span>Journal Menu</button><div class="sc-bdVaJa EwsTm isHide" id="fadeOut"></div><div class="sc-cjHlYL mkXor"><a class="sc-htpNat bUhGXt link sc-dRaagA dULvrJ article-toolbar-link" href="https://downloads.hindawi.com/journals/ecam/2012/378415.pdf" aria-label="" download=""><img alt=" " class="sc-EHOje jOLhQl sc-fEUNkw dfaOeH article_toolbar_icon" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/pdf.svg" height="24"/>PDF<img alt=" " class="sc-EHOje jOLhQl sc-dREXXX cqhPZs" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a></div><nav id="journal__nav" class="sc-hGoxap dEfJbW article__JournalNavigationStyle-sc-10qhnp8-4 gaRePw isHide journalNavCheck"><div class="sc-giadOv eBepOs journalNavCheck"><button class="sc-hSdWYo etauus sc-fjmCvl fSPaCp journalNavCheck" color="">Journal overview<span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__inactive icon-white _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span><span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__active icon-colored icon__hidden _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span></button></div><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/journals/ecam/guidelines/" aria-label="For authors">For authors</a><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/publish-research/reviewers/" aria-label="For reviewers">For reviewers</a><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/publish-research/editors/" aria-label="For editors">For editors</a><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/journals/ecam/contents/year/2022/" aria-label="Table of Contents">Table of Contents</a><div class="sc-giadOv eBepOs journalNavCheck"><button class="sc-hSdWYo etauus sc-fjmCvl bVEEaH journalNavCheck" color="">Special Issues<span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__inactive icon-white _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span><span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__active icon-colored icon__hidden _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span></button></div><a class="sc-htpNat bUhGXt link sc-jtRfpW OGgkt submit__button journalNavCheck" href="https://review.hindawi.com/submit?journal=ecam" aria-label="" target="" id=""><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ jUTgTa" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="text">Submit</span></span><span class="sc-htoDjs kNoiZu sc-dqBHgY cQgXqt fileArrow icon-colored undefined icon-themeable" title="" font-size="16"></span></a><div class="sc-krDsej ewCAZX hide__submenu journalSubmenuCheck" id="journalnav__submenu"><button class="sc-itybZL kdvWPs journalSubmenuCheck"><span class="sc-htoDjs gvAGTV sc-fzsDOv hAFFGk journalSubmenuCheck icon-colored _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span></button></div><div class="sc-dTdPqK lkWWFY hide__submenu journal__nav__desktop" id="journalnav__submenudesktop"><div order="0" class="sc-kUaPvJ ehYbwJ"><div class="sc-gPWkxV legory"></div><div class="sc-gPWkxV legory"></div></div><div class="sc-jVODtj epgILe"></div><span class="sc-fONwsr kCfRMJ"></span></div></nav></div><div class="sc-nrwXf byflLi breadcrumb__wrapper journal_article__BreadCrumbStyle-sc-12fk6zy-2 bjwAQR article"><a class="sc-htpNat bUhGXt link sc-eitiEO jXeALb breadCrumb" href="/journals/ecam/" aria-label="Evidence-Based Complementary and Alternative Medicine">Evidence-Based Complementary and Alternative Medicine</a> / <a class="sc-htpNat bUhGXt link sc-eitiEO jXeALb breadCrumb" href="/journals/ecam/contents/year/2012/" aria-label="2012">2012</a> / <span class="sc-bhlBdH UVThf">Article</span></div><div class="threeColumn__ThreeColumnWrapper-sc-1bf4078-0 dDyxFF threeColumnWrapper"><div class="threeColumn__LeftWrapper-sc-1bf4078-1 fkVFlF leftWrapper"><button type="button" class="sc-eKZiaR dzZrgS section__button  " id="sectionButton"><span class="sc-htoDjs diutvq icon__dots dots__detector icon-colored _3n-7Ho7DlfjMlZbrRr9Q4a icon-themeable" title="" font-size="22"></span>Article Sections</button><div class="sc-bEjcJn jLUVhb static_contents__section_links
           links__hidden "><div id="leftSectionMenu" class="sc-cbkKFq prcY sc-bGbJRg dVCLgr left_section_menu"><p>On this page</p><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#abstract" aria-label="">Abstract</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#introduction" aria-label="">Introduction</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#materials-and-methods" aria-label="">Materials and Methods</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#results" aria-label="">Results</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#abbreviations" aria-label="">Abbreviations</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#acknowledgments" aria-label="">Acknowledgments</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#references" aria-label="">References</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#copyright" aria-label="">Copyright</a></span></div></div></div><div class="threeColumn__ContentWrapper-sc-1bf4078-3 bbzREB contentWrapper"><div class="threeColumn__Content-sc-1bf4078-4 jknsZc content"><div class="articleContent__ArticleContentsWrapper-sc-2yl9jy-0 eSvjPB article_contents"><div class="articleContent__ArticleContentsSectionsWrapper-sc-2yl9jy-1 jntdRu article_contents__sections_wrapper"><div class="sc-kDhYZr iySbrx desktop_tabs"><div class="sc-sPYgB bCmGAV"></div><a class="sc-htpNat bUhGXt link link--active sc-dHIava TdHTO" href="/journals/ecam/2012/378415/" aria-label="Research Article">Research Article</a><a class="sc-htpNat bUhGXt link sc-dHIava bmMPie" href="/journals/ecam/2013/423987/" aria-label="Erratum">Erratum</a><div class="sc-sPYgB bCmGAV"></div></div><div class="sc-kDhYZr iySbrx mobile_tabs row1"><div class="sc-sPYgB bCmGAV row1_edge_left"></div><a class="sc-htpNat bUhGXt link link--active sc-dHIava TdHTO row1_link" href="/journals/ecam/2012/378415/" aria-label="Research Article">Research Article</a><a class="sc-htpNat bUhGXt link sc-dHIava bmMPie row1_link" href="/journals/ecam/2013/423987/" aria-label="Erratum">Erratum</a><div class="sc-sPYgB bCmGAV row1_edge_right"></div></div><div class="sc-bSbAYC fClRDD"><span class="sc-cFlXAS iomKnj">!</span><span class="sc-guztPN fexZtq alert__message">A <b>Erratum</b> for this article has been published.
  To view the article details, please click the Erratum tab above.</span></div><div class="articleContent__ArticleWrapper-sc-2yl9jy-2 eGVCps"><div class="sc-chbbiW mBGSe article_header_class"><p class="sc-kZmsYB bkiEfx article_type">Research Article | <!-- -->Open Access</p><div class="sc-RcBXQ ztvYg article_citation">Volume<!-- --> <!-- -->2012<!-- --> <span class="sc-fZwumE cUsFHx">|</span>Article ID<!-- --> <!-- -->378415<!-- --> <span class="sc-fZwumE cUsFHx">| </span><a class="sc-htpNat bUhGXt link sc-fQejPQ duuwge" href="https://doi.org/10.1155/2012/378415" aria-label="Doi-link">https://doi.org/10.1155/2012/378415</a></div><div class="sc-LKuAh lcOiDF article_full_citation"><div class="sc-hzNEM gsmOCv isHide"><p>Ying-Yi Chen, Fon-Chang Liu, Pei-Yu Chou, Yi-Chung Chien, Wun-Shaing Wayne Chang, Guang-Jhong Huang, Chieh-Hsi Wu, Ming-Jyh Sheu<!-- -->,<!-- --> <!-- -->&quot;<span class="adjust-article-svg-size">Ethanol Extracts of Fruiting Bodies of <i>Antrodia cinnamomea</i> Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways</span>&quot;,<!-- --> <i>Evidence-Based Complementary and Alternative Medicine</i>,<!-- --> <!-- -->vol. <!-- -->2012<!-- -->,<!-- --> <!-- -->Article ID <!-- -->378415<!-- -->,<!-- --> <!-- -->11<!-- --> <!-- --> <!-- --> <!-- -->pages<!-- -->,<!-- --> <!-- -->2012<!-- -->.<!-- --> <!-- -->https://doi.org/10.1155/2012/378415</p></div><button class="sc-hSdWYo etauus sc-iBEsjs kPshFw" color="">Show citation</button></div><h1 class="sc-iRbamj jZOxOO sc-iSDuPN kRoxOt article_title adjust-article-svg-size heading-title">Ethanol Extracts of Fruiting Bodies of <i>Antrodia cinnamomea</i> Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways</h1></div><div class="sc-jrIrqw eHMFfo article_authors"><hr class="sc-cEvuZC XkrFe hr__author"/><span class="">Ying-Yi Chen<!-- -->,<sup>1</sup> </span><span class="">Fon-Chang Liu<!-- -->,<sup>1<!-- -->,<!-- -->2</sup> </span><span class="">Pei-Yu Chou<!-- -->,<sup>3</sup> </span><span class="">Yi-Chung Chien<!-- -->,<sup>3</sup> </span><span class="">Wun-Shaing Wayne Chang<!-- -->,<sup>4</sup> </span><span class="">Guang-Jhong Huang<!-- -->,<sup>5</sup> </span><span class=""><b>Chieh-Hsi Wu</b><a class="sc-htpNat bUhGXt link" href="mailto:" aria-label="Mail Option"><span class="sc-htoDjs kNoiZu sc-hjRWVT irNWJI icon-colored _2zt-1j0LmaF8UjTQAM413G icon-themeable" title="" font-size="16"></span></a>,<sup>1</sup> <!-- --> and </span><span class=""><b>Ming-Jyh Sheu</b><a class="sc-htpNat bUhGXt link" href="mailto:" aria-label="Mail Option"><span class="sc-htoDjs kNoiZu sc-hjRWVT irNWJI icon-colored _2zt-1j0LmaF8UjTQAM413G icon-themeable" title="" font-size="16"></span></a><sup>1</sup></span><div class="sc-fHxwqH dMuGGA isHide"><p><sup>1</sup><span>School of Pharmacy, China Medical University, 91 Hsueh-Shih Road, Taichung 404, Taiwan</span></p><p><sup>2</sup><span>Department of Pharmacy, Da Chien General Hospital, Miaoli 36052, Taiwan</span></p><p><sup>3</sup><span>Department of Life Science, National Chung Hsing University, 250 Kuo Kuang Road, Taichung 402, Taiwan</span></p><p><sup>4</sup><span>National Institute of Cancer Research, National Health Research Institutes, 35 Keyan Road, Zhunan, Miaoli 350, Taiwan</span></p><p><sup>5</sup><span>School of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan</span></p></div><button class="sc-hSdWYo etauus sc-iQtOjA kfDwZY" color="">Show more</button></div><div class="articleContent__EditorWrapper-sc-2yl9jy-3 evMkvU"><div class="articleContent__TextWrapper-sc-2yl9jy-8 fYrLtk"><b>Academic Editor: </b>Vassya Bankova</div><div class="articleContent__PublicationTimeLineWrapper-sc-2yl9jy-4 fjviok"><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC notPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Received</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">18 Jul 2011</span></div><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC notPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Revised</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">25 Oct 2011</span></div><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC notPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Accepted</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">25 Oct 2011</span></div><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC isPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Published</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">21 Feb 2012</span></div></div></div><article class="sc-jtRlXQ exFqMv article_body "><div><div class="xml-content"><h4 class="header" id="abstract">Abstract</h4><p>Cancer metastasis is a primary cause of cancer death. <i>Antrodia cinnamomea</i> (<i>A. cinnamomea</i>), a medicinal mushroom in Taiwan, has shown antioxidant and anticancer activities. In this study, we first observed that ethanol extract of fruiting bodies of <i>A. cinnamomea</i> (EEAC) exerted a concentration-dependent inhibitory effect on migration and motility of the highly metastatic CL1-5 cells in the absence of cytotoxicity. The results of a gelatin zymography assay showed that <i>A. cinnamomea</i> suppressed the activities of matrix metalloproteinase-(MMP-) 2 and MMP-9 in a concentration-dependent manner. Western blot results demonstrated that treatment with <i>A. cinnamomea</i> decreased the expression of MMP-9 and MMP-2; while the expression of the endogenous inhibitors of these proteins, that is, tissue inhibitors of MMP (TIMP-1 and TIMP-2) increased. Further investigation revealed that <i>A. cinnamomea</i> suppressed the phosphorylation of ERK1/2, p38, and JNK1/2. <i>A. cinnamomea</i> also suppressed the expressions of PI3K and phosphorylation of Akt. Furthermore, treatment of CL1-5 cells with inhibitors specific for PI3K (LY 294002), ERK1/2 (PD98059), JNK (SP600125), and p38 MAPK (SB203580) decreased the expression of MMP-2 and MMP-9. This is the first paper confirming the antimigration activity of this potentially beneficial mushroom against human lung adenocarcinoma CL1-5 cancer cells.</p><span class="end-abs"></span><h4 id="introduction">1. Introduction</h4><p>Lung cancer has been the leading cause of cancer-related mortality worldwide. In some countries, it has become the number one cancer cause of death, accounting for more fatalities than prostate cancer, breast cancer, and colorectal cancer combined [<a href="#B1">1</a>]. Human lung adenocarcinoma cell lines CL1-0, CL1-1, CL1-5, and CL1-5-F4 are a series of sublines with progressively invasive ability established by in vitro invasion screening. CL1-5 cells are a human lung adenocarcinoma cell line derived from the parental CL1 cells by five successive Matrigel selections. CL1-5 cells showed a 4- to 6-fold higher invasive ability than the parental cells and their production of 92-kDa MMP-9 also exhibited a drastic increase over that of their parental cells.</p><p>Metastasis is a characteristic of highly malignant cancers with poor clinical outcome. Malignant tumor progression depends upon the capacity to invade, metastasize, and promote the angiogenic host response. One critical characteristic that metastatic cancer cells have acquired is the ability to dissolve basement membranes and the extracellular matrix (ECM). This degradative process is mediated largely by matrix metalloproteinases (MMPs), which are a large family of at least 20 zinc-dependent neutral endopeptidases that together can degrade all known components of ECM [<a href="#B3">2</a>]. MMP-9 is abundantly expressed in various malignant tumors and is postulated to play a critical role in tumor invasion and angiogenesis [<a href="#B4">3</a>]. Thus, the inhibition of MMP activity, including MMP-9, is important for the prevention of cell invasion. CL1-5 cells, a human lung adenocarcinoma cell line, expressed an elevated level of MMP-2, MMP-9 and exhibited a highly invasive and metastatic ability [<a href="#B2">4</a>, <a href="#B5">5</a>]. Meanwhile, the activity of MMPs is prone to the inhibition of endogenous tissue inhibitor of metalloproteinases (TIMPs), which are specific inhibitors of MMPs, and the imbalance between MMPs and TIMPs may contribute to degradation or deposition of ECM [<a href="#B6">6</a>]. The mitogen-activated protein kinases (MAPKs) play an important regulatory role in cell growth, differentiation, apoptosis, and metastasis [<a href="#B7">7</a>]. In addition, phosphatidylinositol-3-kinase/serine/threonine protein kinase (or protein kinase B) (PI3K/Akt) signal transduction pathway is involved in the development, progression, and metastasis of various tumors [<a href="#B8">8</a><a href="#B10">10</a>].</p><p>Traditionally, <i>Antrodia cinnamomea</i> (<i>A. cinnamomea</i>; also named niu-chang-chih in Chinese) has been used as a health food to prevent inflammation, hypertension, itchy skin, and liver cancer [<a href="#B11">11</a>]. There is increasing evidence that <i>A. cinnamomea </i>possesses an extensive range of biological activities, including the liver protection [<a href="#B12">12</a>], anti-inflammation [<a href="#B13">13</a>], and antioxidation [<a href="#B14">14</a>]. Some reports have suggested that extracts of mycelia and fruiting bodies of <i>A. cinnamomea </i>could be a potential chemotherapeutic agent against hepatoma, as well as prostate, breast, bladder, and lung cancer cells [<a href="#B15">15</a><a href="#B20">20</a>], the antimetastatic effect of <i>A. cinnamomea</i> in lung adenocarcinoma CL1-5 cancer cells is still unclear. In the present study, we investigated the antimetastatic effects of <i>A. cinnamomea</i> on a highly metastatic CL1-5 cell lines as well as the underlying mechanisms.</p><h4 id="materials-and-methods">2. Materials and Methods</h4><h5 id="sec2.1">2.1. Chemicals</h5><p><i>A. cinnamomea</i> was kindly provided by Cosmox Biomedical Co. Ltd. (Taoyuan, Taiwan). RPMI Medium 1640, 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT), LY294002, SP600125, and SB203580 were obtained from Sigma Chemical Co. (St. Louis, MO, USA). PD98059 was purchased from Cell Signaling Technology (Beverly, MA, USA). TrypsinEDTA, fetal bovine serum (FBS), and penicillin/streptomycin were from Gibco Life Technologies, Inc. (Paisley, UK). Cell culture supplies were purchased from Costar (Corning, Inc., Cypress, CA, USA). The antibody against AKT, Rac-1, MAPK/extracellular signal-regulated kinase (ERK) 1/2, c-Jun NH<sub>2</sub>-terminal kinase (JNK)/stress-activated protein kinase, and p38 MAPK proteins and phosphorylated proteins were purchased from Cell Signaling Technology (Beverly, MA, USA). Anti-ERK1/2, anti-PI3K, antifocal adhesion kinase (FAK), anti-p-FAK, and horseradish peroxidase-conjugated goat anti-mouse IgG antibody were purchased from Santa Cruz Biotechnology Co. (Santa Cruz, CA, USA), <i></i>-actin was purchased from Chemicon (Temecula, CA, USA).</p><h5 id="sec2.2">2.2. Preparation of Ethanol Extract of Fruiting Bodies of <i>A. cinnamomea</i> (EEAC)</h5><p>The fruiting body of <i>A. cinnamomea</i> was kindly provided by Cosmox Biomedical Co. LTD (Taoyuan, Taiwan) and identified by Dr. Chao-Lin Kuo (School of Chinese Pharmaceutical Sciences and Chinese Medicine Resource, Taiwan). <i>A. cinnamomea</i> was weighed about 1kg and soaked in 10L of 95% ethanol solution (extractive solvent) for 3 days at room temperature. The solid residue of the above soaked herbs was filtered and discarded through a Buchner funnel lined with Whatman filter paper, and the filtrate was concentrated to paste by vacuum distillation using the rotary evaporator (N-11, EYELA; Tokyo, Japan) and vacuum controller (VC-760, TAKARA; Tokyo, Japan) to maintain the desired pressure and temperature at 25C with 40mmHg. The various concentration of EEAC was further diluted with DMSO for the further use.</p><h5 id="sec2.3">2.3. Cell Culture</h5><p>CL1-5 cell lines were kindly provided by Dr. W.-S. Wayne Chang (National Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan). The cells were cultured in RPMI-1640 medium (Gibco, Grand Island, NY, USA) with 10% fetal bovine serum (FBS, Gibco) at 37C in a humidified atmosphere of 5% CO<sub>2</sub>.</p><h5 id="sec2.4">2.4. Cytotoxicity Assay</h5><p>The cells (1  10<sup>5</sup>cells/mL) were cultured in 96-well plate containing RPMI-1640 supplemented with 10% FBS for 24h to become nearly confluent. Then cells were cultured with EEAC for 24h and 36h. Then, the cells were washed twice with PBS and incubated with 100<i></i>L of 0.5mg/mL MTT for 3h at 37C, testing for cell viability. The medium was then discarded and 50<i></i>L of dimethylsulfoxide (DMSO) was added. After 10min incubation, absorbance at 590nm was read by a microplate reader.</p><h5 id="sec2.5">2.5. Wound-Healing Assay</h5><p>For cell motility determination, CL1-5 cells (2  10<sup>5</sup> cells/mL) were seeded in a 12-well tissue culture plate and grown to 8090% confluence. After aspiration of the medium, the center of the cell monolayers was scraped with a sterile micropipette tip to create a denuded zone (gap) of constant width. Subsequently, cellular debris was washed with PBS, and CL1-5 cells were exposed to various concentrations of EEAC (0, 0.125, 0.25, 0.5, and 1.0<i></i>g/mL). Wound closure was monitored and photographed at 0h and 36h with a Nikon inverted microscope. To quantify the migrated cells, pictures of the initial wounded monolayers were compared with the corresponding pictures of cells at the end of the incubation. Artificial lines fitting the cutting edges were drawn on pictures of the original wounds and overlaid on the pictures of cultures after incubation. Cells that had migrated across the white lines were counted in six random fields from each triplicate treatment.</p><h5 id="sec2.6">2.6. Cell Migration Assay</h5><p>Tumor cell migration was assayed in transwell chambers (Millipore) according to the method reported by Weng et al. [<a href="#B6">6</a>] with some modifications. Briefly, transwell chambers with 6.5mm polycarbonate filters of 8<i></i>m pore size were used. CL1-5 cells (1  10<sup>4</sup> cells/mL) and 0, 0.125, 0.25, 0.5, and 1.0<i></i>g/mL of EEAC were suspended in RPMI-1640 (100<i></i>L, serum free), placed in the upper transwell chamber, and incubated for 24h at 37C. Then, the cells on the upper surface of the filter were completely wiped away with a cotton swab, and the lower surface of the filter was fixed in methanol, stained with Giemsa, and counted under a microscope at a magnification of 200x. For each replicate, the tumor cells in 10 randomly selected fields were determined and the counts were averaged.</p><h5 id="sec2.7">2.7. Determination of MMP-2 and MMP-9 by Zymography</h5><p>MMPs in the medium released from CL1-5 cells were assayed using gelatin zymography (8% zymogram gelatin gels) according to the methods reported by Weng et al. with some modification [<a href="#B6">6</a>]. Briefly, the culture medium was electrophoresed (80V for 120min) in a 8% SDS-PAGE gel containing 0.1% gelatin. The gel was then washed at room temperature in a solution containing 2.5% (v/v) Triton X-100 with two changes and subsequently transferred to a reaction buffer for enzymatic reaction containing 1% NaN<sub>3</sub>, 10mM CaCl<sub>2</sub> and 40mM Tris-HCl, pH 8.0, at 37C with shaking overnight (for 1215h). Finally, the MMP gel was stained for 30min with 0.25% (w/v) Coomassie blue in 10% acetic acid (v/v) and 20% methanol (v/v) and destained in 10% acetic acid (v/v) and 20% methanol (v/v).</p><h5 id="sec2.8">2.8. Western Blotting Analysis</h5><p>Whole-cell lysates proteins (40<i></i>g of partially purified protein) were mixed with an equal volume of electrophoresis sample buffer, and the mixture was then boiled for 10min. Then, an equal protein content of total cell lysate from control and EEAC-treated sample were resolved in 12% SDS-PAGE gels. Proteins were then transferred onto nitrocellulose membranes (Millipore, Bedford, MA, USA) by electroblotting using an electroblotting apparatus (Bio-Rad). Nonspecific binding of the membranes was blocked with phosphate-buffered saline (PBS) containing 1% (w/v) nonfat dry milk and TBS-T buffer (Tris-Buffer Saline with 0.1% (v/v) Tween 20) for more than 2h. Membranes were washed with TBS-T buffer three times each for 10min and then incubated with an appropriate dilution of specific primary antibodies in TBS-T buffer overnight at 4C. The membranes were washed with TBS-T buffer and then incubated with an appropriate secondary antibody (horseradish peroxidase-conjugated, goat anti-mouse, or anti-rabbit IgG) for 1h. After washing the membrane three times for 10min in TBS-T buffer, the bands were visualized using ECL reagents (Millipore, Billerica, MA, USA). Band intensity on scanned films was quantified using Kodak Molecular Imaging (MI) software and expressed as relative intensity compared with control.</p><h5 id="sec2.9">2.9. Statistical Analysis</h5><p>Values are expressed as means  SD and analyzed using one-way ANOVA followed by LSD test for comparisons of group means. All statistical analyses were performed using SPSS for Windows, version 10 (SPSS, Inc.); a <svg height="11.175" id="M1" style="vertical-align:-0.0pt;width:10.9375px;" version="1.1" viewbox="0 0 10.9375 11.175" width="10.9375" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,0,0,-.017,.062,11.113)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#13;&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g>
</svg> value &lt;0.05 is considered statistically significant.</p><h4 id="results">3. Results</h4><h5 id="sec3.1">3.1. Cytotoxicity of EEAC to CL1-5 Cells</h5><p>The effect of EEAC (0128<i></i>g/mL) on cell viability was determined by the MTT assay. After incubation for 24h and 36h, cell viability was not significantly affected by EEAC (0.1251.0<i></i>g/mL), as compared to the untreated control (Figure <a href="fig1/#a" target="_blank">1(a)</a>), indicating that EEAC is not toxic to CL1-5 cells at these concentrations. When cells were treated with EEAC at 1.0128<i></i>g/mL for 24h and 36h, cell viability was significantly decreased. EEAC (0.1251.0<i></i>g/mL) were also evaluated their apoptotic effect with flow cytometry, and SubG1 was not significantly affected by EEAC (0.1251.0<i></i>g/mL), as compared to the untreated control (Figure <a href="fig1/#b" target="_blank">1(b)</a>). To avoid inhibition of cell viability in the following experiments, we chose to use EEAC concentrations between 0.125 and 1.0<i></i>g/mL and an incubation time of 36h.</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig1"><div class="floats-partial-content fig-content-fig1"><div class="partial-carousel--single-image"><img alt="(a)" name="378415.fig.001a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.001a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="378415.fig.001b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.001b.jpg" /><br /><strong>(b)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig1"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="378415.fig.001a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.001a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="378415.fig.001b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.001b.jpg" /><br /><strong>(b)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig1"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 1</span><a aria-label="full view" class="caption-partial-url" href="fig1/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>(a) Viability of CL1-5 cells incubated with EEAC (0.125, 0.25, 0.5, 1.0, 2.0, 4.0, 8.0, 16, 32, 64, and 128<i></i>g/mL) for 24h and 36h. Cell viability was measured using MTT assay and is expressed as % of cell survival relative to control. (b) Flow cytometric analysis of EEAC on the cell cycle of CL1-5. All the cells were treated with 1% fetal bovine serum with the addition of EEAC at 0.125<i></i>g/mL, 0.25<i></i>g/mL, 0.5<i></i>g/mL, and 1.0<i></i>g/mL for 36h. The value on the <svg height="7.9499998" id="M2" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 9.625 7.9499998" width="9.625" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,0,0,-.017,.062,7.675)"><path d="M536 404q0 -17 -13.5 -31.5t-26.5 -14.5q-8 0 -15 10q-11 14 -25 14q-22 0 -67 -50q-47 -52 -68 -82l37 -102q31 -88 55 -88t78 59l16 -23q-32 -48 -68.5 -78t-65.5 -30q-19 0 -37.5 20t-29.5 53l-41 116q-72 -106 -114.5 -147.5t-79.5 -41.5q-21 0 -34.5 14t-13.5 37&#13;&#10;q0 16 13.5 31.5t28.5 15.5q12 0 17 -11q5 -10 25 -10q22 0 57.5 36t89.5 111l-40 108q-22 58 -36 58q-21 0 -67 -57l-19 20q81 107 125 107q17 0 30 -22t39 -88l22 -55q68 92 108.5 128.5t74.5 36.5q20 0 32.5 -14t12.5 -30z" id="x1D465"></path></g>
</svg>-axis represents the DNA content, while the shaded area indicates the percentage of cells at the S phase. Percentage of sub G1 contents in CL1-5 cells treated with EEAC. Values are means of three separate experiments, with standard deviation represented by vertical bars. <svg height="17.825001" id="M3" style="vertical-align:-3.276pt" version="1.1" viewbox="0 0 69.150002 17.825001" width="69.150002" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.012,0,0,-.012,2.9,5.525)"><path d="M471 153q-22 -15 -61 -13q-25 31 -45.5 49.5t-56.5 41.5q4 -71 28 -134q-17 -33 -42 -46q-24 12 -42 46q24 63 28 134q-36 -23 -56.5 -41.5t-45.5 -49.5q-36 -2 -61 13q0 28 19 59q65 10 130 43q-65 33 -130 43q-19 31 -19 59q22 15 61 13q25 -31 45.5 -49.5t56.5 -41.5&#13;&#10;q-4 71 -28 134q17 33 42 46q24 -12 42 -46q-24 -63 -28 -134q36 23 56.5 41.5t45.5 49.5q36 2 61 -13q0 -28 -19 -59q-65 -10 -130 -43q65 -33 130 -43q19 -31 19 -59z" id="x2217"></path></g>
<g transform="matrix(.017,0,0,-.017,10.5,14.875)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#13;&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,0,0,-.017,26.038,13.688)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,0,0,-.017,40.724,13.688)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#13;&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,0,0,-.017,48.884,13.688)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,0,0,-.017,52.76,13.688)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#13;&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,0,0,-.017,60.919,13.688)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#13;&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>; <svg height="17.825001" id="M4" style="vertical-align:-3.276pt" version="1.1" viewbox="0 0 76.137497 17.825001" width="76.137497" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.012,0,0,-.012,2.9,5.525)"><path d="M471 153q-22 -15 -61 -13q-25 31 -45.5 49.5t-56.5 41.5q4 -71 28 -134q-17 -33 -42 -46q-24 12 -42 46q24 63 28 134q-36 -23 -56.5 -41.5t-45.5 -49.5q-36 -2 -61 13q0 28 19 59q65 10 130 43q-65 33 -130 43q-19 31 -19 59q22 15 61 13q25 -31 45.5 -49.5t56.5 -41.5&#13;&#10;q-4 71 -28 134q17 33 42 46q24 -12 42 -46q-24 -63 -28 -134q36 23 56.5 41.5t45.5 49.5q36 2 61 -13q0 -28 -19 -59q-65 -10 -130 -43q65 -33 130 -43q19 -31 19 -59z" id="x2217"></path></g><g transform="matrix(.012,0,0,-.012,9.885,5.525)"><path d="M471 153q-22 -15 -61 -13q-25 31 -45.5 49.5t-56.5 41.5q4 -71 28 -134q-17 -33 -42 -46q-24 12 -42 46q24 63 28 134q-36 -23 -56.5 -41.5t-45.5 -49.5q-36 -2 -61 13q0 28 19 59q65 10 130 43q-65 33 -130 43q-19 31 -19 59q22 15 61 13q25 -31 45.5 -49.5t56.5 -41.5&#13;&#10;q-4 71 -28 134q17 33 42 46q24 -12 42 -46q-24 -63 -28 -134q36 23 56.5 41.5t45.5 49.5q36 2 61 -13q0 -28 -19 -59q-65 -10 -130 -43q65 -33 130 -43q19 -31 19 -59z" id="x2217"></path></g>
<g transform="matrix(.017,0,0,-.017,17.488,14.875)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#13;&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,0,0,-.017,33.025,13.688)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,0,0,-.017,47.712,13.688)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#13;&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,0,0,-.017,55.871,13.688)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,0,0,-.017,59.747,13.688)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#13;&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,0,0,-.017,67.906,13.688)"><path d="M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z" id="x31"></path></g>
</svg>. Lower case for 24h and upper case for 36h.</table></div></div></div><h5 id="sec3.2">3.2. Effect of EEAC on Wound-Healing Assay</h5><p>We further assessed the effect of EEAC on the migration of CL1-5 cells using the wound healing assay in which the confluent monolayer was scraped with a sterile micropipette tip to create a scratch wound. As shown in Figure <a href="fig2/#a" target="_blank">2(a)</a>, EEAC inhibited the migration of CL1-5 cells in a dose-dependent manner, with 27.7% and 40.1% inhibition at 0.5 and 1.0<i></i>g/mL after incubation for 36h, respectively, (Figure <a href="fig2/#b" target="_blank">2(b)</a>).</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig2"><div class="floats-partial-content fig-content-fig2"><div class="partial-carousel--single-image"><img alt="(a)" name="378415.fig.002a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.002a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="378415.fig.002b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.002b.jpg" /><br /><strong>(b)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig2"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="378415.fig.002a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.002a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="378415.fig.002b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.002b.jpg" /><br /><strong>(b)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig2"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 2</span><a aria-label="full view" class="caption-partial-url" href="fig2/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effects of EEAC on wound healing migration of CL1-5 cells. Wound was introduced by scraping confluent cell layers with a pipet tip. CL1-5 cells were incubated with EEAC (0.125, 0.25, 0.5, and 1.0<i></i>g/mL) for 36h, and the migration distances of cells were calculated. (a) Representative photographs of invading cells that received either control or EEAC treatment. (b) Migrated cells across the black lines were counted in six random fields from each treatment. The mean number of cells in the denuded zone is quantified by three independent experiments. Values (means  SD, <svg height="11.125" id="M5" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 36.237499 11.125" width="36.237499" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,0,0,-.017,.062,10.863)"><path d="M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2&#13;&#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z" id="x1D45B"></path></g><g transform="matrix(.017,0,0,-.017,13.305,10.863)"><path d="M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z" id="x3D"></path></g><g transform="matrix(.017,0,0,-.017,28.008,10.863)"><path d="M285 378v-2q65 -13 102 -54.5t37 -97.5q0 -57 -30.5 -104.5t-74 -75t-85.5 -42t-72 -14.5q-31 0 -59.5 11t-40.5 23q-19 18 -16 36q1 16 23 33q13 10 24 0q58 -51 124 -51q55 0 88 40t33 112q0 64 -39 96.5t-88 32.5q-29 0 -64 -11l-6 29q77 25 118 57.5t41 84.5&#13;&#10;q0 45 -26.5 69.5t-68.5 24.5q-67 0 -120 -79l-20 20l43 63q51 56 127 56h1q66 0 107 -37t41 -95q0 -42 -31 -71q-22 -23 -68 -54z" id="x33"></path></g>
</svg>) differ significantly (<svg height="11.375" id="M6" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,0,0,-.017,.062,11.113)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#13;&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,0,0,-.017,15.582,11.113)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,0,0,-.017,30.286,11.113)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#13;&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,0,0,-.017,38.446,11.113)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,0,0,-.017,42.321,11.113)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#13;&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,0,0,-.017,50.481,11.113)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#13;&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>).</table></div></div></div><h5 id="sec3.3">3.3. Effect of EEAC on Migration of CL1-5 Cells In Vitro</h5><p>The transwell assay was used to investigate the migration of CL1-5 cells at 24h after EEAC treatment. We found that EEAC added at 0.1251.0<i></i>g/mL significantly decreased the migration (Figures <a href="fig3/#a" target="_blank">3(a)</a> and <a href="fig3/#b" target="_blank">3(b)</a>) of CL1-5 cells and that these effects of EEAC were dose dependent.</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig3"><div class="floats-partial-content fig-content-fig3"><div class="partial-carousel--single-image"><img alt="(a)" name="378415.fig.003a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.003a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="378415.fig.003b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.003b.jpg" /><br /><strong>(b)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig3"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="378415.fig.003a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.003a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="378415.fig.003b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.003b.jpg" /><br /><strong>(b)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig3"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 3</span><a aria-label="full view" class="caption-partial-url" href="fig3/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effects of EEAC on (a) transwell migration assay of CL1-5 cells. CL1-5 cells were incubated with EEAC (0.25, 0.5 and 1.0<i></i>g/mL) for 24h and 36h, and the (b) transwell migration cells were calculated. Photos of the migration CL1-5 cells were taken under a microscope (200-fold magnification). Values (means  SD, <svg height="11.125" id="M7" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 36.237499 11.125" width="36.237499" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,0,0,-.017,.062,10.863)"><path d="M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2&#13;&#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z" id="x1D45B"></path></g><g transform="matrix(.017,0,0,-.017,13.305,10.863)"><path d="M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z" id="x3D"></path></g><g transform="matrix(.017,0,0,-.017,28.008,10.863)"><path d="M285 378v-2q65 -13 102 -54.5t37 -97.5q0 -57 -30.5 -104.5t-74 -75t-85.5 -42t-72 -14.5q-31 0 -59.5 11t-40.5 23q-19 18 -16 36q1 16 23 33q13 10 24 0q58 -51 124 -51q55 0 88 40t33 112q0 64 -39 96.5t-88 32.5q-29 0 -64 -11l-6 29q77 25 118 57.5t41 84.5&#13;&#10;q0 45 -26.5 69.5t-68.5 24.5q-67 0 -120 -79l-20 20l43 63q51 56 127 56h1q66 0 107 -37t41 -95q0 -42 -31 -71q-22 -23 -68 -54z" id="x33"></path></g>
</svg>) differ significantly (<svg height="11.375" id="M8" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,0,0,-.017,.062,11.113)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#13;&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,0,0,-.017,15.582,11.113)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,0,0,-.017,30.286,11.113)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#13;&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,0,0,-.017,38.446,11.113)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,0,0,-.017,42.321,11.113)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#13;&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,0,0,-.017,50.481,11.113)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#13;&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>).</table></div></div></div><h5 id="sec3.4">3.4. EEAC Inhibits the Release of MMP-2 and MMP-9 in CL1-5 Cells</h5><p>To examine the possible antimigration mechanisms of EEAC, we determined the activity of MMP-2 and MMP-9 in culture media of CL1-5 cells by zymographic analysis. In the absence of treatment, CL1-5 cells constitutively secreted high levels of MMP-9 and MMP-2. Our results showed that EEAC inhibited MMP-9 and MMP-2 activities in a concentration-dependent manner (Figures <a href="fig4/#a" target="_blank">4(a)</a> and <a href="fig4/#b" target="_blank">4(b)</a>). These results suggest that the antimigration effect of EEAC is related to the inhibition of the enzymatically degradative processes of CL1-5 migration.</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig4"><div class="floats-partial-content fig-content-fig4"><div class="partial-carousel--single-image"><img alt="(a)" name="378415.fig.004a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.004a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="378415.fig.004b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.004b.jpg" /><br /><strong>(b)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig4"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="378415.fig.004a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.004a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="378415.fig.004b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.004b.jpg" /><br /><strong>(b)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig4"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 4</span><a aria-label="full view" class="caption-partial-url" href="fig4/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effects of EEAC on MMP-2 and MMP-9 activities of CL1-5 cells. (a) Cells were treated with various concentrations (0.125, 0.25, 0.5, and 1.0<i></i>g/mL) of EEAC for 36h. The conditioned media were collected, and MMP-2, and MMP-9 activities were determined by gelatin zymography. (b) The activities of these proteins were subsequently quantified by densitometric analysis. Values (means  SD, <svg height="11.125" id="M9" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 36.237499 11.125" width="36.237499" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,0,0,-.017,.062,10.863)"><path d="M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2&#13;&#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z" id="x1D45B"></path></g><g transform="matrix(.017,0,0,-.017,13.305,10.863)"><path d="M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z" id="x3D"></path></g><g transform="matrix(.017,0,0,-.017,28.008,10.863)"><path d="M285 378v-2q65 -13 102 -54.5t37 -97.5q0 -57 -30.5 -104.5t-74 -75t-85.5 -42t-72 -14.5q-31 0 -59.5 11t-40.5 23q-19 18 -16 36q1 16 23 33q13 10 24 0q58 -51 124 -51q55 0 88 40t33 112q0 64 -39 96.5t-88 32.5q-29 0 -64 -11l-6 29q77 25 118 57.5t41 84.5&#13;&#10;q0 45 -26.5 69.5t-68.5 24.5q-67 0 -120 -79l-20 20l43 63q51 56 127 56h1q66 0 107 -37t41 -95q0 -42 -31 -71q-22 -23 -68 -54z" id="x33"></path></g>
</svg>) differ significantly (<svg height="11.375" id="M10" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,0,0,-.017,.062,11.113)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#13;&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,0,0,-.017,15.582,11.113)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,0,0,-.017,30.286,11.113)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#13;&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,0,0,-.017,38.446,11.113)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,0,0,-.017,42.321,11.113)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#13;&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,0,0,-.017,50.481,11.113)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#13;&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>) (lower case for MMP-2 and upper case for MMP-9).</table></div></div></div><h5 id="sec3.5">3.5. Inhibition by EEAC of MMP-2 and MMP-9</h5><p>To examine the possible antimigration mechanisms of EEAC, we determined the MMP-2 and MMP-9 expressions in culture media of CL1-5 cells by Western blotting assay. Using Western blotting, we analyzed the effects of treating cells with various concentration of EEAC for 36h on MMPs protein expression. Treatment of CL1-5 cells with EEAC induced noticeable reductions in MMP-9 and MMP-2 protein expression (Figure <a href="fig5/" target="_blank">5</a>).</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig5"><div class="floats-partial-content fig-content-fig5"><div class="partial-carousel--single-image"><img alt="" name="378415.fig.005" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.005.jpg" /><br /><strong></strong></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 5</span><a aria-label="full view" class="caption-partial-url" href="fig5/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effects of EEAC on TIMP-1, TIMP-2, MMP-9, and MMP-2 protein expression. CL1-5 cells were treated with 0.125, 0.25, 0.5, and 1.0<i></i>g/mL for 36h, and cell lysates were subjected to SDS-PAGE followed by western blotting and subsequently quantified by densitometric analyses (using control as 100%). The values indicate the density proportion of each protein compared with control.</table></div></div></div><h5 id="sec3.6">3.6. Effect of EEAC on TIMP-1,TIMP-2, FAK, and Phospharylated FAK (p-FAK) Expressions in CL1-5 Cells</h5><p>To further explore the modulation of pro-MMP activation by EEAC, we determined TIMP-1/2 protein expression levels. As shown in Figure <a href="fig5/" target="_blank">5</a>, EEAC strongly increased TIMP-1 and TIMP-2 activity in a concentration-dependent manner. To evaluate the effect of EEAC on FAK and p-FAK protein expression, CL1-5 cells were treated with EEAC at 0, 0.125, 0.25, 0.5, and 1.0<i></i>g/mL for 36h. As shown in Figure <a href="fig5/" target="_blank">5</a>, EEAC suppressed p-FAK expression in CL1-5 cells, when EEAC concentration was higher than 0.25<i></i>g/mL.</p><h5 id="sec3.7">3.7. Effect of EEAC on PI3K, AKT, Phosphorylated AKT (pAKT), and Rac-1 Expressions in CL1-5 Cells</h5><p>PI3Ks are a group of ubiquitously expressed lipid kinases which are important players in a major pathway of cell signaling. The PI3K/AKT pathway has been identified as a major regulator of cellular proliferation, differentiation, and death in multiple cell types [<a href="#B18">18</a>]. To further investigate the involvement of PI3K/AKT, a series of experiments was performed to measure the expression of candidate signaling molecules upon EEAC stimulation. The results showed that incubation of CL1-5 cells with EEAC (0.1251.0<i></i>g/mL) led to a dose-dependent decrease of PI3K and pAKT levels (Figure <a href="fig6/" target="_blank">6</a>). Similarly, EEAC (01.0<i></i>g/mL,36h) suppressed Rac-1 protein expression in a concentration-dependent manner, and the effect became statistically significant when EEAC concentration was higher than 0.25<i></i>g/mL (Figure <a href="fig6/" target="_blank">6</a>).</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig6"><div class="floats-partial-content fig-content-fig6"><div class="partial-carousel--single-image"><img alt="" name="378415.fig.006" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.006.jpg" /><br /><strong></strong></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 6</span><a aria-label="full view" class="caption-partial-url" href="fig6/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Concentration-dependent effects of EEAC on the protein expression level of PI3K, phosphorylated AKT and Rac-1. In the concentration-dependent assay, CL1-5 cells were treated with 0.125, 0.25, 0.5, and 1.0<i></i>g/mL of EEAC for 36h. The expression of PI3K, phosphorylation of AKT and Rac-1 were analyzed by Western blotting. <i></i>-actin was used as a loading control. The values indicate the density proportion of each protein compared with control.</table></div></div></div><h5 id="sec3.8">3.8. Inhibition by EEAC of Phosphorylated FAK, ERK1/2, p38, and JNK1/2</h5><p>We analyzed the phosphorylation of MAPKs in CL1-5 cells after treatment with EEAC (0.1251.0<i></i>g/mL) for 36h. Data in Figure <a href="fig7/" target="_blank">7</a> showed that EEAC significantly dose-dependently affect p-FAK, p-ERK1/2, p-JNK1/2, or p38 and p-p38 proteins at concentrations from 0.1251.0<i></i>g/mL.</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig7"><div class="floats-partial-content fig-content-fig7"><div class="partial-carousel--single-image"><img alt="(a)" name="378415.fig.007a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.007a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="378415.fig.007b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.007b.jpg" /><br /><strong>(b)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig7"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="378415.fig.007a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.007a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="378415.fig.007b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.007b.jpg" /><br /><strong>(b)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig7"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 7</span><a aria-label="full view" class="caption-partial-url" href="fig7/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effects of EEAC on protein levels of MAPK signaling and phosphorylated focal adhesion kinase (p-FAK) in CL1-5 cells. (a) CL1-5 were treated with several different concentrations of EEAC (0.125, 0.25, 0.5, and 1.0<i></i>g/mL) for 36h. (b) Effects of PI3K inhibitor (LY294002; 50<i></i>M), ERK1/2 inhibitor (PD98059; 50<i></i>M), JNK inhibitor (SP600125; 50<i></i>M), and p38 MAPK inhibitor (SB203580; 50<i></i>M) on EEAC-induced protein expressions of MMP-2 and -9. Cells were pretreated with an inhibitor (50<i></i>M) at 1h prior to the treatment with 1.0<i></i>g/mL EEAC for 36h (total inhibitor exposure time was 37h). Protein expressions of MMP-2 and -9 were determined by the western blotting assay.</table></div></div></div><h5 id="sec3.9">3.9. Specific Inhibitor to Analyze the Signaling Transduction</h5><p>To further delineate whether the inhibition of cell migration by EEAC occurs through inhibition of PI3K, ERK, JNK, and p38 signaling, CL1-5 cells were 1h pretreated with a PI3K inhibitor (LY294002; 50<i></i>M), ERK1/2 inhibitor (PD98059; 50<i></i>M), JNK inhibitor (SP600125; 50<i></i>M), p38 MAPK inhibitor (SB203580; 50<i></i>M), and then incubated in the presence or absence of EEAC (1.0<i></i>g/mL) for 36h. The Western blotting assay revealed that EEAC or LY294002 (50<i></i>M), PD98256 (50<i></i>M), SP600125 (50<i></i>M), SB203580 (50<i></i>M) alone decreased MMP-9 and MMP-2 protein expressions. Furthermore, the combined treatment (50<i></i>M, LY294002, SB203580, SP600125 and PD98059 plus 1.0<i></i>g/mL EEAC) resulted in enhanced inhibition of MMP-9 and MMP-2 (Figure <a href="fig7/#b" target="_blank">7(b)</a>).</p><h4 id="discussions">4. Discussions</h4><p>Several cancer cell lines including A498, NPC-TW01, Hep3B, HepG2, TW206, CL1-0, and CL1-5 have been screed for their cell cytotoxicity at 12, 24, 36, and 48h. Our results showed that CL1-0 (IC<sub>50</sub> = 16<i></i>g/mL) and CL1-5 (IC<sub>50</sub> = 16<i></i>g/mL) exhibits more susceptible to EEAC than other cells for 36h exposure. As CL1-5 cells showed higher metastatic ability, we explored the antimigration effects and mechanistic actions of EEAC in human lung adenocarcinoma CL1-5 cells. Our results demonstrate that EEAC significantly inhibited the migration (assessed using the transwell assay and the wound-healing assay) of CL1-5 cells (Figures <a href="fig2/" target="_blank">2</a> and <a href="fig3/" target="_blank">3</a>). We also showed that EEAC remarkably inhibited the activities of MMP-2 and MMP-9 (Figure <a href="fig4/" target="_blank">4</a>). These results demonstrated that the antimetastastic effect of EEAC was associated with the inhibition of enzymatically degradative processes of smooth muscle cells migration. To our knowledge, it is the first study to demonstrate that EEAC reduces the biochemical mechanisms of the migration in CL1-5 cells.</p><p>Several bioactive compound from the ethanol extract of <i>A. cinnamomea</i>, such as antroquinonol, 4-acetylantroquinonol B, and zhankuic acid A, have been reported to reduce cell proliferation of hepatoma, colon and leukemia cancer cells [<a href="#B21">21</a><a href="#B23">23</a>]. Our previous studies demonstrated that the marked compounds (i.e., adenosine, cordycepin, and zhankuic acid A) within EEAC were identified by HPLC and LC/MS/MS to be as indicator compounds for quality check of extraction procedure of each batch (data not shown). According to the relative concentration of external standards, the content of adenosine, cordycepin and zhankuic acid A were calculated to be 0.08, 0.16, and 235mg/g EEAC, respectively, (data not shown). Of these, adenosine might be through binding to adenosine A3 receptors (A3-AR) to decrease the telomeric signal, resulting in G0/G1 arrest of lymphoma cell. Moreover, A3 receptor antagonist cotreated with cordycepin would reverse cordycepin-induced in mouse Leydig tumor cell death, which indicate the possible relationship between A3-AR and cordycepin-induced death effect [<a href="#B24">24</a>, <a href="#B25">25</a>]. Wu et al. indicated that cordycepin could induce cell arrest at G2/M and subG1 phases followed by significant apoptotic cell death in human OEC-M1 oral cancer cell line [<a href="#B26">26</a>]. Similarly, cordycepin has also been found to cause G2/M arrest in human bladder and colon cancer cells through upregulation of p21<sup>WAF1</sup> level as well as reduction of cyclin B1, Cdc2, and Cdc25c proteins in a p53-independent manner by regulating c-Jun N-terminal kinase activation [<a href="#B27">27</a>, <a href="#B28">28</a>]. Furthermore, Geethangili and Tzeng reported that zhankuic acid A exhibited cytotoxic activity against P-388 murine and leukemia cells with an IC50 value of 1.8 and 5.4<i></i>g/mL, respectively, [<a href="#B29">29</a>].</p><p>During cancer progression, certain tumor cells become motile and attack the host tissue leading to metastasis. Focal adhesion kinase (FAK) can be activated in response to various stimuli and plays an important role in the cancer cell proliferation and metastasis [<a href="#B30">30</a>]. Compiling evidence implies that FAK regulates focal adhesion signaling by phosphorylating various substrates and by acting as a scaffold for protein-protein interactions, as well as the MMPs-mediated matrix degradation, which consecutively regulates downstream signaling cascades [<a href="#B31">31</a>]. FAK, a cytoplasmic kinase that is involved in ECM and integrin-mediated signaling pathways, has been suggested to have an essential role in metastasis through the modulation of tumor cell migration and invasion [<a href="#B32">32</a>]. Majorly, integrin-mediated FAK signaling is phosphorylation of Tyr<sup>397</sup>. Particularly, phosphorylation of Tyr<sup>397</sup> forms a high-affinity binding site for Src-homology domain 2 (SH2), domains of Src family kinase, therefore promoting Src kinase activity. As a result, a major function of FAK is to recruit and activatr Src at cell-extracellular matrix adhesion sites. Activated FAK in cancer cells relays signals through multiple downstream targets. For example, activated FAK binds the SH2 of PI3K, thereby transporting the catalytic subunit of PI3K to the membrane, where it catalyzes the phosphorylation of inositol lipids in lung cancer cell migration [<a href="#B33">33</a>]. The residues surrounding Tyr<sup>397</sup> can also constitute a sequence that binds to the Ras signaling pathway. The downstream targets of the Ras signaling pathway include ERK1/2 [<a href="#B34">34</a>]. Indeed, these pathways are activated during integrin binding to the ECM, resulting in the transduction of external stimuli from the ECM to the nucleus [<a href="#B35">35</a>]. Certain result suggests that anti-invasive effect in androgen-independent prostate cancer by controlling MMP-9 expression through the suppression of the EGFR/JNK pathway [<a href="#B36">36</a>]. FAK and MAPK signaling involved in MMP-2 secretion has been shown in QG90 lung cancer cells [<a href="#B37">37</a>]. Moreover, it was found that the MMP-9 gene promoter is partially regulated through activation of the ERK1/2 pathway [<a href="#B38">38</a>]. In recent, p38 is implicating mediating bladder cancer invasion via regulation of MMP-2 and MMP-9 at the level of mRNA stability [<a href="#B39">39</a>]. Also, p38<i></i> MAPK activates c-Jun, and the activated c-Jun recruits p38<i></i> as a cofactor into MMP-9 promoter to induce its trans-activation and cell invasion [<a href="#B40">40</a>]. In this study, we found that EEAC inhibited the activation of FAK, as evidenced by reduced phosphorylation of FAK (Figure <a href="fig7/#a" target="_blank">7(a)</a>). We also demonstrated that treatment with EEAC inhibited phosphorylation of ERK1/2, phospho-p38, and JNK1/2 activity (Figure <a href="fig7/#a" target="_blank">7(a)</a>). The use of specific inhibitors revealed that PI3K, ERK, JNK, and p38 play important roles in regulating cell death induced by EEAC in CL1-5 cells (Figure <a href="fig7/#b" target="_blank">7(b)</a>). In this study, the Western blotting assay was used to examine the effects of specific MAPK inhibitors, as the same method has often been used to examine the effects of specific MAPK inhibitors [<a href="#B6">6</a>]. Therefore, it appears that FAK can promote CL1-5 cancer cell migration through the MAPK signaling and MMP-2 and MMP-9 pathway.</p><p>In addition, we showed that EEAC inhibited PI3K/AKT in CL1-5 cells. Thus, it seems that FAK promotes CL1-5 cancer cell migration in concert with the activation of the PI3K/AKT signaling pathways. Increased phosphorylation of FAK and its downstream targets, Src, ERK1/2, PI3K, and AKT have been shown in A549 lung epithelial cells stimulated by fibronectin. Consistent with this observation, depletion of FAK by siRNA resulted in the inhibition of Src, ERK1/2, PI3K, and AKT activity [<a href="#B33">33</a>]. Several studies have indicated that FAK/PI3K/Akt is involved in the regulation of MMP-2 and MMP-9 activities on different cell types [<a href="#B9">9</a>, <a href="#B41">41</a>]. Shibata et al. [<a href="#B42">42</a>] have shown that stimulated ovarian cancer cells with fibronectin activated MMP-9 secretion, while both antisense oligonucleotide to FAK and dominant-negative mutation of Ras abolished this phenomenon. To assess whether EEAC inhibits the phosphorylation of FAK, AKT, and the protein level of PI3K, CL1-5 cells were treated with various concentrations of EEAC (0.125, 0.25, 0.5, and 1.0<i></i>g/mL) for 36h. Figure <a href="fig6/" target="_blank">6</a> showed EEAC significantly inhibited the activation of FAK and AKT as shown by the decrease in the phosphorylation of FAK and AKT. In addition, EEAC inhibited the protein levels of PI3K in a dose-dependent manner (Figure <a href="fig6/" target="_blank">6</a>). Zeng et al. [<a href="#B43">43</a>] reported that activated FAK-induced PI3K is required for the production of matrix metalloproteinases (MMPs). Also, PI3K is one of the critical downstream signal molecules of FAK pathways [<a href="#B44">44</a>]. Therefore, our results demonstrated that EEAC inhibited the expressions of p-FAK, pAKT, and PI3K.</p><p>The Rho family of small guanosine triphosphatases (GTPases) (including RhoA, RhoB, c-Raf, Rac-1, and Cdc42) are critical in regulating actin reorganization associated with cell growth, migration, transformation, and gene expression [<a href="#B45">45</a>]. The Rho family of GTPases has been reported to be involved in the regulation of the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway [<a href="#B46">46</a>]. In addition, Campbell et al. [<a href="#B9">9</a>] reported that PI3K/AKT signal transduction pathway regulates cell invasion and metastasis of nonsmall cell lung cancer (NSCLC) and is closely associated with the development and progression of various tumors. Rac1 was reported to act as a downstream effect of PI3-K in several growth factor-stimulated pathways [<a href="#B47">47</a>] and to induce invasion and metastasis in cancer cells [<a href="#B48">48</a>]. Rac1 activation also played a critical role in the migration of cancer cells [<a href="#B49">49</a>]. Rac-1 has been implicated in the regulation of the contraction and retraction forces that are required for cell migration [<a href="#B50">50</a>]. Increased Rac-1 expression enhances the phosphorylation of myosin, which cross-links actin filaments and generates contractile forces, promoting movement of the cell body and facilitating cell rear detachment. Rac-1 is also implicated in the invasion of human microvascular endothelial cells. Active-Rac-1 could induce the expression of MMP-9 metalloproteinase and promote migration of endothelial cells [<a href="#B51">51</a>]. Rac-1 may exert this activity through upregulate transcription factors such as NF-<i></i>B known to be involved in the expression of certain metalloproteinases including MMP-9. Our finding that EEAC concentration dependently decreased Rac-1 protein expression (Figure <a href="fig6/" target="_blank">6</a>), suggesting that EEAC may also inhibit the metastasis of CL1-5 cells through the PI3K/AktRac-1 and Rac-1MMP-9 pathways.</p><p>In conclusion, we have demonstrated that EEAC inhibits the migration of human lung adenocarcinoma cancer CL1-5 cells. Mechanistically, we show that this effect of EEAC may occur through inactivation of the ERK1/2 signaling pathway, exerting inhibitory effects on FAK, p-FAK, and Rac-1 protein expressions and inhibiting PI3K, and phospho-Akt levels, thereby decreasing the activities of MMP-2, MMP-9 of CL1-5 cells (Figure <a href="fig8/" target="_blank">8</a>). Further preclinical and clinical studies are required to demonstrate the potential of EEAC as an anticancer agent.</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig8"><div class="floats-partial-content fig-content-fig8"><div class="partial-carousel--single-image"><img alt="" name="378415.fig.008" src="https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.008.jpg" /><br /><strong></strong></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 8</span><a aria-label="full view" class="caption-partial-url" href="fig8/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Proposed signaling pathways for EEAC-mediated inhibition against migration of CL1-5 cells. The effect of EEAC is achieved likely through the inhibition of FAK, which regulates Rac-1/MMP-9 expression through MAPK and PI3K/AKT signaling pathways.</table></div></div></div><h4 id="abbreviations">Abbreviations</h4><table class="gloss-abbr"><tr><td>MMPs:</td><td>Matrix metalloproteinases</td></tr><tr><td> uPA:</td><td>Urokinase-type plasminogen activator</td></tr><tr><td> ECM:</td><td>Extracellular matrix</td></tr><tr><td> MAPK:</td><td>Mitogen-activated protein kinase</td></tr><tr><td> ERK:</td><td>Extracellular signaling-regulating kinase</td></tr><tr><td> JNK/SAPK:</td><td>c-Jun N-terminal kinase/stress-activated protein kinase</td></tr><tr><td> PI3K:</td><td>Phosphoinositide 3-kinase</td></tr><tr><td>FAK:</td><td>Focal adhesion kinase</td></tr><tr><td> RhoA:</td><td>Ras homologue gene family, member A.</td></tr></table><h4 id="acknowledgments">Acknowledgments</h4><p>The present study was partially supported by CMU98-S-08 and CMU99-TC-29 from China Medical University, Taichung, Taiwan. Also the support was from the National Science Council (NSC 1002320-B-039-014-). This study was supported in part by Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004 and DOH100-TD-B-111-005). W.-S. Chang provided the CL1-5 cells. All authors read and approved the final Paper. The authors have no conflict of interests to report. The authors would like to thank Dr. Jeffrey Conrad for critically reading the paper. They appreciate Dr. Lu Teh-Ling for her kindly provided us SB203580, a p38 inhibitor.</p></div><div class="xml-content"><h4 class="references" id="references">References</h4><ol><li id="B1">A. Jemal, T. Murray, E. Ward et al., Cancer statistics, 2005, <i>Ca-A Cancer Journal for Clinicians</i>, vol. 55, no. 1, pp. 1030, 2005. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Cancer%20statistics,%202005&author=A. Jemal&author=T. Murray&author=E. Ward et al.&publication_year=2005" target="_blank">Google Scholar</a></span><li id="B3">S. Man, W. Gao, Y. Zhang et al., Formosanin C-inhibited pulmonary metastasis through repression of matrix metalloproteinases on mouse lung adenocarcinoma, <i>Cancer Biology and Therapy</i>, vol. 11, no. 6, pp. 592598, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.4161/cbt.11.6.14668">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Formosanin%20C-inhibited%20pulmonary%20metastasis%20through%20repression%20of%20matrix%20metalloproteinases%20on%20mouse%20lung%20adenocarcinoma&author=S. Man&author=W. Gao&author=Y. Zhang et al.&publication_year=2011" target="_blank">Google Scholar</a></span><li id="B4">K. Lirdprapamongkol, J. P. Kramb, T. Suthiphongchai et al., Vanillin suppresses metastatic potential of human cancer cells through PI3K inhibition and decreases angiogenesis in Vivo, <i>Journal of Agricultural and Food Chemistry</i>, vol. 57, no. 8, pp. 30553063, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1021/jf803366f">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Vanillin%20suppresses%20metastatic%20potential%20of%20human%20cancer%20cells%20through%20PI3K%20inhibition%20and%20decreases%20angiogenesis%20in%20Vivo&author=K. Lirdprapamongkol&author=J. P. Kramb&author=T. Suthiphongchai et al.&publication_year=2009" target="_blank">Google Scholar</a></span><li id="B2">Y. W. Chu, P. C. Yang, S. C. Yang et al., Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line, <i>American Journal of Respiratory Cell and Molecular Biology</i>, vol. 17, no. 3, pp. 353360, 1997. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Selection%20of%20invasive%20and%20metastatic%20subpopulations%20from%20a%20human%20lung%20adenocarcinoma%20cell%20line&author=Y. W. Chu&author=P. C. Yang&author=S. C. Yang et al.&publication_year=1997" target="_blank">Google Scholar</a></span><li id="B5">M. Kodate, T. Kasai, H. Hashimoto, K. Yasumoto, Y. Iwata, and H. Manabe, Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung, <i>Pathology International</i>, vol. 47, no. 7, pp. 461469, 1997. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Expression%20of%20matrix%20metalloproteinase%20(gelatinase)%20in%20T1%20adenocarcinoma%20of%20the%20lung&author=M. Kodate&author=T. Kasai&author=H. Hashimoto&author=K. Yasumoto&author=Y. Iwata&author=&author=H. Manabe&publication_year=1997" target="_blank">Google Scholar</a></span><li id="B6">C. J. Weng, C. F. Wu, H. W. Huang, C. H. Wu, C. T. Ho, and G. C. Yen, Evaluation of anti-invasion effect of resveratrol and related methoxy analogues on human hepatocarcinoma cells, <i>Journal of Agricultural and Food Chemistry</i>, vol. 58, no. 5, pp. 28862894, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1021/jf904182y">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Evaluation%20of%20anti-invasion%20effect%20of%20resveratrol%20and%20related%20methoxy%20analogues%20on%20human%20hepatocarcinoma%20cells&author=C. J. Weng&author=C. F. Wu&author=H. W. Huang&author=C. H. Wu&author=C. T. Ho&author=&author=G. C. Yen&publication_year=2010" target="_blank">Google Scholar</a></span><li id="B7">G. J. Huang, C. M. Yang, Y. S. Chang et al., Hispolon suppresses SK-Hep1 human hepatoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen activator through the PI3K/Akt and ERK signaling pathways, <i>Journal of Agricultural and Food Chemistry</i>, vol. 58, no. 17, pp. 94689475, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1021/jf101508r">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Hispolon%20suppresses%20SK-Hep1%20human%20hepatoma%20cell%20metastasis%20by%20inhibiting%20matrix%20metalloproteinase-2/9%20and%20urokinase-plasminogen%20activator%20through%20the%20PI3K/Akt%20and%20ERK%20signaling%20pathways&author=G. J. Huang&author=C. M. Yang&author=Y. S. Chang et al.&publication_year=2010" target="_blank">Google Scholar</a></span><li id="B8">A. K. Gupta, D. E. Soto, M. D. Feldman et al., Signaling pathways in NSCLC as a predictor of outcome and response to therapy, <i>Lung</i>, vol. 182, no. 3, pp. 151162, 2004. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Signaling%20pathways%20in%20NSCLC%20as%20a%20predictor%20of%20outcome%20and%20response%20to%20therapy&author=A. K. Gupta&author=D. E. Soto&author=M. D. Feldman et al.&publication_year=2004" target="_blank">Google Scholar</a></span><li id="B9">I. G. Campbell, S. E. Russell, D. Y. H. Choong et al., Mutation of the PIK3CA gene in ovarian and breast cancer, <i>Cancer Research</i>, vol. 64, no. 21, pp. 76787681, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1158/0008-5472.CAN-04-2933">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Mutation%20of%20the%20PIK3CA%20gene%20in%20ovarian%20and%20breast%20cancer&author=I. G. Campbell&author=S. E. Russell&author=D. Y. H. Choong et al.&publication_year=2004" target="_blank">Google Scholar</a></span><li id="B10">Y. W. Shih, P. S. Chen, C. H. Wu, Y. F. Jeng, and C. J. Wang, <i></i>-Chaconine-reduced metastasis involves a PI3K/Akt signaling pathway with downregulation of NF-<i></i>B in human lung adenocarcinoma A549 cells, <i>Journal of Agricultural and Food Chemistry</i>, vol. 55, no. 26, pp. 1103511043, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1021/jf072423r">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=a-Chaconine-reduced%20metastasis%20involves%20a%20PI3K/Akt%20signaling%20pathway%20with%20downregulation%20of%20NF-?B%20in%20human%20lung%20adenocarcinoma%20A549%20cells&author=Y. W. Shih&author=P. S. Chen&author=C. H. Wu&author=Y. F. Jeng&author=&author=C. J. Wang&publication_year=2007" target="_blank">Google Scholar</a></span><li id="B11">Z. T. Tsai and S. L. Liaw, <i>The Use and the Effect of Ganoderma</i>, San Yun Press, Taichung, Taiwan, 1985. <span class="reflinks"></span><li id="B12">Z. H. Ao, Z. H. Xu, Z. M. Lu, H. Y. Xu, X. M. Zhang, and W. F. Dou, Niuchangchih (<i>Antrodia camphorata</i>) and its potential in treating liver diseases, <i>Journal of Ethnopharmacology</i>, vol. 121, no. 2, pp. 194212, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.jep.2008.10.039">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Niuchangchih%20(Antrodia%20camphorata)%20and%20its%20potential%20in%20treating%20liver%20diseases&author=Z. H. Ao&author=Z. H. Xu&author=Z. M. Lu&author=H. Y. Xu&author=X. M. Zhang&author=&author=W. F. Dou&publication_year=2009" target="_blank">Google Scholar</a></span><li id="B13">C. C. Chen, Y. W. Liu, Y. B. Ker et al., Chemical characterization and anti-inflammatory effect of polysaccharides fractionated from submerge-cultured <i>Antrodia camphorata</i> mycelia, <i>Journal of Agricultural and Food Chemistry</i>, vol. 55, no. 13, pp. 50075012, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1021/jf063484c">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Chemical%20characterization%20and%20anti-inflammatory%20effect%20of%20polysaccharides%20fractionated%20from%20submerge-cultured%20Antrodia%20camphorata%20mycelia&author=C. C. Chen&author=Y. W. Liu&author=Y. B. Ker et al.&publication_year=2007" target="_blank">Google Scholar</a></span><li id="B14">H. L. Yang, Y. C. Hseu, J. Y. Chen et al., Antrodia camphorata in submerged culture protects low density lipoproteins against oxidative modification, <i>American Journal of Chinese Medicine</i>, vol. 34, no. 2, pp. 217231, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1142/S0192415X06003783">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Antrodia%20camphorata%20in%20submerged%20culture%20protects%20low%20density%20lipoproteins%20against%20oxidative%20modification&author=H. L. Yang&author=Y. C. Hseu&author=J. Y. Chen et al.&publication_year=2006" target="_blank">Google Scholar</a></span><li id="B15">H. Wu, C. L. Pan, Y. C. Yao, S. S. Chang, S. L. Li, and T. F. Wu, Proteomic analysis of the effect of Antrodia camphorata extract on human lung cancer A549 cell, <i>Proteomics</i>, vol. 6, no. 3, pp. 826835, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1002/pmic.200401341">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Proteomic%20analysis%20of%20the%20effect%20of%20Antrodia%20camphorata%20extract%20on%20human%20lung%20cancer%20A549%20cell&author=H. Wu&author=C. L. Pan&author=Y. C. Yao&author=S. S. Chang&author=S. L. Li&author=&author=T. F. Wu&publication_year=2006" target="_blank">Google Scholar</a></span><li id="B16">Y. C. Hseu, S. C. Chen, H. C. Chen, J. W. Liao, and H. L. Yang, Antrodia camphorata inhibits proliferation of human breast cancer cells in vitro and in vivo, <i>Food and Chemical Toxicology</i>, vol. 46, no. 8, pp. 26802688, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.fct.2008.04.036">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Antrodia%20camphorata%20inhibits%20proliferation%20of%20human%20breast%20cancer%20cells%20in%20vitro%20and%20in%20vivo&author=Y. C. Hseu&author=S. C. Chen&author=H. C. Chen&author=J. W. Liao&author=&author=H. L. Yang&publication_year=2008" target="_blank">Google Scholar</a></span><li id="B17">Y. W. Lin, J. H. Pan, R. H. Liu, Y. H. Kuo, L. Y. Sheen, and B. H. Chiang, The 4-acetylantroquinonol B isolated from mycelium of Antrodia cinnamomea inhibits proliferation of hepatoma cells, <i>Journal of the Science of Food and Agriculture</i>, vol. 90, no. 10, pp. 17391744, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1002/jsfa.4010">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%204-acetylantroquinonol%20B%20isolated%20from%20mycelium%20of%20Antrodia%20cinnamomea%20inhibits%20proliferation%20of%20hepatoma%20cells&author=Y. W. Lin&author=J. H. Pan&author=R. H. Liu&author=Y. H. Kuo&author=L. Y. Sheen&author=&author=B. H. Chiang&publication_year=2010" target="_blank">Google Scholar</a></span><li id="B18">H. L. Yang, Y. H. Kuo, C. T. Tsai et al., Anti-metastatic activities of Antrodia camphorata against human breast cancer cells mediated through suppression of the MAPK signaling pathway, <i>Food and Chemical Toxicology</i>, vol. 49, no. 1, pp. 290298, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.fct.2010.10.031">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Anti-metastatic%20activities%20of%20Antrodia%20camphorata%20against%20human%20breast%20cancer%20cells%20mediated%20through%20suppression%20of%20the%20MAPK%20signaling%20pathway&author=H. L. Yang&author=Y. H. Kuo&author=C. T. Tsai et al.&publication_year=2011" target="_blank">Google Scholar</a></span><li id="B19">M. H. Pan, C. C. Lin, J. K. Lin, and W. J. Chen, Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-<i></i>1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling, <i>Journal of Agricultural and Food Chemistry</i>, vol. 55, no. 13, pp. 50305037, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1021/jf070316r">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Tea%20polyphenol%20(-)-epigallocatechin%203-gallate%20suppresses%20heregulin-1-induced%20fatty%20acid%20synthase%20expression%20in%20human%20breast%20cancer%20cells%20by%20inhibiting%20phosphatidylinositol%203-kinase/Akt%20and%20mitogen-activated%20protein%20kinase%20cascade%20signaling&author=M. H. Pan&author=C. C. Lin&author=J. K. Lin&author=&author=W. J. Chen&publication_year=2007" target="_blank">Google Scholar</a></span><li id="B20">S. J. Lee, S. K. Kim, W. S. Choi, W. J. Kim, and S. K. Moon, Cordycepin causes p21WAF1-mediated G2/M cell-cycle arrest by regulating c-Jun N-terminal kinase activation in human bladder cancer cells, <i>Archives of Biochemistry and Biophysics</i>, vol. 490, no. 2, pp. 103109, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.abb.2009.09.001">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Cordycepin%20causes%20p21WAF1-mediated%20G2/M%20cell-cycle%20arrest%20by%20regulating%20c-Jun%20N-terminal%20kinase%20activation%20in%20human%20bladder%20cancer%20cells&author=S. J. Lee&author=S. K. Kim&author=W. S. Choi&author=W. J. Kim&author=&author=S. K. Moon&publication_year=2009" target="_blank">Google Scholar</a></span><li id="B21">P. C. Chiang, S. C. Lin, S. L. Pan et al., Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: a crucial role of AMPK and mTOR pathways, <i>Biochemical Pharmacology</i>, vol. 79, no. 2, pp. 162171, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.bcp.2009.08.022">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Antroquinonol%20displays%20anticancer%20potential%20against%20human%20hepatocellular%20carcinoma%20cells:%20a%20crucial%20role%20of%20AMPK%20and%20mTOR%20pathways&author=P. C. Chiang&author=S. C. Lin&author=S. L. Pan et al.&publication_year=2010" target="_blank">Google Scholar</a></span><li id="B22">Y. W. Lin, J. H. Pan, R. H. Liu, Y. H. Kuo, L. Y. Sheen, and B. H. Chiang, The 4-acetylantroquinonol B isolated from mycelium of Antrodia cinnamomea inhibits proliferation of hepatoma cells, <i>Journal of the Science of Food and Agriculture</i>, vol. 90, no. 10, pp. 17391744, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1002/jsfa.4010">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%204-acetylantroquinonol%20B%20isolated%20from%20mycelium%20of%20Antrodia%20cinnamomea%20inhibits%20proliferation%20of%20hepatoma%20cells&author=Y. W. Lin&author=J. H. Pan&author=R. H. Liu&author=Y. H. Kuo&author=L. Y. Sheen&author=&author=B. H. Chiang&publication_year=2010" target="_blank">Google Scholar</a></span><li id="B23">C. T. Yeh, Y. K. Rao, C. J. Yao et al., Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells, <i>Cancer Letters</i>, vol. 285, no. 1, pp. 7379, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.canlet.2009.05.002">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Cytotoxic%20triterpenes%20from%20Antrodia%20camphorata%20and%20their%20mode%20of%20action%20in%20HT-29%20human%20colon%20cancer%20cells&author=C. T. Yeh&author=Y. K. Rao&author=C. J. Yao et al.&publication_year=2009" target="_blank">Google Scholar</a></span><li id="B24">P. Fishman, S. Bar-Yehuda, G. Ohana et al., Adenosine acts as an inhibitor of lymphoma cell growtha major role for the A3 adenosine receptor, <i>European Journal of Cancer</i>, vol. 36, no. 11, pp. 14521458, 2000. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0959-8049(00)00130-1">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Adenosine%20acts%20as%20an%20inhibitor%20of%20lymphoma%20cell%20growtha%20major%20role%20for%20the%20A3%20adenosine%20receptor&author=P. Fishman&author=S. Bar-Yehuda&author=G. Ohana et al.&publication_year=2000" target="_blank">Google Scholar</a></span><li id="B25">B.-M. Huang, B.-S. Pan, and C.-Y. Lin, The effect of cordycepin on steroidogenesis and apoptosis in MA-10 mouse Leydig tumor cells, <i>Evidence-Based Complementary and Alternative Medicine</i>, vol. 2011, Article ID 750468, 14 pages, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1155/2011/750468">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20effect%20of%20cordycepin%20on%20steroidogenesis%20and%20apoptosis%20in%20MA-10%20mouse%20Leydig%20tumor%20cells&author=B.-M. Huang&author=B.-S. Pan&author=&author=C.-Y. Lin&publication_year=2011" target="_blank">Google Scholar</a></span><li id="B26">W. C. Wu, J. R. Hsiao, Y. Y. Lian, C. Y. Lin, and B. M. Huang, The apoptotic effect of cordycepin on human OEC-M1 oral cancer cell line, <i>Cancer Chemotherapy and Pharmacology</i>, vol. 60, no. 1, pp. 103111, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1007/s00280-006-0354-y">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20apoptotic%20effect%20of%20cordycepin%20on%20human%20OEC-M1%20oral%20cancer%20cell%20line&author=W. C. Wu&author=J. R. Hsiao&author=Y. Y. Lian&author=C. Y. Lin&author=&author=B. M. Huang&publication_year=2007" target="_blank">Google Scholar</a></span><li id="B27">S. J. Lee, S. K. Kim, W. S. Choi, W. J. Kim, and S. K. Moon, Cordycepin causes p21WAF1-mediated G2/M cell-cycle arrest by regulating c-Jun N-terminal kinase activation in human bladder cancer cells, <i>Archives of Biochemistry and Biophysics</i>, vol. 490, no. 2, pp. 103109, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.abb.2009.09.001">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Cordycepin%20causes%20p21WAF1-mediated%20G2/M%20cell-cycle%20arrest%20by%20regulating%20c-Jun%20N-terminal%20kinase%20activation%20in%20human%20bladder%20cancer%20cells&author=S. J. Lee&author=S. K. Kim&author=W. S. Choi&author=W. J. Kim&author=&author=S. K. Moon&publication_year=2009" target="_blank">Google Scholar</a></span><li id="B28">S. J. Lee, G. S. Moon, K. H. Jung, W. J. Kim, and S. K. Moon, c-Jun N-terminal kinase 1 is required for cordycepin-mediated induction of G2/M cell-cycle arrest via p21WAF1 expression in human colon cancer cells, <i>Food and Chemical Toxicology</i>, vol. 48, no. 1, pp. 277283, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.fct.2009.09.042">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=c-Jun%20N-terminal%20kinase%201%20is%20required%20for%20cordycepin-mediated%20induction%20of%20G2/M%20cell-cycle%20arrest%20via%20p21WAF1%20expression%20in%20human%20colon%20cancer%20cells&author=S. J. Lee&author=G. S. Moon&author=K. H. Jung&author=W. J. Kim&author=&author=S. K. Moon&publication_year=2010" target="_blank">Google Scholar</a></span><li id="B29">Y.-M. Tzeng and M. Geethangili, Review of pharmacological effects of antrodia camphorata and its bioactive compounds, <i>Evidence-Based Complementary and Alternative Medicine</i>, vol. 2011, Article ID 212641, 17 pages, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1093/ecam/nep108">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Review%20of%20pharmacological%20effects%20of%20antrodia%20camphorata%20and%20its%20bioactive%20compounds&author=Y.-M. Tzeng &author=M. Geethangili&publication_year=2011" target="_blank">Google Scholar</a></span><li id="B30">J. T. Parsons, Focal adhesion kinase: the first ten years, <i>Journal of Cell Science</i>, vol. 116, no. 8, pp. 14091416, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1242/jcs.00373">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Focal%20adhesion%20kinase:%20the%20first%20ten%20years&author=J. T. Parsons&publication_year=2003" target="_blank">Google Scholar</a></span><li id="B31">M. Canel, P. Secades, M. Garzn-Arango et al., Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression, <i>British Journal of Cancer</i>, vol. 98, no. 7, pp. 12741284, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1038/sj.bjc.6604286">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Involvement%20of%20focal%20adhesion%20kinase%20in%20cellular%20invasion%20of%20head%20and%20neck%20squamous%20cell%20carcinomas%20via%20regulation%20of%20MMP-2%20expression&author=M. Canel&author=P. Secades&author=M. Garzn-Arango et al.&publication_year=2008" target="_blank">Google Scholar</a></span><li id="B32">C. Hwangbo, J. Kim, J. J. Lee, and J. H. Lee, Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase C<i></i> and the PDZ adapter protein mda-9/syntenin, <i>Cancer Research</i>, vol. 70, no. 4, pp. 16451655, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1158/0008-5472.CAN-09-2447">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Activation%20of%20the%20integrin%20effector%20kinase%20focal%20adhesion%20kinase%20in%20cancer%20cells%20is%20regulated%20by%20crosstalk%20between%20protein%20kinase%20Ca%20and%20the%20PDZ%20adapter%20protein%20mda-9/syntenin&author=C. Hwangbo&author=J. Kim&author=J. J. Lee&author=&author=J. H. Lee&publication_year=2010" target="_blank">Google Scholar</a></span><li id="B33">X. N. Meng, Y. Jin, Y. Yu et al., Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion, <i>British Journal of Cancer</i>, vol. 101, no. 2, pp. 327334, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1038/sj.bjc.6605154">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Characterisation%20of%20fibronectin-mediated%20FAK%20signalling%20pathways%20in%20lung%20cancer%20cell%20migration%20and%20invasion&author=X. N. Meng&author=Y. Jin&author=Y. Yu et al.&publication_year=2009" target="_blank">Google Scholar</a></span><li id="B34">K. C. Lai, A. N. C. Huang, S. C. Hsu et al., Benzyl Lsothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway, <i>Journal of Agricultural and Food Chemistry</i>, vol. 58, no. 5, pp. 29352942, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1021/jf9036694">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Benzyl%20Lsothiocyanate%20(BITC)%20inhibits%20migration%20and%20invasion%20of%20human%20colon%20cancer%20HT29%20cells%20by%20inhibiting%20matrix%20metalloproteinase-2/-9%20and%20urokinase%20plasminogen%20(uPA)%20through%20PKC%20and%20MAPK%20signaling%20pathway&author=K. C. Lai&author=A. N. C. Huang&author=S. C. Hsu et al.&publication_year=2010" target="_blank">Google Scholar</a></span><li id="B35">H. F. Liao, Y. Y. Chen, J. J. Liu et al., Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis, <i>Journal of Agricultural and Food Chemistry</i>, vol. 51, no. 27, pp. 79077912, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1021/jf034729d">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Inhibitory%20effect%20of%20caffeic%20acid%20phenethyl%20ester%20on%20angiogenesis,%20tumor%20invasion,%20and%20metastasis&author=H. F. Liao&author=Y. Y. Chen&author=J. J. Liu et al.&publication_year=2003" target="_blank">Google Scholar</a></span><li id="B36">P. T. Kuo, T. P. Lin, L. C. Liu et al., Penta-O-galloyl-<i></i>-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression, <i>Journal of Agricultural and Food Chemistry</i>, vol. 57, no. 8, pp. 33313339, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1021/jf803725h">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Penta-O-galloyl--D-glucose%20suppresses%20prostate%20cancer%20bone%20metastasis%20by%20transcriptionally%20repressing%20EGF-induced%20MMP-9%20expression&author=P. T. Kuo&author=T. P. Lin&author=L. C. Liu et al.&publication_year=2009" target="_blank">Google Scholar</a></span><li id="B37">Y. Zhang, A. A. Thant, Y. Hiraiwa et al., A role for focal adhesion kinase in hyluronan-dependent MMP-2 secretion in a human small-cell lung carcinoma cell line, QG90, <i>Biochemical and Biophysical Research Communications</i>, vol. 290, no. 3, pp. 11231127, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1006/bbrc.2001.6321">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20role%20for%20focal%20adhesion%20kinase%20in%20hyluronan-dependent%20MMP-2%20secretion%20in%20a%20human%20small-cell%20lung%20carcinoma%20cell%20line,%20QG90&author=Y. Zhang&author=A. A. Thant&author=Y. Hiraiwa et al.&publication_year=2002" target="_blank">Google Scholar</a></span><li id="B38">C.-Y. Huang, Y.-M. Chang, Y.-T. Shih et al., Schwann cell migration induced by earthworm extract via activation of PAs and MMP2/9 mediated through ERK1/2 and p38, <i>Evidence-based Complementary and Alternative Medicine</i>, vol. 2011, Article ID 395458, 12 pages, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1093/ecam/nep131">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Schwann%20cell%20migration%20induced%20by%20earthworm%20extract%20via%20activation%20of%20PAs%20and%20MMP2/9%20mediated%20through%20ERK1/2%20and%20p38&author=C.-Y. Huang&author=Y.-M. Chang&author=Y.-T. Shih et al.&publication_year=2011" target="_blank">Google Scholar</a></span><li id="B39">B. Kumar, S. Koul, J. Petersen et al., p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity, <i>Cancer Research</i>, vol. 70, no. 2, pp. 832841, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1158/0008-5472.CAN-09-2918">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=p38%20mitogen-activated%20protein%20kinase-driven%20MAPKAPK2%20regulates%20invasion%20of%20bladder%20cancer%20by%20modulation%20of%20MMP-2%20and%20MMP-9%20activity&author=B. Kumar&author=S. Koul&author=J. Petersen et al.&publication_year=2010" target="_blank">Google Scholar</a></span><li id="B40">M. Loesch, H. Y. Zhi, S. W. Hou et al., p38<i></i> MAPK cooperates with c-Jun in trans-activating matrix metalloproteinase 9, <i>Journal of Biological Chemistry</i>, vol. 285, no. 20, pp. 1514915158, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1074/jbc.M110.105429">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=p38?%20MAPK%20cooperates%20with%20c-Jun%20in%20trans-activating%20matrix%20metalloproteinase%209&author=M. Loesch&author=H. Y. Zhi&author=S. W. Hou et al.&publication_year=2010" target="_blank">Google Scholar</a></span><li id="B41">K. C. Chan, H. H. Ho, C. N. Huang, M. C. Lin, H. M. Chen, and C. J. Wang, Mulberry leaf extract inhibits vascular smooth muscle cell migration involving a block of small GTPase and Akt/NF-kB signals, <i>Journal of Agricultural and Food Chemistry</i>, vol. 57, no. 19, pp. 91479153, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1021/jf902507k">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Mulberry%20leaf%20extract%20inhibits%20vascular%20smooth%20muscle%20cell%20migration%20involving%20a%20block%20of%20small%20GTPase%20and%20Akt/NF-kB%20signals&author=K. C. Chan&author=H. H. Ho&author=C. N. Huang&author=M. C. Lin&author=H. M. Chen&author=&author=C. J. Wang&publication_year=2009" target="_blank">Google Scholar</a></span><li id="B42">K. Shibata, F. Kikkawa, A. Nawa et al., Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells, <i>Cancer Research</i>, vol. 58, no. 5, pp. 900903, 1998. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Both%20focal%20adhesion%20kinase%20and%20c-Ras%20are%20required%20for%20the%20enhanced%20matrix%20metalloproteinase%209%20secretion%20by%20fibronectin%20in%20ovarian%20cancer%20cells&author=K. Shibata&author=F. Kikkawa&author=A. Nawa et al.&publication_year=1998" target="_blank">Google Scholar</a></span><li id="B43">Z. Z. Zeng, Y. Jia, N. J. Hahn, S. M. Markwart, K. F. Rockwood, and D. L. Livant, Role of focal adhesion kinase and phosphatidylinositol 3-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells, <i>Cancer Research</i>, vol. 66, no. 16, pp. 80918099, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1158/0008-5472.CAN-05-4400">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Role%20of%20focal%20adhesion%20kinase%20and%20phosphatidylinositol%203'-kinase%20in%20integrin%20fibronectin%20receptor-mediated,%20matrix%20metalloproteinase-1-dependent%20invasion%20by%20metastatic%20prostate%20cancer%20cells&author=Z. Z. Zeng&author=Y. Jia&author=N. J. Hahn&author=S. M. Markwart&author=K. F. Rockwood&author=&author=D. L. Livant&publication_year=2006" target="_blank">Google Scholar</a></span><li id="B44">Y. A. Choi, H. K. Lim, J. R. Kim et al., Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway, <i>Journal of Biological Chemistry</i>, vol. 279, no. 35, pp. 3657936585, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1074/jbc.M314235200">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Group%20IB%20secretory%20phospholipase%20A2%20promotes%20matrix%20metalloproteinase-2-mediated%20cell%20migration%20via%20the%20phosphatidylinositol%203-kinase%20and%20Akt%20pathway&author=Y. A. Choi&author=H. K. Lim&author=J. R. Kim et al.&publication_year=2004" target="_blank">Google Scholar</a></span><li id="B45">K. Wennerberg and C. J. Der, Rho-family GTPases: it's not only Rac and Rho (and i like it), <i>Journal of Cell Science</i>, vol. 117, no. 8, pp. 13011312, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1242/jcs.01118">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Rho-family%20GTPases:%20it's%20not%20only%20Rac%20and%20Rho%20(and%20i%20like%20it)&author=K. Wennerberg &author=C. J. Der&publication_year=2004" target="_blank">Google Scholar</a></span><li id="B46">S. C. Hubchak, E. E. Sparks, T. Hayashida, and H. W. Schnaper, Rac1 promotes TGF-<i></i>-stimulated mesangial cell type I collagen expression through a PI3K/Akt-dependent mechanism, <i>American Journal of Physiology</i>, vol. 297, no. 5, pp. F1316F1323, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1152/ajprenal.00345.2009">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Rac1%20promotes%20TGF--stimulated%20mesangial%20cell%20type%20I%20collagen%20expression%20through%20a%20PI3K/Akt-dependent%20mechanism&author=S. C. Hubchak&author=E. E. Sparks&author=T. Hayashida&author=&author=H. W. Schnaper&publication_year=2009" target="_blank">Google Scholar</a></span><li id="B47">M. Higuchi, N. Masuyama, Y. Fukui, A. Suzuki, and Y. Gotoh, Akt mediates Rac/Cdc42-regulated cell motility in growth factor-stimulated cells and in invasive PTEN knockout cells, <i>Current Biology</i>, vol. 11, no. 24, pp. 19581962, 2001. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0960-9822(01)00599-1">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Akt%20mediates%20Rac/Cdc42-regulated%20cell%20motility%20in%20growth%20factor-stimulated%20cells%20and%20in%20invasive%20PTEN%20knockout%20cells&author=M. Higuchi&author=N. Masuyama&author=Y. Fukui&author=A. Suzuki&author=&author=Y. Gotoh&publication_year=2001" target="_blank">Google Scholar</a></span><li id="B48">L. S. Price and J. G. Collard, Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion, <i>Seminars in Cancer Biology</i>, vol. 11, no. 2, pp. 167173, 2001. <span class="reflinks">View at: <a href="https://doi.org/10.1006/scbi.2000.0367">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Regulation%20of%20the%20cytoskeleton%20by%20Rho-family%20GTPases:%20implications%20for%20tumour%20cell%20invasion&author=L. S. Price &author=J. G. Collard&publication_year=2001" target="_blank">Google Scholar</a></span><li id="B49">J. C. Stam, F. Michiels, R. A. Van Der Kammen, W. H. Moolenaar, and J. G. Collard, Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling, <i>EMBO Journal</i>, vol. 17, no. 14, pp. 40664074, 1998. <span class="reflinks">View at: <a href="https://doi.org/10.1093/emboj/17.14.4066">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Invasion%20of%20T-lymphoma%20cells:%20cooperation%20between%20Rho%20family%20GTPases%20and%20lysophospholipid%20receptor%20signaling&author=J. C. Stam&author=F. Michiels&author=R. A. Van Der Kammen&author=W. H. Moolenaar&author=&author=J. G. Collard&publication_year=1998" target="_blank">Google Scholar</a></span><li id="B50">Y. C. Lee, T. H. Cheng, J. S. Lee et al., Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells, <i>Molecular and Cellular Biochemistry</i>, pp. 113, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1007/s11010-010-0618-z">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Nobiletin,%20a%20citrus%20flavonoid,%20suppresses%20invasion%20and%20migration%20involving%20FAK/PI3K/Akt%20and%20small%20GTPase%20signals%20in%20human%20gastric%20adenocarcinoma%20AGS%20cells&author=Y. C. Lee&author=T. H. Cheng&author=J. S. Lee et al.&publication_year=2010" target="_blank">Google Scholar</a></span><li id="B51">N. Shirvaikar, L. A. Marquez-Curtis, M. Z. Ratajczak, and A. Janowska-Wieczorek, Hyaluronic acid and thrombin upregulate MT1-MMP through PI3K and Rac-1 signaling and prime the homing-related responses of cord blood hematopoietic stem/progenitor cells, <i>Stem Cells and Development</i>, vol. 20, no. 1, pp. 1930, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1089/scd.2010.0118">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Hyaluronic%20acid%20and%20thrombin%20upregulate%20MT1-MMP%20through%20PI3K%20and%20Rac-1%20signaling%20and%20prime%20the%20homing-related%20responses%20of%20cord%20blood%20hematopoietic%20stem/progenitor%20cells&author=N. Shirvaikar&author=L. A. Marquez-Curtis&author=M. Z. Ratajczak&author=&author=A. Janowska-Wieczorek&publication_year=2011" target="_blank">Google Scholar</a></span></li></ol></div><div class="xml-content"><h4 class="copyright" id="copyright">Copyright</h4><p>Copyright  2012 Ying-Yi Chen et al. This is an open access article distributed under the <a rel="license" href="http://creativecommons.org/licenses/by/3.0/">  Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></div></div></article></div></div></div><div class="biblio__Wrapper-sc-1nou1lz-0 eyHfWh journal_article__BiblioIntegratorWidget-sc-12fk6zy-5 dbAANp article_widget biblioWrapper hide"><hr/><h4 class="biblio__H4-sc-1nou1lz-2 becpDt hrTitleRef">More related articles</h4><div id="biblio_widget" class="biblio__BiblioWrapper-sc-1nou1lz-1 kbSZJl"></div></div></div></div><div class="threeColumn__RightWrapper-sc-1bf4078-2 jzTMLK rightWrapper" id="rightSectionMenu"><div><div class="journal_article__ArticleStickyTopToolbar-sc-12fk6zy-0 gbrQxi article_sticky_top_toolbar"><div class="sc-cBdUnI hRnXob article_top_toolbar"><a class="sc-htpNat bUhGXt link sc-jtRfpW dUABlg sc-exkUMo hymroZ pdf_desktop button__group" href="https://downloads.hindawi.com/journals/ecam/2012/378415.pdf" aria-label="" target="_blank" id="toolbar__dcNavSmall"><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ eujois" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/pdf.svg" height="24"/><span class="text">PDF</span></span><span class="sc-htoDjs bqeMOy sc-dqBHgY cQgXqt fileArrow icon-colored _3P4iUn1NDM5G77nWCamJ4l icon-themeable" title="" font-size="20"></span></a><a class="sc-htpNat bUhGXt link sc-jtRfpW dUABlg sc-kcDeIU cbcyj ref_desktop" href="/journals/ecam/2012/378415.ris" aria-label="" target="" id="toolbar__dcNavLarge"><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ eujois" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="text">Download Citation</span></span><span class="sc-htoDjs bqeMOy sc-dqBHgY cQgXqt fileArrow icon-colored _3P4iUn1NDM5G77nWCamJ4l icon-themeable" title="" font-size="20"></span></a><a class="sc-htpNat bUhGXt link sc-jtRfpW dUABlg sc-BngTV hmDWcT ref_desktop" href="/journals/ecam/2012/378415.ris" aria-label="" target="" id="toolbar__dcNavSmall"><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ eujois" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="text">Citation</span></span><span class="sc-htoDjs bqeMOy sc-dqBHgY cQgXqt fileArrow icon-colored _3P4iUn1NDM5G77nWCamJ4l icon-themeable" title="" font-size="20"></span></a></div></div><div class="journal_article__ArticleStickyBottomToolbar-sc-12fk6zy-1 isgRZA article_sticky_bottom_toolbar"><div class="sc-cTjmhe ihmyEq article_bottom_toolbar"><div class="sc-cugefK itFKcQ accordion" property="background-color" color="#D8D8D8" id="toolbar__dofNav"><span><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="sc-dRFtgE jrsDZP">Download other formats</span><span class="sc-gkFcWv gWTCXQ">More</span></span><span class="sc-htoDjs bMdQcY sc-gbOuXE jGPvPL icon-colored _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="11"></span></div><div class="sc-fnwBNb etzuBr"><a class="sc-htpNat bUhGXt link sc-iNhVCk gWgCNb open_panel" href="https://downloads.hindawi.com/journals/ecam/2012/378415.epub" aria-label="ePub" property="background-color" color="#D8D8D8"><div class="sc-eAKXzc WHkfb">ePub</div><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a><a class="sc-htpNat bUhGXt link sc-iNhVCk gWgCNb open_panel" href="https://downloads.hindawi.com/journals/ecam/2012/378415.xml" aria-label="XML" property="background-color" color="#D8D8D8"><div class="sc-eAKXzc WHkfb">XML</div><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0iVVRGLTgiPz4KPHN2ZyB3aWR0aD0iMjBweCIgaGVpZ2h0PSIyMnB4IiB2aWV3Qm94PSIwIDAgMjAgMjIiIHZlcnNpb249IjEuMSIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiB4bWxuczp4bGluaz0iaHR0cDovL3d3dy53My5vcmcvMTk5OS94bGluayI+CiAgICA8IS0tIEdlbmVyYXRvcjogU2tldGNoIDUzLjIgKDcyNjQzKSAtIGh0dHBzOi8vc2tldGNoYXBwLmNvbSAtLT4KICAgIDx0aXRsZT5jaGV2cm9uLWRvd24gY29weSAzPC90aXRsZT4KICAgIDxkZXNjPkNyZWF0ZWQgd2l0aCBTa2V0Y2guPC9kZXNjPgogICAgPGRlZnM+CiAgICAgICAgPHBhdGggZD0iTTExLDEzLjU4NTc4NjQgTDExLDIgQzExLDEuNDQ3NzE1MjUgMTEuNDQ3NzE1MywxIDEyLDEgQzEyLjU1MjI4NDcsMSAxMywxLjQ0NzcxNTI1IDEzLDIgTDEzLDEzLjU4NTc4NjQgTDE1LjI5Mjg5MzIsMTEuMjkyODkzMiBDMTUuNjgzNDE3NSwxMC45MDIzNjg5IDE2LjMxNjU4MjUsMTAuOTAyMzY4OSAxNi43MDcxMDY4LDExLjI5Mjg5MzIgQzE3LjA5NzYzMTEsMTEuNjgzNDE3NSAxNy4wOTc2MzExLDEyLjMxNjU4MjUgMTYuNzA3MTA2OCwxMi43MDcxMDY4IEwxMi43MDcxMDY4LDE2LjcwNzEwNjggQzEyLjMxNjU4MjUsMTcuMDk3NjMxMSAxMS42ODM0MTc1LDE3LjA5NzYzMTEgMTEuMjkyODkzMiwxNi43MDcxMDY4IEw3LjI5Mjg5MzIyLDEyLjcwNzEwNjggQzYuOTAyMzY4OTMsMTIuMzE2NTgyNSA2LjkwMjM2ODkzLDExLjY4MzQxNzUgNy4yOTI4OTMyMiwxMS4yOTI4OTMyIEM3LjY4MzQxNzUxLDEwLjkwMjM2ODkgOC4zMTY1ODI0OSwxMC45MDIzNjg5IDguNzA3MTA2NzgsMTEuMjkyODkzMiBMMTEsMTMuNTg1Nzg2NCBaIE0yLDE3IEMyLDE2LjQ0NzcxNTMgMi40NDc3MTUyNSwxNiAzLDE2IEMzLjU1MjI4NDc1LDE2IDQsMTYuNDQ3NzE1MyA0LDE3IEw0LDIwIEM0LDIwLjU1MjI4NDcgNC40NDc3MTUyNSwyMSA1LDIxIEwxOSwyMSBDMTkuNTUyMjg0NywyMSAyMCwyMC41NTIyODQ3IDIwLDIwIEwyMCwxNyBDMjAsMTYuNDQ3NzE1MyAyMC40NDc3MTUzLDE2IDIxLDE2IEMyMS41NTIyODQ3LDE2IDIyLDE2LjQ0NzcxNTMgMjIsMTcgTDIyLDIwIEMyMiwyMS42NTY4NTQyIDIwLjY1Njg1NDIsMjMgMTksMjMgTDUsMjMgQzMuMzQzMTQ1NzUsMjMgMiwyMS42NTY4NTQyIDIsMjAgTDIsMTcgWiIgaWQ9InBhdGgtMSI+PC9wYXRoPgogICAgPC9kZWZzPgogICAgPGcgaWQ9IlN5bWJvbHMiIHN0cm9rZT0ibm9uZSIgc3Ryb2tlLXdpZHRoPSIxIiBmaWxsPSJub25lIiBmaWxsLXJ1bGU9ImV2ZW5vZGQiPgogICAgICAgIDxnIGlkPSJTaWRlYmFycy9EZXNrdG9wL0FydGljbGUtU2lkZWJhciIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoLTI5MS4wMDAwMDAsIC0xMzQuMDAwMDAwKSI+CiAgICAgICAgICAgIDxnIGlkPSJEb3dubG9hZC1yZWZlcmVuY2UiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDAuMDAwMDAwLCAxMTIuMDAwMDAwKSI+CiAgICAgICAgICAgICAgICA8ZyBpZD0iVHlwZS1hbmQtaWNvbnMiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDIwLjAwMDAwMCwgMjEuMDAwMDAwKSI+CiAgICAgICAgICAgICAgICAgICAgPGcgaWQ9Ikljb25zL0Rvd25sb2FkIiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgyNjkuMDAwMDAwLCAwLjAwMDAwMCkiPgogICAgICAgICAgICAgICAgICAgICAgICA8ZyBpZD0iZG93bmxvYWQiPgogICAgICAgICAgICAgICAgICAgICAgICAgICAgPG1hc2sgaWQ9Im1hc2stMiIgZmlsbD0id2hpdGUiPgogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDx1c2UgeGxpbms6aHJlZj0iI3BhdGgtMSI+PC91c2U+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICA8L21hc2s+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICA8dXNlIGlkPSJDb21iaW5lZC1TaGFwZSIgZmlsbD0iIzAwMDAwMCIgZmlsbC1ydWxlPSJub256ZXJvIiB4bGluazpocmVmPSIjcGF0aC0xIj48L3VzZT4KICAgICAgICAgICAgICAgICAgICAgICAgICAgIDxnIGlkPSJDT0xPUi8tUHJpbWFyeS1HcmVlbiIgbWFzaz0idXJsKCNtYXNrLTIpIiBmaWxsPSIjNkJBNDM5IiBmaWxsLXJ1bGU9ImV2ZW5vZGQiPgogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDxyZWN0IGlkPSJSZWN0YW5nbGUiIHg9IjAiIHk9IjAiIHdpZHRoPSIyNCIgaGVpZ2h0PSIyNCI+PC9yZWN0PgogICAgICAgICAgICAgICAgICAgICAgICAgICAgPC9nPgogICAgICAgICAgICAgICAgICAgICAgICA8L2c+CiAgICAgICAgICAgICAgICAgICAgPC9nPgogICAgICAgICAgICAgICAgPC9nPgogICAgICAgICAgICA8L2c+CiAgICAgICAgPC9nPgogICAgPC9nPgo8L3N2Zz4=" height="24"/></a></div><a class="sc-htpNat bUhGXt link sc-imABML ibWUzs" href="https://reprints.hindawi.com/378415/confirm" aria-label="Order Printed Copies" target="_blank" property="background-color" color="#D8D8D8" id="toolbar__opcNav"><span><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="sc-dRFtgE jrsDZP">Order printed copies</span><span class="sc-gkFcWv gWTCXQ">Order</span></span><span class="sc-htoDjs kNoiZu sc-gbOuXE jGPvPL right__icon icon-colored _32KP5uexH-Bgs7Kj8Gk1Tz icon-themeable" title="" font-size="16"></span></a><div class="sc-hBbWxd kdRRST"><div class="sc-dyGzUR cHatnS"><div>Views<span>4174</span></div><div>Downloads<span>1634</span></div></div><div><div class="sc-drKuOJ kxdGAZ"><span class="__dimensions_badge_embed__" data-doi="10.1155/2012/378415" data-style="small_circle"></span>Citations</div></div></div><nav class="sc-bRBYWo fXBKFa sc-hUfwpO jHPgUP" id="toolbar__iconNav"><h3 class="sc-Rmtcm hNPrIr">Share Post</h3><ul class="sc-hzDkRC bnbfTS"><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://twitter.com/share?url=https://doi.org/10.1155/2012/378415&amp;via=Hindawi" aria-label="Sharing on Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialTwitter" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a></li><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://www.linkedin.com/shareArticle/?url=https://doi.org/10.1155/2012/378415" aria-label="Sharing on Linkedin" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialLinkedin" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/socialLinkedin.svg" height="24"/></a></li><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://www.facebook.com/sharer/sharer.php?u=https://doi.org/10.1155/2012/378415" aria-label="Sharing on Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialFacebook" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/socialFacebook-HINDAWI.svg" height="24"/></a></li><li class="iconBorder"><div class="wechat-container"><img alt=" " class="sc-EHOje jOLhQl socialWechat" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><div class="addthis_inline_share_toolbox"></div><script type="text/javascript" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-5ec5076f7164b9b5"></script></div></li><li><a class="sc-htpNat bUhGXt link" href="mailto:?subject=Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways&amp;body=https://doi.org/10.1155/2012/378415" aria-label="Sharing on Mail" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialMail" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a></li></ul></nav></div></div><div class="biblio__Wrapper-sc-1nou1lz-0 cBTaXT journal_article__BiblioIntegratorSidebar-sc-12fk6zy-4 cYsVdk biblioWrapperRight biblioWrapper hide"><hr/><h4 class="biblio__H4-sc-1nou1lz-2 becpDt hrTitleRef">Related articles</h4><div id="biblio_sidebar" class="biblio__BiblioWrapper-sc-1nou1lz-1 kbSZJl"></div></div></div></div></div></div></main><footer class="sc-jKJlTe inBNwS"><section class="sc-eNQAEJ dkutRV"><div class="sc-bZQynM bNmdOy E_HUmlU2Hj3PpkDmWzKPd primary__footer footer__bodypadding"><div class="sc-hMqMXs hlGpbO mobile">Follow us:<nav role="navigation" class="sc-kkGfuU filPdg"><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://twitter.com/hindawi" aria-label="Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.linkedin.com/company/hindawilimited/" aria-label="LinkedIn" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.youtube.com/channel/UCDIK_O7FATPEkhad_sQVaSg" aria-label="Youtube" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.facebook.com/HindawiLimited/" aria-label="Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a></nav></div><nav class="E_HUmlU2Hj3PpkDmWzKPd _3wm8FgzqRuRWouJG31YgKx" role="navigation"><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link about_us" href="/about/" aria-label="About us">About us</a></li><li><a class="sc-htpNat bUhGXt link contact_us" href="/about/contact/" aria-label="Contact us">Contact us</a></li><li><a class="sc-htpNat bUhGXt link partnerships" href="/publishing-partnerships/" aria-label="Partnerships">Partnerships</a></li><li><a class="sc-htpNat bUhGXt link blog" href="/blog/" aria-label="Blog">Blog</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link journals" href="/journals/" aria-label="Journals">Journals</a></li><li><a class="sc-htpNat bUhGXt link article_processing_charges" href="/publish-research/authors/article-processing-charges/" aria-label="Article Processing Charges">Article Processing Charges</a></li><li><a class="sc-htpNat bUhGXt link print_editions" href="/print-editions/" aria-label="Print editions">Print editions</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link authors" href="/publish-research/authors/" aria-label="Authors">Authors</a></li><li><a class="sc-htpNat bUhGXt link editors" href="/publish-research/editors/" aria-label="Editors">Editors</a></li><li><a class="sc-htpNat bUhGXt link reviewers" href="/publish-research/reviewers/" aria-label="Reviewers">Reviewers</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link hindawi_xml_corpus" href="/hindawi-xml-corpus/" aria-label="Hindawi XML Corpus">Hindawi XML Corpus</a></li><li><a class="sc-htpNat bUhGXt link open_archives_initiative" href="/open-archives-initiative/" aria-label="Open Archives Initiative">Open Archives Initiative</a></li><li><a class="sc-htpNat bUhGXt link fraud_prevention" href="/preventing-and-protecting-against-fraud/" aria-label="Fraud prevention">Fraud prevention</a></li></ul></nav><div class="sc-hMqMXs hlGpbO desktop">Follow us:<nav role="navigation" class="sc-kkGfuU filPdg"><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://twitter.com/hindawi" aria-label="Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.linkedin.com/company/hindawilimited/" aria-label="LinkedIn" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.youtube.com/channel/UCDIK_O7FATPEkhad_sQVaSg" aria-label="Youtube" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.facebook.com/HindawiLimited/" aria-label="Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a></nav></div></div></section><div class="sc-bZQynM bNmdOy"><section class="sc-iAyFgw gCiATD"><a class="sc-htpNat bUhGXt link" href="/privacy/" aria-label="Privacy Policy">Privacy Policy<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/terms/" aria-label="Terms of Service">Terms of Service<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/responsible-disclosure-policy/" aria-label="Responsible Disclosure Policy">Responsible Disclosure Policy<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/cookie-policy/" aria-label="Cookie Policy">Cookie Policy<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/copyright/" aria-label="Copyright">Copyright<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/modern-slavery-statement/" aria-label="Modern slavery statement">Modern slavery statement<!-- --> </a></section></div></footer><div class="sc-OxbzP eEFYIL  advWrapper hideBanner"><span><p>Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors.&nbsp;<a href="https://www.hindawi.com/article-year-award/" rel="noopener noreferrer" target="_blank">Read the winning articles</a>.</p>
</span><button class="sc-bYnzgO dsXEHZ"><img alt=" " class="sc-EHOje iiusBg sc-cPuPxo iXKuYd" title="" role="presentation" src="data:image/svg+xml;base64,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" height="16"/></button></div></div></div><noscript>
        <iframe src="//www.googletagmanager.com/ns.html?id=GTM-MQ4MGW"
            height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript></div><script id="__NEXT_DATA__" type="application/json">{"dataManager":"[]","props":{"pageProps":{"isLiveUrl":true,"appConfig":{"journals":{"call_for_paper":{"title":"Call for papers","description":"\u003cp\u003eThis Issue is now open for submissions.\u003c/p\u003e\n\u003cp\u003ePapers are published upon acceptance, regardless of the Special Issue publication date.\u003c/p\u003e\n"},"article_left_nav_keywords":["Introduction","Materials and Methods","Results","Discussion","Conclusion","Abstract","Data Availability","Additional Points","Ethical Approval","Consent","Disclosure","Conflicts of Interests","Authors Contributions","Funding Statement","Acknowledgements","Acknowledgments","Supplementary Materials","Reference","Dataset Description","Dataset Files","Abstract","Introduction","Introduction and Materials","Introduction and Methods","Materials","Materials and Methods","Methods","Results","Discussion","Results and Discussion","Discussion and Conclusion","Results and Conclusion","Conclusion","Conclusions","Data Availability","Additional Points","Ethical Approval","Consent","Disclosure","Conflicts of Interest","Authors Contributions","Funding Statement","Acknowledgements","Supplementary Materials","References","Appendix","Abbreviations","Preliminaries","Introduction and Preliminaries","Notation","Proof of Theorem","Proofs","Analysis of Results","Examples","Numerical Example","Applications","Numerical Simulation","Model","Model Formulation","Systematic Palaeontology","Nomenclatural Acts","Taxonomic Implications","Experimental","Synthesis","Overview","Characterization","Background","Experimental","Theories","Calculations","Model Verification","Model Implementation","Geographic location","Study Area","Geological setting","Data Collection","Field Testing","Data and Sampling","Dataset","Literature Review","Related Works","Related Work","System Model","Methods and Data","Experimental Results","Results and Analysis","Evaluation","Implementation","Case Presentation","Case Report","Search Terms","Case Description","Case Series","Background","Limitations","Additional Points","Case","Case 1"," Case 2 etc.","Concern Details","Retraction Details"," Copyright"],"journal_nav_static_text":"","newsletters":{"text":"","link":{"url":null},"hide_marketing_msg":null},"si_message":{"open":{"title":"Special Issues","text":"We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.","type":"special","link":{"title":"Submit to Special Issue","url":"/journals/ecam/osi"}},"propose":{"title":"Special Issues","text":"Do you think there is an emerging area of research that really needs to be highlighted? Or an existing research area that has been overlooked or would benefit from deeper investigation? Raise the profile of a research area by leading a Special Issue.","type":"special","link":{"title":"Submit your proposal","url":"/si-proposal"}},"abstract":{"title":"Abstracting and Indexing","text":"This journal's articles appear in a wide range of abstracting and indexing databases, and are covered by numerous other services that aid discovery and access. Find out more about where and how the content of this journal is available.","type":"special","link":{"title":"Find out more","url":"/abstract-msg"}}},"menu":{"prsi":"/publish-research/editors/special-issues/proposing-special-issue","asi":"/publish-research/editors/special-issues","pe":"/publish-research/authors/publication-ethics","fr":"/publish-research/reviewers","fe":"/publish-research/editors"},"featured_article_message":{"ceased":{"title":"{journal_name} has ceased publication and is no longer accepting submissions.","summary":"All previously published articles are available through the Table of Contents. \r\n\r\nThe journal is archived in Portico and via the LOCKSS initiative, which provides permanent archiving for electronic scholarly journals."},"sold":{"title":"{journal_name} is not currently considering new submissions.","summary":"All previously published articles are available through the Table of Contents. The journal is archived in Portico and via the LOCKSS initiative, which provides permanent archiving for electronic scholarly journals."}},"journal_manuscript_link":"https://review.hindawi.com/submit?journal={journal_subcode}","contact_us":{"title":"Contact","text":"\u003cp\u003eEditorial enquiries should be directed to\u0026nbsp;\u003ca href=\"mailto:{journal_subcode}@hindawi.com\"\u003e{journal_subcode}@hindawi.com\u003c/a\u003e.\u003c/p\u003e\r\n\r\n\u003cp\u003eGeneral enquiries should be directed to \u003ca href=\"mailto:help@hindawi.com\"\u003ehelp@hindawi.com\u003c/a\u003e.\u003c/p\u003e\r\n\r\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\r\n"},"open_access":{"title":"Open Access","text":"\u003cp dir=\"ltr\"\u003e\u003cem\u003e{journal_name}\u003c/em\u003e is an open access journal. All articles are immediately available to read and reuse upon publication. More information about our Open Access policy can be found on our \u003ca href=\"https://www.hindawi.com/copyright/\"\u003ecopyright page\u003c/a\u003e.\u003c/p\u003e\r\n"},"default_image":{"small":"","large":""}},"manuscript_link":"https://mts.hindawi.com/","willey_link":"/publishing-partnerships/wiley-hindawi-publishing-partnership","gdpr_message":"","order_printed_url":"https://reprints.hindawi.com/{article_id}/confirm","adv_banner_message":"\u003cp\u003eArticle of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors.\u0026nbsp;\u003ca href=\"https://www.hindawi.com/article-year-award/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003eRead the winning articles\u003c/a\u003e.\u003c/p\u003e\r\n","theme":"HINDAWI","logo":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/logo.svg","favicon":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/favicon.ico","social_share_options":["facebook","twitter","linkedin","wechat","mail"],"use_journal_etoc_pages":true,"GTM_ID":"GTM-MQ4MGW","SITE_NAME":"Hindawi","secureSiteUrl":"https://www.hindawi.com","features":{"isMaintenanceOn":false},"useLazyLoad":false,"hasJournalReportPage":false},"data":{"id":6699,"title":"Evidence-Based Complementary and Alternative Medicine","journal_manuscript_link":"","image":{"url":"https://static-01.hindawi.com/s3fs-public/styles/featured_hero_banner/public/2019-10/ECAM_hero.jpg?itok=9epnhPpu","alt":"Evidence-Based Complementary and Alternative Medicine"},"text_colour_code":"#ffffff","about_journal":"/journals/ecam/about","is_wiley_partner":0,"metrics_data":{"id":6699,"title":"Evidence-Based Complementary and Alternative Medicine","url":"/journals/ecam","apc":{"label":"APC","value":"$2550","link":{"text":"","url":""}},"image":{"url":"https://images.hindawi.com/journals/ecam/ecam.banner.small.jpg","alt":"Evidence-Based Complementary and Alternative Medicine"},"metrics":[{"label":"Acceptance rate","value":"27%"},{"label":"Submission to final decision","value":"68 days"},{"label":"Acceptance to publication","value":"33 days"},{"label":"CiteScore","value":"3.000"},{"label":"Journal Citation Indicator","value":"0.730"},{"label":"Impact Factor","value":"2.629"}],"logos":[],"toolbar_metrics_or_logo":"metrics","partner_link":false},"links_block":[{"title":"Author guidelines","link":"/journals/ecam/guidelines","icon_class":"fileText"},{"title":"Editorial board","link":"/journals/ecam/editors","icon_class":"users"},{"title":"Databases and indexing","link":"/journals/ecam/ai","icon_class":"desktop"}],"featured_type":"automatic","status":1,"journal_level":0,"journal_subcode":"ecam","journal_issn":"1741-427X","hide_marketing_msg":0,"publishing_collaborations":[],"journal_blocks":[{"title":"Journal profile","text":"\u003cp\u003e\u003cem\u003eEvidence-Based Complementary and Alternative Medicine\u003c/em\u003e seeks to apply scientific rigor to the study of complementary and alternative medicine, emphasizing on health outcome, while documenting biological mechanisms of action.\u003c/p\u003e\r\n","type":"profile","link":{"title":"About this journal","url":"/journals/ecam/about"}},{"title":"Editor spotlight","text":"\u003cp\u003e\u003cem\u003eEvidence-Based Complementary and Alternative Medicine\u003c/em\u003e maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.\u003c/p\u003e\r\n","type":"spotlight","link":{"title":"Meet the editorial board","url":"/journals/ecam/editors"}},{"title":"Special Issues","text":"We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.","type":"special","link":{"title":"Submit to Special Issue","url":"/journals/ecam/osi"}}],"si_message_type":{"type":"open","link":{"title":"Submit to Special Issue","url":"/journals/ecam/osi"}},"meta_info":{"title":"Evidence-Based Complementary and Alternative Medicine | Hindawi","meta_data":[{"name":"title","content":"Evidence-Based Complementary and Alternative Medicine | Hindawi"},{"name":"description","content":"Evidence-Based Complementary and Alternative Medicine seeks to apply scientific rigor to the study of complementary and alternative medicine, emphasizing on health outcome, while documenting biological mechanisms of action."},{"property":"og:site_name","content":"Hindawi"},{"property":"og:url","content":"current_url"},{"property":"og:title","content":"Evidence-Based Complementary and Alternative Medicine"},{"property":"og:description","content":"Evidence-Based Complementary and Alternative Medicine seeks to apply scientific rigor to the study of complementary and alternative medicine, emphasizing on health outcome, while documenting biological mechanisms of action."},{"property":"og:image","content":"https://images.hindawi.com/journals/ecam/ecam.banner.jpg"},{"property":"og:image:type","content":"image/jpeg"},{"property":"og:image:width","content":"600"},{"property":"og:image:height","content":"315"},{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:description","content":"Evidence-Based Complementary and Alternative Medicine seeks to apply scientific rigor to the study of complementary and alternative medicine, emphasizing on health outcome, while documenting biological mechanisms of action."},{"name":"twitter:site","content":"Hindawi"},{"name":"twitter:title","content":"Evidence-Based Complementary and Alternative Medicine"},{"name":"twitter:url","content":"current_url"},{"name":"twitter:image","content":"https://images.hindawi.com/journals/ecam/ecam.banner.jpg"}]},"journal_header_uses_logo":false,"global_manuscript_link":"https://review.hindawi.com/submit?journal=ecam","newsletters":{"text":"","link":{"url":null},"hide_marketing_msg":null}},"meta":{"meta_data":[{"name":"title","content":"Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways"},{"rel":"canonical","href":"https://www.hindawi.com/journals/ecam/2012/378415/"},{"name":"description","content":"Cancer metastasis is a primary cause of cancer death. \u003ci\u003eAntrodia cinnamomea\u003c/i\u003e (\u003ci\u003eA. cinnamomea\u003c/i\u003e), a medicinal mushroom in Taiwan, has shown antioxidant and anticancer activities. In this study, we first observed that ethanol extract of fruiting bodies of \u003ci\u003eA. cinnamomea\u003c/i\u003e (EEAC) exerted a concentration-dependent inhibitory effect on migration and motility of the highly metastatic CL1-5 cells in the absence of cytotoxicity. The results of a gelatin zymography assay showed that \u003ci\u003eA. cinnamomea\u003c/i\u003e suppressed the activities of matrix metalloproteinase-(MMP-) 2 and MMP-9 in a concentration-dependent manner. Western blot results demonstrated that treatment with \u003ci\u003eA. cinnamomea\u003c/i\u003e decreased the expression of MMP-9 and MMP-2; while the expression of the endogenous inhibitors of these proteins, that is, tissue inhibitors of MMP (TIMP-1 and TIMP-2) increased. Further investigation revealed that \u003ci\u003eA. cinnamomea\u003c/i\u003e suppressed the phosphorylation of ERK1/2, p38, and JNK1/2. \u003ci\u003eA. cinnamomea\u003c/i\u003e also suppressed the expressions of PI3K and phosphorylation of Akt. Furthermore, treatment of CL1-5 cells with inhibitors specific for PI3K (LY 294002), ERK1/2 (PD98059), JNK (SP600125), and p38 MAPK (SB203580) decreased the expression of MMP-2 and MMP-9. This is the first paper confirming the antimigration activity of this potentially beneficial mushroom against human lung adenocarcinoma CL1-5 cancer cells."},{"property":"og:url","content":"current_url"},{"property":"og:type","content":"website"},{"property":"og:image","content":"https://images.hindawi.com/journals/ecam/ecam.banner.jpg"},{"property":"og:image:type","content":"image/jpeg"},{"property":"og:image:width","content":"600"},{"property":"og:image:height","content":"315"},{"property":"og:title","content":"Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways"},{"name":"twitter:site","content":"website"},{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:image","content":"https://images.hindawi.com/journals/ecam/ecam.banner.jpg"},{"name":"twitter:title","content":"Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways"},{"property":"og:description","content":"Cancer metastasis is a primary cause of cancer death. \u003ci\u003eAntrodia cinnamomea\u003c/i\u003e (\u003ci\u003eA. cinnamomea\u003c/i\u003e), a medicinal mushroom in Taiwan, has shown antioxidant and anticancer activities. In this study, we first observed that ethanol extract of fruiting bodies of \u003ci\u003eA. cinnamomea\u003c/i\u003e (EEAC) exerted a concentration-dependent inhibitory effect on migration and motility of the highly metastatic CL1-5 cells in the absence of cytotoxicity. The results of a gelatin zymography assay showed that \u003ci\u003eA. cinnamomea\u003c/i\u003e suppressed the activities of matrix metalloproteinase-(MMP-) 2 and MMP-9 in a concentration-dependent manner. Western blot results demonstrated that treatment with \u003ci\u003eA. cinnamomea\u003c/i\u003e decreased the expression of MMP-9 and MMP-2; while the expression of the endogenous inhibitors of these proteins, that is, tissue inhibitors of MMP (TIMP-1 and TIMP-2) increased. Further investigation revealed that \u003ci\u003eA. cinnamomea\u003c/i\u003e suppressed the phosphorylation of ERK1/2, p38, and JNK1/2. \u003ci\u003eA. cinnamomea\u003c/i\u003e also suppressed the expressions of PI3K and phosphorylation of Akt. Furthermore, treatment of CL1-5 cells with inhibitors specific for PI3K (LY 294002), ERK1/2 (PD98059), JNK (SP600125), and p38 MAPK (SB203580) decreased the expression of MMP-2 and MMP-9. This is the first paper confirming the antimigration activity of this potentially beneficial mushroom against human lung adenocarcinoma CL1-5 cancer cells."},{"name":"twitter:description","content":"Cancer metastasis is a primary cause of cancer death. \u003ci\u003eAntrodia cinnamomea\u003c/i\u003e (\u003ci\u003eA. cinnamomea\u003c/i\u003e), a medicinal mushroom in Taiwan, has shown antioxidant and anticancer activities. In this study, we first observed that ethanol extract of fruiting bodies of \u003ci\u003eA. cinnamomea\u003c/i\u003e (EEAC) exerted a concentration-dependent inhibitory effect on migration and motility of the highly metastatic CL1-5 cells in the absence of cytotoxicity. The results of a gelatin zymography assay showed that \u003ci\u003eA. cinnamomea\u003c/i\u003e suppressed the activities of matrix metalloproteinase-(MMP-) 2 and MMP-9 in a concentration-dependent manner. Western blot results demonstrated that treatment with \u003ci\u003eA. cinnamomea\u003c/i\u003e decreased the expression of MMP-9 and MMP-2; while the expression of the endogenous inhibitors of these proteins, that is, tissue inhibitors of MMP (TIMP-1 and TIMP-2) increased. Further investigation revealed that \u003ci\u003eA. cinnamomea\u003c/i\u003e suppressed the phosphorylation of ERK1/2, p38, and JNK1/2. \u003ci\u003eA. cinnamomea\u003c/i\u003e also suppressed the expressions of PI3K and phosphorylation of Akt. Furthermore, treatment of CL1-5 cells with inhibitors specific for PI3K (LY 294002), ERK1/2 (PD98059), JNK (SP600125), and p38 MAPK (SB203580) decreased the expression of MMP-2 and MMP-9. This is the first paper confirming the antimigration activity of this potentially beneficial mushroom against human lung adenocarcinoma CL1-5 cancer cells."},{"name":"citation_title","content":"Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways"},{"name":"citation_author","content":"Chen, Ying-Yi"},{"name":"citation_author","content":"Liu, Fon-Chang"},{"name":"citation_author","content":"Chou, Pei-Yu"},{"name":"citation_author","content":"Chien, Yi-Chung"},{"name":"citation_author","content":"Chang, Wun-Shaing Wayne"},{"name":"citation_author","content":"Huang, Guang-Jhong"},{"name":"citation_author","content":"Wu, Chieh-Hsi"},{"name":"citation_author","content":"Sheu, Ming-Jyh"},{"name":"citation_journal_title","content":"Evidence-Based Complementary and Alternative Medicine"},{"name":"citation_publisher","content":"Hindawi"},{"name":"citation_volume","content":2012},{"name":"citation_year","content":"2012"},{"name":"citation_date","content":"2012/02/21"},{"name":"citation_online_date","content":"2012/02/21"},{"name":"citation_doi","content":"https://doi.org/10.1155/2012/378415"},{"name":"citation_issn","content":"1741-427X"},{"name":"citation_abstract","content":"Cancer metastasis is a primary cause of cancer death. \u003ci\u003eAntrodia cinnamomea\u003c/i\u003e (\u003ci\u003eA. cinnamomea\u003c/i\u003e), a medicinal mushroom in Taiwan, has shown antioxidant and anticancer activities. In this study, we first observed that ethanol extract of fruiting bodies of \u003ci\u003eA. cinnamomea\u003c/i\u003e (EEAC) exerted a concentration-dependent inhibitory effect on migration and motility of the highly metastatic CL1-5 cells in the absence of cytotoxicity. The results of a gelatin zymography assay showed that \u003ci\u003eA. cinnamomea\u003c/i\u003e suppressed the activities of matrix metalloproteinase-(MMP-) 2 and MMP-9 in a concentration-dependent manner. Western blot results demonstrated that treatment with \u003ci\u003eA. cinnamomea\u003c/i\u003e decreased the expression of MMP-9 and MMP-2; while the expression of the endogenous inhibitors of these proteins, that is, tissue inhibitors of MMP (TIMP-1 and TIMP-2) increased. Further investigation revealed that \u003ci\u003eA. cinnamomea\u003c/i\u003e suppressed the phosphorylation of ERK1/2, p38, and JNK1/2. \u003ci\u003eA. cinnamomea\u003c/i\u003e also suppressed the expressions of PI3K and phosphorylation of Akt. Furthermore, treatment of CL1-5 cells with inhibitors specific for PI3K (LY 294002), ERK1/2 (PD98059), JNK (SP600125), and p38 MAPK (SB203580) decreased the expression of MMP-2 and MMP-9. This is the first paper confirming the antimigration activity of this potentially beneficial mushroom against human lung adenocarcinoma CL1-5 cancer cells."},{"name":"citation_fulltext_html_url","content":"current_url"},{"name":"citation_pdf_url","content":"https://downloads.hindawi.com/journals/ecam/2012/378415.pdf"},{"name":"citation_xml_url","content":"https://downloads.hindawi.com/journals/ecam/2012/378415.xml"},{"name":"dc.creator","content":"Chen, Ying-Yi"},{"name":"dc.creator","content":"Liu, Fon-Chang"},{"name":"dc.creator","content":"Chou, Pei-Yu"},{"name":"dc.creator","content":"Chien, Yi-Chung"},{"name":"dc.creator","content":"Chang, Wun-Shaing Wayne"},{"name":"dc.creator","content":"Huang, Guang-Jhong"},{"name":"dc.creator","content":"Wu, Chieh-Hsi"},{"name":"dc.creator","content":"Sheu, Ming-Jyh"},{"name":"dc.title","content":"Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways"},{"name":"dc.description","content":"Cancer metastasis is a primary cause of cancer death. \u003ci\u003eAntrodia cinnamomea\u003c/i\u003e (\u003ci\u003eA. cinnamomea\u003c/i\u003e), a medicinal mushroom in Taiwan, has shown antioxidant and anticancer activities. In this study, we first observed that ethanol extract of fruiting bodies of \u003ci\u003eA. cinnamomea\u003c/i\u003e (EEAC) exerted a concentration-dependent inhibitory effect on migration and motility of the highly metastatic CL1-5 cells in the absence of cytotoxicity. The results of a gelatin zymography assay showed that \u003ci\u003eA. cinnamomea\u003c/i\u003e suppressed the activities of matrix metalloproteinase-(MMP-) 2 and MMP-9 in a concentration-dependent manner. Western blot results demonstrated that treatment with \u003ci\u003eA. cinnamomea\u003c/i\u003e decreased the expression of MMP-9 and MMP-2; while the expression of the endogenous inhibitors of these proteins, that is, tissue inhibitors of MMP (TIMP-1 and TIMP-2) increased. Further investigation revealed that \u003ci\u003eA. cinnamomea\u003c/i\u003e suppressed the phosphorylation of ERK1/2, p38, and JNK1/2. \u003ci\u003eA. cinnamomea\u003c/i\u003e also suppressed the expressions of PI3K and phosphorylation of Akt. Furthermore, treatment of CL1-5 cells with inhibitors specific for PI3K (LY 294002), ERK1/2 (PD98059), JNK (SP600125), and p38 MAPK (SB203580) decreased the expression of MMP-2 and MMP-9. This is the first paper confirming the antimigration activity of this potentially beneficial mushroom against human lung adenocarcinoma CL1-5 cancer cells."},{"name":"dc.publisher","content":"Hindawi"},{"name":"dc.format","content":"text/html"},{"name":"dc.language","content":"en"},{"name":"dc.identifier","content":"https://doi.org/10.1155/2012/378415"},{"name":"dc.type","content":"Research Article"},{"name":"dc.date","content":"2012/02/21"},{"name":"dcterms.issued","content":"2012/02/21"},{"name":"prism.publicationDate","content":"2012/02/21"},{"name":"prism.volume","content":2012},{"name":"prism.section","content":"Research Article"},{"name":"prism.doi","content":"https://doi.org/10.1155/2012/378415"},{"name":"prism.issn","content":"1741-427X"},{"name":"dc.source","content":"Evidence-Based Complementary and Alternative Medicine"},{"name":"prism.publicationName","content":"Evidence-Based Complementary and Alternative Medicine"},{"name":"authors","content":"Ying-Yi Chen | Fon-Chang Liu | ... | Ming-Jyh Sheu"}],"title":"Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways","current_url":"https://www.hindawi.com/journals/ecam/2012/378415/","site_url":"https://www.hindawi.com","gdprMsg":"","manuscript_link":"https://mts.hindawi.com/","footerData":{"status":200,"data":{"upper_menu_items":{"footer":[{"title":"About us","external":0,"relative":"/about","expanded":0,"enabled":1},{"title":"Contact us","external":0,"relative":"/about/contact","expanded":0,"enabled":1},{"title":"Partnerships","external":0,"relative":"/publishing-partnerships","expanded":0,"enabled":1},{"title":"Blog","external":0,"relative":"/blog","expanded":0,"enabled":1}],"footer-1":[{"title":"Journals","external":0,"relative":"/journals","expanded":0,"enabled":1},{"title":"Article Processing Charges","external":0,"relative":"/publish-research/authors/article-processing-charges","expanded":0,"enabled":1},{"title":"Print editions","external":0,"relative":"/print-editions","expanded":0,"enabled":1}],"footer-2":[{"title":"Authors","external":0,"relative":"/publish-research/authors","expanded":0,"enabled":1},{"title":"Editors","external":0,"relative":"/publish-research/editors","expanded":0,"enabled":1},{"title":"Reviewers","external":0,"relative":"/publish-research/reviewers","expanded":0,"enabled":1}],"footer-3":[{"title":"Hindawi XML Corpus","external":0,"relative":"/hindawi-xml-corpus","expanded":0,"enabled":1},{"title":"Open Archives Initiative","external":0,"relative":"/open-archives-initiative","expanded":0,"enabled":1},{"title":"Fraud prevention","external":0,"relative":"/preventing-and-protecting-against-fraud","expanded":0,"enabled":1}]},"lower_menu_items":{"lower-footer":[{"title":"Privacy Policy","external":0,"relative":"/privacy","expanded":0,"enabled":1},{"title":"Terms of Service","external":0,"relative":"/terms","expanded":0,"enabled":1},{"title":"Responsible Disclosure Policy","external":0,"relative":"/responsible-disclosure-policy","expanded":0,"enabled":1},{"title":"Cookie Policy","external":0,"relative":"/cookie-policy","expanded":0,"enabled":1},{"title":"Copyright","external":0,"relative":"/copyright","expanded":0,"enabled":1},{"title":"Modern slavery statement","external":0,"relative":"/modern-slavery-statement","expanded":0,"enabled":1}]},"config":{"footer_config_logo":"","footer_config_copyright":""}},"headers":{},"journalCode":"ecam"},"isLiveUrl":true,"advMsg":"\u003cp\u003eArticle of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors.\u0026nbsp;\u003ca href=\"https://www.hindawi.com/article-year-award/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003eRead the winning articles\u003c/a\u003e.\u003c/p\u003e\r\n","statusCode":false,"showPreviewButtons":false,"currentPath":"/journals/ecam/2012/378415/","bibblioKey":"0d7b3db3-a45f-4dfa-b751-991c0907e6ab","assetPrefix":"https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c","logo":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/logo.svg","favicon":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/favicon.ico","headerData":{"status":200,"data":{"header_menu_items":{"header-menu":[{"title":"Journals","external":0,"link":"/journals","expanded":0,"enabled":1},{"title":"Publish with us","external":0,"link":"/publish-research","expanded":0,"enabled":1},{"title":"Publishing partnerships","external":0,"link":"/publishing-partnerships","expanded":0,"enabled":1},{"title":"About us","external":0,"link":"/about","expanded":0,"enabled":1},{"title":"Blog","external":0,"link":"/blog","expanded":0,"enabled":1}]}},"headers":{}},"theme":"HINDAWI","sharingOptions":["facebook","twitter","linkedin","wechat","mail"],"useJournalEtocPages":true,"isUserFromChina":false,"useLazyLoad":false,"hasJournalReportPage":false},"ceased":false,"journalAlias":"/journals/ecam","journalNavigationBarData":{"items":[{"title":"Journal overview","link":"/journals/ecam/jo","key":"jo","children":[{"title":"About this Journal","link":"/journals/ecam/about","key":"about"},{"title":"Editorial Board","link":"/journals/ecam/editors","key":"editors"},{"title":"Peer Review Process","link":"/journals/ecam/prp","key":"prp"},{"title":"Publication Ethics","link":"/publish-research/authors/publication-ethics","key":"pe"},{"title":"Abstracting and Indexing","link":"/journals/ecam/ai","key":"ai"},{"title":"Article Processing Charges","link":"/journals/ecam/apc","key":"apc"}]},{"title":"For authors","link":"/journals/ecam/guidelines","key":"guidelines","children":[]},{"title":"For reviewers","link":"/publish-research/reviewers","key":"fr","children":[]},{"title":"For editors","link":"/publish-research/editors","key":"fe","children":[]},{"title":"Table of Contents","link":"/journals/ecam/contents/year/2022","children":[]},{"title":"Special Issues","link":"/journals/ecam/si","children":[{"title":"Open Special Issues","link":"/journals/ecam/osi","key":"osi"},{"title":"Published Special Issues","link":"/journals/ecam/psi","key":"psi"},{"title":"Propose Special Issue","link":"/publish-research/editors/special-issues/proposing-special-issue","key":"prsi"},{"title":"About Special Issues","link":"/publish-research/editors/special-issues","key":"asi"}]}],"archived":false,"navText":""},"journalUrl":"/journals/ecam","article":{"retracted":false,"related_articles":[{"title":"Research Article","link":"/journals/ecam/2012/378415/","childrens":[]},{"title":"Erratum","link":"/journals/ecam/2013/423987","childrens":[{"special_issue":false,"volume":"2013","pdf":"downloads.hindawi.com/journals/ecam/2013/423987.pdf","abstract":"","id":"423987","type":"Erratum","title":"Erratum to \u0026#x201c;Ethanol Extracts of Fruiting Bodies of \u003ci\u003eAntrodia cinnamomea\u003c/i\u003e Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways\u0026#x201d;","date":"13 Feb 2013","journal":"Evidence-Based Complementary and Alternative Medicine","alias":"/journals/ecam/2013/423987","authors":[{"name":"Ying-Yi Chen"},{"name":"Fon-Chang Liu"},{"name":"Pei-Yu Chou"},{"name":"Yi-Chung Chien"},{"name":"Wun-Shaing Wayne Chang"},{"name":"Guan-Jhong Huang"},{"name":"Chieh-Hsi Wu"},{"name":"Ming-Jyh Sheu"}],"reference":"/journals/ecam/2013/423987.ris"}]}],"id":"378415","title":"Ethanol Extracts of Fruiting Bodies of \u003ci\u003eAntrodia cinnamomea\u003c/i\u003e Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways","title_toc":"Ethanol Extracts of Fruiting Bodies of \u003ci\u003eAntrodia cinnamomea\u003c/i\u003e Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways","type":"Research Article","volume":2012,"pub_year":"2012","article_id":"378415","pages":11,"first_page":"","last_page":"","issue_no":"","doi":"https://doi.org/10.1155/2012/378415","doi_simple":"10.1155/2012/378415","shorten_url":"https://doi.org/10.1155/2012/378415","inPress":false,"academic_editors":[{"name":"Vassya Bankova"}],"guest_editors":[],"published_date":"21 Feb 2012","received_date":"18 Jul 2011","revised_date":"25 Oct 2011","accepted_date":"25 Oct 2011","authors":[{"name":"Ying-Yi Chen","email":"","orcid":"","sup":["1"]},{"name":"Fon-Chang Liu","email":"","orcid":"","sup":["1","2"]},{"name":"Pei-Yu Chou","email":"","orcid":"","sup":["3"]},{"name":"Yi-Chung Chien","email":"","orcid":"","sup":["3"]},{"name":"Wun-Shaing Wayne Chang","email":"","orcid":"","sup":["4"]},{"name":"Guang-Jhong Huang","email":"","orcid":"","sup":["5"]},{"name":"Chieh-Hsi Wu","email":"wt.ude.umc.liam@uwshhc","orcid":"","sup":["1"]},{"name":"Ming-Jyh Sheu","email":"moc.liamg@wtdtm31naebyos","orcid":"","sup":["1"]}],"affiliations":[{"id":"1","text":"School of Pharmacy, China Medical University, 91 Hsueh-Shih Road, Taichung 404, Taiwan"},{"id":"2","text":"Department of Pharmacy, Da Chien General Hospital, Miaoli 36052, Taiwan"},{"id":"3","text":"Department of Life Science, National Chung Hsing University, 250 Kuo Kuang Road, Taichung 402, Taiwan"},{"id":"4","text":"National Institute of Cancer Research, National Health Research Institutes, 35 Keyan Road, Zhunan, Miaoli 350, Taiwan"},{"id":"5","text":"School of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan"}],"is_special_issue":0,"special_issue_details":{"title":"","url":""},"body":"\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"header\" id=\"abstract\"\u003eAbstract\u003c/h4\u003e\u003cp\u003eCancer metastasis is a primary cause of cancer death. \u003ci\u003eAntrodia cinnamomea\u003c/i\u003e (\u003ci\u003eA. cinnamomea\u003c/i\u003e), a medicinal mushroom in Taiwan, has shown antioxidant and anticancer activities. In this study, we first observed that ethanol extract of fruiting bodies of \u003ci\u003eA. cinnamomea\u003c/i\u003e (EEAC) exerted a concentration-dependent inhibitory effect on migration and motility of the highly metastatic CL1-5 cells in the absence of cytotoxicity. The results of a gelatin zymography assay showed that \u003ci\u003eA. cinnamomea\u003c/i\u003e suppressed the activities of matrix metalloproteinase-(MMP-) 2 and MMP-9 in a concentration-dependent manner. Western blot results demonstrated that treatment with \u003ci\u003eA. cinnamomea\u003c/i\u003e decreased the expression of MMP-9 and MMP-2; while the expression of the endogenous inhibitors of these proteins, that is, tissue inhibitors of MMP (TIMP-1 and TIMP-2) increased. Further investigation revealed that \u003ci\u003eA. cinnamomea\u003c/i\u003e suppressed the phosphorylation of ERK1/2, p38, and JNK1/2. \u003ci\u003eA. cinnamomea\u003c/i\u003e also suppressed the expressions of PI3K and phosphorylation of Akt. Furthermore, treatment of CL1-5 cells with inhibitors specific for PI3K (LY 294002), ERK1/2 (PD98059), JNK (SP600125), and p38 MAPK (SB203580) decreased the expression of MMP-2 and MMP-9. This is the first paper confirming the antimigration activity of this potentially beneficial mushroom against human lung adenocarcinoma CL1-5 cancer cells.\u003c/p\u003e\u003cspan class=\"end-abs\"\u003e\u003c/span\u003e\u003ch4 id=\"introduction\"\u003e1. Introduction\u003c/h4\u003e\u003cp\u003eLung cancer has been the leading cause of cancer-related mortality worldwide. In some countries, it has become the number one cancer cause of death, accounting for more fatalities than prostate cancer, breast cancer, and colorectal cancer combined [\u003ca href=\"#B1\"\u003e1\u003c/a\u003e]. Human lung adenocarcinoma cell lines CL1-0, CL1-1, CL1-5, and CL1-5-F4 are a series of sublines with progressively invasive ability established by in vitro invasion screening. CL1-5 cells are a human lung adenocarcinoma cell line derived from the parental CL1 cells by five successive Matrigel selections. CL1-5 cells showed a 4- to 6-fold higher invasive ability than the parental cells and their production of 92-kDa MMP-9 also exhibited a drastic increase over that of their parental cells.\u003c/p\u003e\u003cp\u003eMetastasis is a characteristic of highly malignant cancers with poor clinical outcome. Malignant tumor progression depends upon the capacity to invade, metastasize, and promote the angiogenic host response. One critical characteristic that metastatic cancer cells have acquired is the ability to dissolve basement membranes and the extracellular matrix (ECM). This degradative process is mediated largely by matrix metalloproteinases (MMPs), which are a large family of at least 20 zinc-dependent neutral endopeptidases that together can degrade all known components of ECM [\u003ca href=\"#B3\"\u003e2\u003c/a\u003e]. MMP-9 is abundantly expressed in various malignant tumors and is postulated to play a critical role in tumor invasion and angiogenesis [\u003ca href=\"#B4\"\u003e3\u003c/a\u003e]. Thus, the inhibition of MMP activity, including MMP-9, is important for the prevention of cell invasion. CL1-5 cells, a human lung adenocarcinoma cell line, expressed an elevated level of MMP-2, MMP-9 and exhibited a highly invasive and metastatic ability [\u003ca href=\"#B2\"\u003e4\u003c/a\u003e, \u003ca href=\"#B5\"\u003e5\u003c/a\u003e]. Meanwhile, the activity of MMPs is prone to the inhibition of endogenous tissue inhibitor of metalloproteinases (TIMPs), which are specific inhibitors of MMPs, and the imbalance between MMPs and TIMPs may contribute to degradation or deposition of ECM [\u003ca href=\"#B6\"\u003e6\u003c/a\u003e]. The mitogen-activated protein kinases (MAPKs) play an important regulatory role in cell growth, differentiation, apoptosis, and metastasis [\u003ca href=\"#B7\"\u003e7\u003c/a\u003e]. In addition, phosphatidylinositol-3-kinase/serine/threonine protein kinase (or protein kinase B) (PI3K/Akt) signal transduction pathway is involved in the development, progression, and metastasis of various tumors [\u003ca href=\"#B8\"\u003e8\u003c/a\u003e\u003ca href=\"#B10\"\u003e10\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eTraditionally, \u003ci\u003eAntrodia cinnamomea\u003c/i\u003e (\u003ci\u003eA. cinnamomea\u003c/i\u003e; also named niu-chang-chih in Chinese) has been used as a health food to prevent inflammation, hypertension, itchy skin, and liver cancer [\u003ca href=\"#B11\"\u003e11\u003c/a\u003e]. There is increasing evidence that \u003ci\u003eA. cinnamomea \u003c/i\u003epossesses an extensive range of biological activities, including the liver protection [\u003ca href=\"#B12\"\u003e12\u003c/a\u003e], anti-inflammation [\u003ca href=\"#B13\"\u003e13\u003c/a\u003e], and antioxidation [\u003ca href=\"#B14\"\u003e14\u003c/a\u003e]. Some reports have suggested that extracts of mycelia and fruiting bodies of \u003ci\u003eA. cinnamomea \u003c/i\u003ecould be a potential chemotherapeutic agent against hepatoma, as well as prostate, breast, bladder, and lung cancer cells [\u003ca href=\"#B15\"\u003e15\u003c/a\u003e\u003ca href=\"#B20\"\u003e20\u003c/a\u003e], the antimetastatic effect of \u003ci\u003eA. cinnamomea\u003c/i\u003e in lung adenocarcinoma CL1-5 cancer cells is still unclear. In the present study, we investigated the antimetastatic effects of \u003ci\u003eA. cinnamomea\u003c/i\u003e on a highly metastatic CL1-5 cell lines as well as the underlying mechanisms.\u003c/p\u003e\u003ch4 id=\"materials-and-methods\"\u003e2. Materials and Methods\u003c/h4\u003e\u003ch5 id=\"sec2.1\"\u003e2.1. Chemicals\u003c/h5\u003e\u003cp\u003e\u003ci\u003eA. cinnamomea\u003c/i\u003e was kindly provided by Cosmox Biomedical Co. Ltd. (Taoyuan, Taiwan). RPMI Medium 1640, 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT), LY294002, SP600125, and SB203580 were obtained from Sigma Chemical Co. (St. Louis, MO, USA). PD98059 was purchased from Cell Signaling Technology (Beverly, MA, USA). TrypsinEDTA, fetal bovine serum (FBS), and penicillin/streptomycin were from Gibco Life Technologies, Inc. (Paisley, UK). Cell culture supplies were purchased from Costar (Corning, Inc., Cypress, CA, USA). The antibody against AKT, Rac-1, MAPK/extracellular signal-regulated kinase (ERK) 1/2, c-Jun NH\u003csub\u003e2\u003c/sub\u003e-terminal kinase (JNK)/stress-activated protein kinase, and p38 MAPK proteins and phosphorylated proteins were purchased from Cell Signaling Technology (Beverly, MA, USA). Anti-ERK1/2, anti-PI3K, antifocal adhesion kinase (FAK), anti-p-FAK, and horseradish peroxidase-conjugated goat anti-mouse IgG antibody were purchased from Santa Cruz Biotechnology Co. (Santa Cruz, CA, USA), \u003ci\u003e\u003c/i\u003e-actin was purchased from Chemicon (Temecula, CA, USA).\u003c/p\u003e\u003ch5 id=\"sec2.2\"\u003e2.2. Preparation of Ethanol Extract of Fruiting Bodies of \u003ci\u003eA. cinnamomea\u003c/i\u003e (EEAC)\u003c/h5\u003e\u003cp\u003eThe fruiting body of \u003ci\u003eA. cinnamomea\u003c/i\u003e was kindly provided by Cosmox Biomedical Co. LTD (Taoyuan, Taiwan) and identified by Dr. Chao-Lin Kuo (School of Chinese Pharmaceutical Sciences and Chinese Medicine Resource, Taiwan). \u003ci\u003eA. cinnamomea\u003c/i\u003e was weighed about 1kg and soaked in 10L of 95% ethanol solution (extractive solvent) for 3 days at room temperature. The solid residue of the above soaked herbs was filtered and discarded through a Buchner funnel lined with Whatman filter paper, and the filtrate was concentrated to paste by vacuum distillation using the rotary evaporator (N-11, EYELA; Tokyo, Japan) and vacuum controller (VC-760, TAKARA; Tokyo, Japan) to maintain the desired pressure and temperature at 25C with 40mmHg. The various concentration of EEAC was further diluted with DMSO for the further use.\u003c/p\u003e\u003ch5 id=\"sec2.3\"\u003e2.3. Cell Culture\u003c/h5\u003e\u003cp\u003eCL1-5 cell lines were kindly provided by Dr. W.-S. Wayne Chang (National Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan). The cells were cultured in RPMI-1640 medium (Gibco, Grand Island, NY, USA) with 10% fetal bovine serum (FBS, Gibco) at 37C in a humidified atmosphere of 5% CO\u003csub\u003e2\u003c/sub\u003e.\u003c/p\u003e\u003ch5 id=\"sec2.4\"\u003e2.4. Cytotoxicity Assay\u003c/h5\u003e\u003cp\u003eThe cells (1  10\u003csup\u003e5\u003c/sup\u003ecells/mL) were cultured in 96-well plate containing RPMI-1640 supplemented with 10% FBS for 24h to become nearly confluent. Then cells were cultured with EEAC for 24h and 36h. Then, the cells were washed twice with PBS and incubated with 100\u003ci\u003e\u003c/i\u003eL of 0.5mg/mL MTT for 3h at 37C, testing for cell viability. The medium was then discarded and 50\u003ci\u003e\u003c/i\u003eL of dimethylsulfoxide (DMSO) was added. After 10min incubation, absorbance at 590nm was read by a microplate reader.\u003c/p\u003e\u003ch5 id=\"sec2.5\"\u003e2.5. Wound-Healing Assay\u003c/h5\u003e\u003cp\u003eFor cell motility determination, CL1-5 cells (2  10\u003csup\u003e5\u003c/sup\u003e cells/mL) were seeded in a 12-well tissue culture plate and grown to 8090% confluence. After aspiration of the medium, the center of the cell monolayers was scraped with a sterile micropipette tip to create a denuded zone (gap) of constant width. Subsequently, cellular debris was washed with PBS, and CL1-5 cells were exposed to various concentrations of EEAC (0, 0.125, 0.25, 0.5, and 1.0\u003ci\u003e\u003c/i\u003eg/mL). Wound closure was monitored and photographed at 0h and 36h with a Nikon inverted microscope. To quantify the migrated cells, pictures of the initial wounded monolayers were compared with the corresponding pictures of cells at the end of the incubation. Artificial lines fitting the cutting edges were drawn on pictures of the original wounds and overlaid on the pictures of cultures after incubation. Cells that had migrated across the white lines were counted in six random fields from each triplicate treatment.\u003c/p\u003e\u003ch5 id=\"sec2.6\"\u003e2.6. Cell Migration Assay\u003c/h5\u003e\u003cp\u003eTumor cell migration was assayed in transwell chambers (Millipore) according to the method reported by Weng et al. [\u003ca href=\"#B6\"\u003e6\u003c/a\u003e] with some modifications. Briefly, transwell chambers with 6.5mm polycarbonate filters of 8\u003ci\u003e\u003c/i\u003em pore size were used. CL1-5 cells (1  10\u003csup\u003e4\u003c/sup\u003e cells/mL) and 0, 0.125, 0.25, 0.5, and 1.0\u003ci\u003e\u003c/i\u003eg/mL of EEAC were suspended in RPMI-1640 (100\u003ci\u003e\u003c/i\u003eL, serum free), placed in the upper transwell chamber, and incubated for 24h at 37C. Then, the cells on the upper surface of the filter were completely wiped away with a cotton swab, and the lower surface of the filter was fixed in methanol, stained with Giemsa, and counted under a microscope at a magnification of 200x. For each replicate, the tumor cells in 10 randomly selected fields were determined and the counts were averaged.\u003c/p\u003e\u003ch5 id=\"sec2.7\"\u003e2.7. Determination of MMP-2 and MMP-9 by Zymography\u003c/h5\u003e\u003cp\u003eMMPs in the medium released from CL1-5 cells were assayed using gelatin zymography (8% zymogram gelatin gels) according to the methods reported by Weng et al. with some modification [\u003ca href=\"#B6\"\u003e6\u003c/a\u003e]. Briefly, the culture medium was electrophoresed (80V for 120min) in a 8% SDS-PAGE gel containing 0.1% gelatin. The gel was then washed at room temperature in a solution containing 2.5% (v/v) Triton X-100 with two changes and subsequently transferred to a reaction buffer for enzymatic reaction containing 1% NaN\u003csub\u003e3\u003c/sub\u003e, 10mM CaCl\u003csub\u003e2\u003c/sub\u003e and 40mM Tris-HCl, pH 8.0, at 37C with shaking overnight (for 1215h). Finally, the MMP gel was stained for 30min with 0.25% (w/v) Coomassie blue in 10% acetic acid (v/v) and 20% methanol (v/v) and destained in 10% acetic acid (v/v) and 20% methanol (v/v).\u003c/p\u003e\u003ch5 id=\"sec2.8\"\u003e2.8. Western Blotting Analysis\u003c/h5\u003e\u003cp\u003eWhole-cell lysates proteins (40\u003ci\u003e\u003c/i\u003eg of partially purified protein) were mixed with an equal volume of electrophoresis sample buffer, and the mixture was then boiled for 10min. Then, an equal protein content of total cell lysate from control and EEAC-treated sample were resolved in 12% SDS-PAGE gels. Proteins were then transferred onto nitrocellulose membranes (Millipore, Bedford, MA, USA) by electroblotting using an electroblotting apparatus (Bio-Rad). Nonspecific binding of the membranes was blocked with phosphate-buffered saline (PBS) containing 1% (w/v) nonfat dry milk and TBS-T buffer (Tris-Buffer Saline with 0.1% (v/v) Tween 20) for more than 2h. Membranes were washed with TBS-T buffer three times each for 10min and then incubated with an appropriate dilution of specific primary antibodies in TBS-T buffer overnight at 4C. The membranes were washed with TBS-T buffer and then incubated with an appropriate secondary antibody (horseradish peroxidase-conjugated, goat anti-mouse, or anti-rabbit IgG) for 1h. After washing the membrane three times for 10min in TBS-T buffer, the bands were visualized using ECL reagents (Millipore, Billerica, MA, USA). Band intensity on scanned films was quantified using Kodak Molecular Imaging (MI) software and expressed as relative intensity compared with control.\u003c/p\u003e\u003ch5 id=\"sec2.9\"\u003e2.9. Statistical Analysis\u003c/h5\u003e\u003cp\u003eValues are expressed as means  SD and analyzed using one-way ANOVA followed by LSD test for comparisons of group means. All statistical analyses were performed using SPSS for Windows, version 10 (SPSS, Inc.); a \u003csvg height=\"11.175\" id=\"M1\" style=\"vertical-align:-0.0pt;width:10.9375px;\" version=\"1.1\" viewbox=\"0 0 10.9375 11.175\" width=\"10.9375\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,0,0,-.017,.062,11.113)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#13;\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e value \u0026lt;0.05 is considered statistically significant.\u003c/p\u003e\u003ch4 id=\"results\"\u003e3. Results\u003c/h4\u003e\u003ch5 id=\"sec3.1\"\u003e3.1. Cytotoxicity of EEAC to CL1-5 Cells\u003c/h5\u003e\u003cp\u003eThe effect of EEAC (0128\u003ci\u003e\u003c/i\u003eg/mL) on cell viability was determined by the MTT assay. After incubation for 24h and 36h, cell viability was not significantly affected by EEAC (0.1251.0\u003ci\u003e\u003c/i\u003eg/mL), as compared to the untreated control (Figure \u003ca href=\"fig1/#a\" target=\"_blank\"\u003e1(a)\u003c/a\u003e), indicating that EEAC is not toxic to CL1-5 cells at these concentrations. When cells were treated with EEAC at 1.0128\u003ci\u003e\u003c/i\u003eg/mL for 24h and 36h, cell viability was significantly decreased. EEAC (0.1251.0\u003ci\u003e\u003c/i\u003eg/mL) were also evaluated their apoptotic effect with flow cytometry, and SubG1 was not significantly affected by EEAC (0.1251.0\u003ci\u003e\u003c/i\u003eg/mL), as compared to the untreated control (Figure \u003ca href=\"fig1/#b\" target=\"_blank\"\u003e1(b)\u003c/a\u003e). To avoid inhibition of cell viability in the following experiments, we chose to use EEAC concentrations between 0.125 and 1.0\u003ci\u003e\u003c/i\u003eg/mL and an incubation time of 36h.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig1\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig1\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"378415.fig.001a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.001a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"378415.fig.001b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.001b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig1\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"378415.fig.001a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.001a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"378415.fig.001b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.001b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig1\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 1\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig1/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003e(a) Viability of CL1-5 cells incubated with EEAC (0.125, 0.25, 0.5, 1.0, 2.0, 4.0, 8.0, 16, 32, 64, and 128\u003ci\u003e\u003c/i\u003eg/mL) for 24h and 36h. Cell viability was measured using MTT assay and is expressed as % of cell survival relative to control. (b) Flow cytometric analysis of EEAC on the cell cycle of CL1-5. All the cells were treated with 1% fetal bovine serum with the addition of EEAC at 0.125\u003ci\u003e\u003c/i\u003eg/mL, 0.25\u003ci\u003e\u003c/i\u003eg/mL, 0.5\u003ci\u003e\u003c/i\u003eg/mL, and 1.0\u003ci\u003e\u003c/i\u003eg/mL for 36h. The value on the \u003csvg height=\"7.9499998\" id=\"M2\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 9.625 7.9499998\" width=\"9.625\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,0,0,-.017,.062,7.675)\"\u003e\u003cpath d=\"M536 404q0 -17 -13.5 -31.5t-26.5 -14.5q-8 0 -15 10q-11 14 -25 14q-22 0 -67 -50q-47 -52 -68 -82l37 -102q31 -88 55 -88t78 59l16 -23q-32 -48 -68.5 -78t-65.5 -30q-19 0 -37.5 20t-29.5 53l-41 116q-72 -106 -114.5 -147.5t-79.5 -41.5q-21 0 -34.5 14t-13.5 37\u0026#13;\u0026#10;q0 16 13.5 31.5t28.5 15.5q12 0 17 -11q5 -10 25 -10q22 0 57.5 36t89.5 111l-40 108q-22 58 -36 58q-21 0 -67 -57l-19 20q81 107 125 107q17 0 30 -22t39 -88l22 -55q68 92 108.5 128.5t74.5 36.5q20 0 32.5 -14t12.5 -30z\" id=\"x1D465\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e-axis represents the DNA content, while the shaded area indicates the percentage of cells at the S phase. Percentage of sub G1 contents in CL1-5 cells treated with EEAC. Values are means of three separate experiments, with standard deviation represented by vertical bars. \u003csvg height=\"17.825001\" id=\"M3\" style=\"vertical-align:-3.276pt\" version=\"1.1\" viewbox=\"0 0 69.150002 17.825001\" width=\"69.150002\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.012,0,0,-.012,2.9,5.525)\"\u003e\u003cpath d=\"M471 153q-22 -15 -61 -13q-25 31 -45.5 49.5t-56.5 41.5q4 -71 28 -134q-17 -33 -42 -46q-24 12 -42 46q24 63 28 134q-36 -23 -56.5 -41.5t-45.5 -49.5q-36 -2 -61 13q0 28 19 59q65 10 130 43q-65 33 -130 43q-19 31 -19 59q22 15 61 13q25 -31 45.5 -49.5t56.5 -41.5\u0026#13;\u0026#10;q-4 71 -28 134q17 33 42 46q24 -12 42 -46q-24 -63 -28 -134q36 23 56.5 41.5t45.5 49.5q36 2 61 -13q0 -28 -19 -59q-65 -10 -130 -43q65 -33 130 -43q19 -31 19 -59z\" id=\"x2217\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003cg transform=\"matrix(.017,0,0,-.017,10.5,14.875)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#13;\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,26.038,13.688)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,40.724,13.688)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#13;\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,48.884,13.688)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,52.76,13.688)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#13;\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,60.919,13.688)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#13;\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e; \u003csvg height=\"17.825001\" id=\"M4\" style=\"vertical-align:-3.276pt\" version=\"1.1\" viewbox=\"0 0 76.137497 17.825001\" width=\"76.137497\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.012,0,0,-.012,2.9,5.525)\"\u003e\u003cpath d=\"M471 153q-22 -15 -61 -13q-25 31 -45.5 49.5t-56.5 41.5q4 -71 28 -134q-17 -33 -42 -46q-24 12 -42 46q24 63 28 134q-36 -23 -56.5 -41.5t-45.5 -49.5q-36 -2 -61 13q0 28 19 59q65 10 130 43q-65 33 -130 43q-19 31 -19 59q22 15 61 13q25 -31 45.5 -49.5t56.5 -41.5\u0026#13;\u0026#10;q-4 71 -28 134q17 33 42 46q24 -12 42 -46q-24 -63 -28 -134q36 23 56.5 41.5t45.5 49.5q36 2 61 -13q0 -28 -19 -59q-65 -10 -130 -43q65 -33 130 -43q19 -31 19 -59z\" id=\"x2217\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.012,0,0,-.012,9.885,5.525)\"\u003e\u003cpath d=\"M471 153q-22 -15 -61 -13q-25 31 -45.5 49.5t-56.5 41.5q4 -71 28 -134q-17 -33 -42 -46q-24 12 -42 46q24 63 28 134q-36 -23 -56.5 -41.5t-45.5 -49.5q-36 -2 -61 13q0 28 19 59q65 10 130 43q-65 33 -130 43q-19 31 -19 59q22 15 61 13q25 -31 45.5 -49.5t56.5 -41.5\u0026#13;\u0026#10;q-4 71 -28 134q17 33 42 46q24 -12 42 -46q-24 -63 -28 -134q36 23 56.5 41.5t45.5 49.5q36 2 61 -13q0 -28 -19 -59q-65 -10 -130 -43q65 -33 130 -43q19 -31 19 -59z\" id=\"x2217\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003cg transform=\"matrix(.017,0,0,-.017,17.488,14.875)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#13;\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,33.025,13.688)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,47.712,13.688)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#13;\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,55.871,13.688)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,59.747,13.688)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#13;\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,67.906,13.688)\"\u003e\u003cpath d=\"M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z\" id=\"x31\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e. Lower case for 24h and upper case for 36h.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.2\"\u003e3.2. Effect of EEAC on Wound-Healing Assay\u003c/h5\u003e\u003cp\u003eWe further assessed the effect of EEAC on the migration of CL1-5 cells using the wound healing assay in which the confluent monolayer was scraped with a sterile micropipette tip to create a scratch wound. As shown in Figure \u003ca href=\"fig2/#a\" target=\"_blank\"\u003e2(a)\u003c/a\u003e, EEAC inhibited the migration of CL1-5 cells in a dose-dependent manner, with 27.7% and 40.1% inhibition at 0.5 and 1.0\u003ci\u003e\u003c/i\u003eg/mL after incubation for 36h, respectively, (Figure \u003ca href=\"fig2/#b\" target=\"_blank\"\u003e2(b)\u003c/a\u003e).\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig2\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig2\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"378415.fig.002a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.002a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"378415.fig.002b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.002b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig2\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"378415.fig.002a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.002a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"378415.fig.002b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.002b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig2\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 2\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig2/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffects of EEAC on wound healing migration of CL1-5 cells. Wound was introduced by scraping confluent cell layers with a pipet tip. CL1-5 cells were incubated with EEAC (0.125, 0.25, 0.5, and 1.0\u003ci\u003e\u003c/i\u003eg/mL) for 36h, and the migration distances of cells were calculated. (a) Representative photographs of invading cells that received either control or EEAC treatment. (b) Migrated cells across the black lines were counted in six random fields from each treatment. The mean number of cells in the denuded zone is quantified by three independent experiments. Values (means  SD, \u003csvg height=\"11.125\" id=\"M5\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 36.237499 11.125\" width=\"36.237499\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,0,0,-.017,.062,10.863)\"\u003e\u003cpath d=\"M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2\u0026#13;\u0026#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z\" id=\"x1D45B\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,13.305,10.863)\"\u003e\u003cpath d=\"M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z\" id=\"x3D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,28.008,10.863)\"\u003e\u003cpath d=\"M285 378v-2q65 -13 102 -54.5t37 -97.5q0 -57 -30.5 -104.5t-74 -75t-85.5 -42t-72 -14.5q-31 0 -59.5 11t-40.5 23q-19 18 -16 36q1 16 23 33q13 10 24 0q58 -51 124 -51q55 0 88 40t33 112q0 64 -39 96.5t-88 32.5q-29 0 -64 -11l-6 29q77 25 118 57.5t41 84.5\u0026#13;\u0026#10;q0 45 -26.5 69.5t-68.5 24.5q-67 0 -120 -79l-20 20l43 63q51 56 127 56h1q66 0 107 -37t41 -95q0 -42 -31 -71q-22 -23 -68 -54z\" id=\"x33\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e) differ significantly (\u003csvg height=\"11.375\" id=\"M6\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,0,0,-.017,.062,11.113)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#13;\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,15.582,11.113)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,30.286,11.113)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#13;\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,38.446,11.113)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,42.321,11.113)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#13;\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,50.481,11.113)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#13;\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e).\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.3\"\u003e3.3. Effect of EEAC on Migration of CL1-5 Cells In Vitro\u003c/h5\u003e\u003cp\u003eThe transwell assay was used to investigate the migration of CL1-5 cells at 24h after EEAC treatment. We found that EEAC added at 0.1251.0\u003ci\u003e\u003c/i\u003eg/mL significantly decreased the migration (Figures \u003ca href=\"fig3/#a\" target=\"_blank\"\u003e3(a)\u003c/a\u003e and \u003ca href=\"fig3/#b\" target=\"_blank\"\u003e3(b)\u003c/a\u003e) of CL1-5 cells and that these effects of EEAC were dose dependent.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig3\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig3\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"378415.fig.003a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.003a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"378415.fig.003b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.003b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig3\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"378415.fig.003a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.003a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"378415.fig.003b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.003b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig3\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 3\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig3/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffects of EEAC on (a) transwell migration assay of CL1-5 cells. CL1-5 cells were incubated with EEAC (0.25, 0.5 and 1.0\u003ci\u003e\u003c/i\u003eg/mL) for 24h and 36h, and the (b) transwell migration cells were calculated. Photos of the migration CL1-5 cells were taken under a microscope (200-fold magnification). Values (means  SD, \u003csvg height=\"11.125\" id=\"M7\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 36.237499 11.125\" width=\"36.237499\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,0,0,-.017,.062,10.863)\"\u003e\u003cpath d=\"M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2\u0026#13;\u0026#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z\" id=\"x1D45B\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,13.305,10.863)\"\u003e\u003cpath d=\"M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z\" id=\"x3D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,28.008,10.863)\"\u003e\u003cpath d=\"M285 378v-2q65 -13 102 -54.5t37 -97.5q0 -57 -30.5 -104.5t-74 -75t-85.5 -42t-72 -14.5q-31 0 -59.5 11t-40.5 23q-19 18 -16 36q1 16 23 33q13 10 24 0q58 -51 124 -51q55 0 88 40t33 112q0 64 -39 96.5t-88 32.5q-29 0 -64 -11l-6 29q77 25 118 57.5t41 84.5\u0026#13;\u0026#10;q0 45 -26.5 69.5t-68.5 24.5q-67 0 -120 -79l-20 20l43 63q51 56 127 56h1q66 0 107 -37t41 -95q0 -42 -31 -71q-22 -23 -68 -54z\" id=\"x33\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e) differ significantly (\u003csvg height=\"11.375\" id=\"M8\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,0,0,-.017,.062,11.113)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#13;\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,15.582,11.113)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,30.286,11.113)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#13;\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,38.446,11.113)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,42.321,11.113)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#13;\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,50.481,11.113)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#13;\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e).\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.4\"\u003e3.4. EEAC Inhibits the Release of MMP-2 and MMP-9 in CL1-5 Cells\u003c/h5\u003e\u003cp\u003eTo examine the possible antimigration mechanisms of EEAC, we determined the activity of MMP-2 and MMP-9 in culture media of CL1-5 cells by zymographic analysis. In the absence of treatment, CL1-5 cells constitutively secreted high levels of MMP-9 and MMP-2. Our results showed that EEAC inhibited MMP-9 and MMP-2 activities in a concentration-dependent manner (Figures \u003ca href=\"fig4/#a\" target=\"_blank\"\u003e4(a)\u003c/a\u003e and \u003ca href=\"fig4/#b\" target=\"_blank\"\u003e4(b)\u003c/a\u003e). These results suggest that the antimigration effect of EEAC is related to the inhibition of the enzymatically degradative processes of CL1-5 migration.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig4\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig4\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"378415.fig.004a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.004a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"378415.fig.004b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.004b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig4\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"378415.fig.004a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.004a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"378415.fig.004b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.004b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig4\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 4\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig4/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffects of EEAC on MMP-2 and MMP-9 activities of CL1-5 cells. (a) Cells were treated with various concentrations (0.125, 0.25, 0.5, and 1.0\u003ci\u003e\u003c/i\u003eg/mL) of EEAC for 36h. The conditioned media were collected, and MMP-2, and MMP-9 activities were determined by gelatin zymography. (b) The activities of these proteins were subsequently quantified by densitometric analysis. Values (means  SD, \u003csvg height=\"11.125\" id=\"M9\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 36.237499 11.125\" width=\"36.237499\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,0,0,-.017,.062,10.863)\"\u003e\u003cpath d=\"M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2\u0026#13;\u0026#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z\" id=\"x1D45B\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,13.305,10.863)\"\u003e\u003cpath d=\"M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z\" id=\"x3D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,28.008,10.863)\"\u003e\u003cpath d=\"M285 378v-2q65 -13 102 -54.5t37 -97.5q0 -57 -30.5 -104.5t-74 -75t-85.5 -42t-72 -14.5q-31 0 -59.5 11t-40.5 23q-19 18 -16 36q1 16 23 33q13 10 24 0q58 -51 124 -51q55 0 88 40t33 112q0 64 -39 96.5t-88 32.5q-29 0 -64 -11l-6 29q77 25 118 57.5t41 84.5\u0026#13;\u0026#10;q0 45 -26.5 69.5t-68.5 24.5q-67 0 -120 -79l-20 20l43 63q51 56 127 56h1q66 0 107 -37t41 -95q0 -42 -31 -71q-22 -23 -68 -54z\" id=\"x33\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e) differ significantly (\u003csvg height=\"11.375\" id=\"M10\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,0,0,-.017,.062,11.113)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#13;\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,15.582,11.113)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,30.286,11.113)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#13;\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,38.446,11.113)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,42.321,11.113)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#13;\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,0,0,-.017,50.481,11.113)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#13;\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e) (lower case for MMP-2 and upper case for MMP-9).\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.5\"\u003e3.5. Inhibition by EEAC of MMP-2 and MMP-9\u003c/h5\u003e\u003cp\u003eTo examine the possible antimigration mechanisms of EEAC, we determined the MMP-2 and MMP-9 expressions in culture media of CL1-5 cells by Western blotting assay. Using Western blotting, we analyzed the effects of treating cells with various concentration of EEAC for 36h on MMPs protein expression. Treatment of CL1-5 cells with EEAC induced noticeable reductions in MMP-9 and MMP-2 protein expression (Figure \u003ca href=\"fig5/\" target=\"_blank\"\u003e5\u003c/a\u003e).\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig5\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig5\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"\" name=\"378415.fig.005\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.005.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 5\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig5/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffects of EEAC on TIMP-1, TIMP-2, MMP-9, and MMP-2 protein expression. CL1-5 cells were treated with 0.125, 0.25, 0.5, and 1.0\u003ci\u003e\u003c/i\u003eg/mL for 36h, and cell lysates were subjected to SDS-PAGE followed by western blotting and subsequently quantified by densitometric analyses (using control as 100%). The values indicate the density proportion of each protein compared with control.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.6\"\u003e3.6. Effect of EEAC on TIMP-1,TIMP-2, FAK, and Phospharylated FAK (p-FAK) Expressions in CL1-5 Cells\u003c/h5\u003e\u003cp\u003eTo further explore the modulation of pro-MMP activation by EEAC, we determined TIMP-1/2 protein expression levels. As shown in Figure \u003ca href=\"fig5/\" target=\"_blank\"\u003e5\u003c/a\u003e, EEAC strongly increased TIMP-1 and TIMP-2 activity in a concentration-dependent manner. To evaluate the effect of EEAC on FAK and p-FAK protein expression, CL1-5 cells were treated with EEAC at 0, 0.125, 0.25, 0.5, and 1.0\u003ci\u003e\u003c/i\u003eg/mL for 36h. As shown in Figure \u003ca href=\"fig5/\" target=\"_blank\"\u003e5\u003c/a\u003e, EEAC suppressed p-FAK expression in CL1-5 cells, when EEAC concentration was higher than 0.25\u003ci\u003e\u003c/i\u003eg/mL.\u003c/p\u003e\u003ch5 id=\"sec3.7\"\u003e3.7. Effect of EEAC on PI3K, AKT, Phosphorylated AKT (pAKT), and Rac-1 Expressions in CL1-5 Cells\u003c/h5\u003e\u003cp\u003ePI3Ks are a group of ubiquitously expressed lipid kinases which are important players in a major pathway of cell signaling. The PI3K/AKT pathway has been identified as a major regulator of cellular proliferation, differentiation, and death in multiple cell types [\u003ca href=\"#B18\"\u003e18\u003c/a\u003e]. To further investigate the involvement of PI3K/AKT, a series of experiments was performed to measure the expression of candidate signaling molecules upon EEAC stimulation. The results showed that incubation of CL1-5 cells with EEAC (0.1251.0\u003ci\u003e\u003c/i\u003eg/mL) led to a dose-dependent decrease of PI3K and pAKT levels (Figure \u003ca href=\"fig6/\" target=\"_blank\"\u003e6\u003c/a\u003e). Similarly, EEAC (01.0\u003ci\u003e\u003c/i\u003eg/mL,36h) suppressed Rac-1 protein expression in a concentration-dependent manner, and the effect became statistically significant when EEAC concentration was higher than 0.25\u003ci\u003e\u003c/i\u003eg/mL (Figure \u003ca href=\"fig6/\" target=\"_blank\"\u003e6\u003c/a\u003e).\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig6\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig6\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"\" name=\"378415.fig.006\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.006.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 6\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig6/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eConcentration-dependent effects of EEAC on the protein expression level of PI3K, phosphorylated AKT and Rac-1. In the concentration-dependent assay, CL1-5 cells were treated with 0.125, 0.25, 0.5, and 1.0\u003ci\u003e\u003c/i\u003eg/mL of EEAC for 36h. The expression of PI3K, phosphorylation of AKT and Rac-1 were analyzed by Western blotting. \u003ci\u003e\u003c/i\u003e-actin was used as a loading control. The values indicate the density proportion of each protein compared with control.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.8\"\u003e3.8. Inhibition by EEAC of Phosphorylated FAK, ERK1/2, p38, and JNK1/2\u003c/h5\u003e\u003cp\u003eWe analyzed the phosphorylation of MAPKs in CL1-5 cells after treatment with EEAC (0.1251.0\u003ci\u003e\u003c/i\u003eg/mL) for 36h. Data in Figure \u003ca href=\"fig7/\" target=\"_blank\"\u003e7\u003c/a\u003e showed that EEAC significantly dose-dependently affect p-FAK, p-ERK1/2, p-JNK1/2, or p38 and p-p38 proteins at concentrations from 0.1251.0\u003ci\u003e\u003c/i\u003eg/mL.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig7\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig7\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"378415.fig.007a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.007a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"378415.fig.007b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.007b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig7\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"378415.fig.007a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.007a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"378415.fig.007b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.007b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig7\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 7\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig7/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffects of EEAC on protein levels of MAPK signaling and phosphorylated focal adhesion kinase (p-FAK) in CL1-5 cells. (a) CL1-5 were treated with several different concentrations of EEAC (0.125, 0.25, 0.5, and 1.0\u003ci\u003e\u003c/i\u003eg/mL) for 36h. (b) Effects of PI3K inhibitor (LY294002; 50\u003ci\u003e\u003c/i\u003eM), ERK1/2 inhibitor (PD98059; 50\u003ci\u003e\u003c/i\u003eM), JNK inhibitor (SP600125; 50\u003ci\u003e\u003c/i\u003eM), and p38 MAPK inhibitor (SB203580; 50\u003ci\u003e\u003c/i\u003eM) on EEAC-induced protein expressions of MMP-2 and -9. Cells were pretreated with an inhibitor (50\u003ci\u003e\u003c/i\u003eM) at 1h prior to the treatment with 1.0\u003ci\u003e\u003c/i\u003eg/mL EEAC for 36h (total inhibitor exposure time was 37h). Protein expressions of MMP-2 and -9 were determined by the western blotting assay.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.9\"\u003e3.9. Specific Inhibitor to Analyze the Signaling Transduction\u003c/h5\u003e\u003cp\u003eTo further delineate whether the inhibition of cell migration by EEAC occurs through inhibition of PI3K, ERK, JNK, and p38 signaling, CL1-5 cells were 1h pretreated with a PI3K inhibitor (LY294002; 50\u003ci\u003e\u003c/i\u003eM), ERK1/2 inhibitor (PD98059; 50\u003ci\u003e\u003c/i\u003eM), JNK inhibitor (SP600125; 50\u003ci\u003e\u003c/i\u003eM), p38 MAPK inhibitor (SB203580; 50\u003ci\u003e\u003c/i\u003eM), and then incubated in the presence or absence of EEAC (1.0\u003ci\u003e\u003c/i\u003eg/mL) for 36h. The Western blotting assay revealed that EEAC or LY294002 (50\u003ci\u003e\u003c/i\u003eM), PD98256 (50\u003ci\u003e\u003c/i\u003eM), SP600125 (50\u003ci\u003e\u003c/i\u003eM), SB203580 (50\u003ci\u003e\u003c/i\u003eM) alone decreased MMP-9 and MMP-2 protein expressions. Furthermore, the combined treatment (50\u003ci\u003e\u003c/i\u003eM, LY294002, SB203580, SP600125 and PD98059 plus 1.0\u003ci\u003e\u003c/i\u003eg/mL EEAC) resulted in enhanced inhibition of MMP-9 and MMP-2 (Figure \u003ca href=\"fig7/#b\" target=\"_blank\"\u003e7(b)\u003c/a\u003e).\u003c/p\u003e\u003ch4 id=\"discussions\"\u003e4. Discussions\u003c/h4\u003e\u003cp\u003eSeveral cancer cell lines including A498, NPC-TW01, Hep3B, HepG2, TW206, CL1-0, and CL1-5 have been screed for their cell cytotoxicity at 12, 24, 36, and 48h. Our results showed that CL1-0 (IC\u003csub\u003e50\u003c/sub\u003e = 16\u003ci\u003e\u003c/i\u003eg/mL) and CL1-5 (IC\u003csub\u003e50\u003c/sub\u003e = 16\u003ci\u003e\u003c/i\u003eg/mL) exhibits more susceptible to EEAC than other cells for 36h exposure. As CL1-5 cells showed higher metastatic ability, we explored the antimigration effects and mechanistic actions of EEAC in human lung adenocarcinoma CL1-5 cells. Our results demonstrate that EEAC significantly inhibited the migration (assessed using the transwell assay and the wound-healing assay) of CL1-5 cells (Figures \u003ca href=\"fig2/\" target=\"_blank\"\u003e2\u003c/a\u003e and \u003ca href=\"fig3/\" target=\"_blank\"\u003e3\u003c/a\u003e). We also showed that EEAC remarkably inhibited the activities of MMP-2 and MMP-9 (Figure \u003ca href=\"fig4/\" target=\"_blank\"\u003e4\u003c/a\u003e). These results demonstrated that the antimetastastic effect of EEAC was associated with the inhibition of enzymatically degradative processes of smooth muscle cells migration. To our knowledge, it is the first study to demonstrate that EEAC reduces the biochemical mechanisms of the migration in CL1-5 cells.\u003c/p\u003e\u003cp\u003eSeveral bioactive compound from the ethanol extract of \u003ci\u003eA. cinnamomea\u003c/i\u003e, such as antroquinonol, 4-acetylantroquinonol B, and zhankuic acid A, have been reported to reduce cell proliferation of hepatoma, colon and leukemia cancer cells [\u003ca href=\"#B21\"\u003e21\u003c/a\u003e\u003ca href=\"#B23\"\u003e23\u003c/a\u003e]. Our previous studies demonstrated that the marked compounds (i.e., adenosine, cordycepin, and zhankuic acid A) within EEAC were identified by HPLC and LC/MS/MS to be as indicator compounds for quality check of extraction procedure of each batch (data not shown). According to the relative concentration of external standards, the content of adenosine, cordycepin and zhankuic acid A were calculated to be 0.08, 0.16, and 235mg/g EEAC, respectively, (data not shown). Of these, adenosine might be through binding to adenosine A3 receptors (A3-AR) to decrease the telomeric signal, resulting in G0/G1 arrest of lymphoma cell. Moreover, A3 receptor antagonist cotreated with cordycepin would reverse cordycepin-induced in mouse Leydig tumor cell death, which indicate the possible relationship between A3-AR and cordycepin-induced death effect [\u003ca href=\"#B24\"\u003e24\u003c/a\u003e, \u003ca href=\"#B25\"\u003e25\u003c/a\u003e]. Wu et al. indicated that cordycepin could induce cell arrest at G2/M and subG1 phases followed by significant apoptotic cell death in human OEC-M1 oral cancer cell line [\u003ca href=\"#B26\"\u003e26\u003c/a\u003e]. Similarly, cordycepin has also been found to cause G2/M arrest in human bladder and colon cancer cells through upregulation of p21\u003csup\u003eWAF1\u003c/sup\u003e level as well as reduction of cyclin B1, Cdc2, and Cdc25c proteins in a p53-independent manner by regulating c-Jun N-terminal kinase activation [\u003ca href=\"#B27\"\u003e27\u003c/a\u003e, \u003ca href=\"#B28\"\u003e28\u003c/a\u003e]. Furthermore, Geethangili and Tzeng reported that zhankuic acid A exhibited cytotoxic activity against P-388 murine and leukemia cells with an IC50 value of 1.8 and 5.4\u003ci\u003e\u003c/i\u003eg/mL, respectively, [\u003ca href=\"#B29\"\u003e29\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eDuring cancer progression, certain tumor cells become motile and attack the host tissue leading to metastasis. Focal adhesion kinase (FAK) can be activated in response to various stimuli and plays an important role in the cancer cell proliferation and metastasis [\u003ca href=\"#B30\"\u003e30\u003c/a\u003e]. Compiling evidence implies that FAK regulates focal adhesion signaling by phosphorylating various substrates and by acting as a scaffold for protein-protein interactions, as well as the MMPs-mediated matrix degradation, which consecutively regulates downstream signaling cascades [\u003ca href=\"#B31\"\u003e31\u003c/a\u003e]. FAK, a cytoplasmic kinase that is involved in ECM and integrin-mediated signaling pathways, has been suggested to have an essential role in metastasis through the modulation of tumor cell migration and invasion [\u003ca href=\"#B32\"\u003e32\u003c/a\u003e]. Majorly, integrin-mediated FAK signaling is phosphorylation of Tyr\u003csup\u003e397\u003c/sup\u003e. Particularly, phosphorylation of Tyr\u003csup\u003e397\u003c/sup\u003e forms a high-affinity binding site for Src-homology domain 2 (SH2), domains of Src family kinase, therefore promoting Src kinase activity. As a result, a major function of FAK is to recruit and activatr Src at cell-extracellular matrix adhesion sites. Activated FAK in cancer cells relays signals through multiple downstream targets. For example, activated FAK binds the SH2 of PI3K, thereby transporting the catalytic subunit of PI3K to the membrane, where it catalyzes the phosphorylation of inositol lipids in lung cancer cell migration [\u003ca href=\"#B33\"\u003e33\u003c/a\u003e]. The residues surrounding Tyr\u003csup\u003e397\u003c/sup\u003e can also constitute a sequence that binds to the Ras signaling pathway. The downstream targets of the Ras signaling pathway include ERK1/2 [\u003ca href=\"#B34\"\u003e34\u003c/a\u003e]. Indeed, these pathways are activated during integrin binding to the ECM, resulting in the transduction of external stimuli from the ECM to the nucleus [\u003ca href=\"#B35\"\u003e35\u003c/a\u003e]. Certain result suggests that anti-invasive effect in androgen-independent prostate cancer by controlling MMP-9 expression through the suppression of the EGFR/JNK pathway [\u003ca href=\"#B36\"\u003e36\u003c/a\u003e]. FAK and MAPK signaling involved in MMP-2 secretion has been shown in QG90 lung cancer cells [\u003ca href=\"#B37\"\u003e37\u003c/a\u003e]. Moreover, it was found that the MMP-9 gene promoter is partially regulated through activation of the ERK1/2 pathway [\u003ca href=\"#B38\"\u003e38\u003c/a\u003e]. In recent, p38 is implicating mediating bladder cancer invasion via regulation of MMP-2 and MMP-9 at the level of mRNA stability [\u003ca href=\"#B39\"\u003e39\u003c/a\u003e]. Also, p38\u003ci\u003e\u003c/i\u003e MAPK activates c-Jun, and the activated c-Jun recruits p38\u003ci\u003e\u003c/i\u003e as a cofactor into MMP-9 promoter to induce its trans-activation and cell invasion [\u003ca href=\"#B40\"\u003e40\u003c/a\u003e]. In this study, we found that EEAC inhibited the activation of FAK, as evidenced by reduced phosphorylation of FAK (Figure \u003ca href=\"fig7/#a\" target=\"_blank\"\u003e7(a)\u003c/a\u003e). We also demonstrated that treatment with EEAC inhibited phosphorylation of ERK1/2, phospho-p38, and JNK1/2 activity (Figure \u003ca href=\"fig7/#a\" target=\"_blank\"\u003e7(a)\u003c/a\u003e). The use of specific inhibitors revealed that PI3K, ERK, JNK, and p38 play important roles in regulating cell death induced by EEAC in CL1-5 cells (Figure \u003ca href=\"fig7/#b\" target=\"_blank\"\u003e7(b)\u003c/a\u003e). In this study, the Western blotting assay was used to examine the effects of specific MAPK inhibitors, as the same method has often been used to examine the effects of specific MAPK inhibitors [\u003ca href=\"#B6\"\u003e6\u003c/a\u003e]. Therefore, it appears that FAK can promote CL1-5 cancer cell migration through the MAPK signaling and MMP-2 and MMP-9 pathway.\u003c/p\u003e\u003cp\u003eIn addition, we showed that EEAC inhibited PI3K/AKT in CL1-5 cells. Thus, it seems that FAK promotes CL1-5 cancer cell migration in concert with the activation of the PI3K/AKT signaling pathways. Increased phosphorylation of FAK and its downstream targets, Src, ERK1/2, PI3K, and AKT have been shown in A549 lung epithelial cells stimulated by fibronectin. Consistent with this observation, depletion of FAK by siRNA resulted in the inhibition of Src, ERK1/2, PI3K, and AKT activity [\u003ca href=\"#B33\"\u003e33\u003c/a\u003e]. Several studies have indicated that FAK/PI3K/Akt is involved in the regulation of MMP-2 and MMP-9 activities on different cell types [\u003ca href=\"#B9\"\u003e9\u003c/a\u003e, \u003ca href=\"#B41\"\u003e41\u003c/a\u003e]. Shibata et al. [\u003ca href=\"#B42\"\u003e42\u003c/a\u003e] have shown that stimulated ovarian cancer cells with fibronectin activated MMP-9 secretion, while both antisense oligonucleotide to FAK and dominant-negative mutation of Ras abolished this phenomenon. To assess whether EEAC inhibits the phosphorylation of FAK, AKT, and the protein level of PI3K, CL1-5 cells were treated with various concentrations of EEAC (0.125, 0.25, 0.5, and 1.0\u003ci\u003e\u003c/i\u003eg/mL) for 36h. Figure \u003ca href=\"fig6/\" target=\"_blank\"\u003e6\u003c/a\u003e showed EEAC significantly inhibited the activation of FAK and AKT as shown by the decrease in the phosphorylation of FAK and AKT. In addition, EEAC inhibited the protein levels of PI3K in a dose-dependent manner (Figure \u003ca href=\"fig6/\" target=\"_blank\"\u003e6\u003c/a\u003e). Zeng et al. [\u003ca href=\"#B43\"\u003e43\u003c/a\u003e] reported that activated FAK-induced PI3K is required for the production of matrix metalloproteinases (MMPs). Also, PI3K is one of the critical downstream signal molecules of FAK pathways [\u003ca href=\"#B44\"\u003e44\u003c/a\u003e]. Therefore, our results demonstrated that EEAC inhibited the expressions of p-FAK, pAKT, and PI3K.\u003c/p\u003e\u003cp\u003eThe Rho family of small guanosine triphosphatases (GTPases) (including RhoA, RhoB, c-Raf, Rac-1, and Cdc42) are critical in regulating actin reorganization associated with cell growth, migration, transformation, and gene expression [\u003ca href=\"#B45\"\u003e45\u003c/a\u003e]. The Rho family of GTPases has been reported to be involved in the regulation of the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway [\u003ca href=\"#B46\"\u003e46\u003c/a\u003e]. In addition, Campbell et al. [\u003ca href=\"#B9\"\u003e9\u003c/a\u003e] reported that PI3K/AKT signal transduction pathway regulates cell invasion and metastasis of nonsmall cell lung cancer (NSCLC) and is closely associated with the development and progression of various tumors. Rac1 was reported to act as a downstream effect of PI3-K in several growth factor-stimulated pathways [\u003ca href=\"#B47\"\u003e47\u003c/a\u003e] and to induce invasion and metastasis in cancer cells [\u003ca href=\"#B48\"\u003e48\u003c/a\u003e]. Rac1 activation also played a critical role in the migration of cancer cells [\u003ca href=\"#B49\"\u003e49\u003c/a\u003e]. Rac-1 has been implicated in the regulation of the contraction and retraction forces that are required for cell migration [\u003ca href=\"#B50\"\u003e50\u003c/a\u003e]. Increased Rac-1 expression enhances the phosphorylation of myosin, which cross-links actin filaments and generates contractile forces, promoting movement of the cell body and facilitating cell rear detachment. Rac-1 is also implicated in the invasion of human microvascular endothelial cells. Active-Rac-1 could induce the expression of MMP-9 metalloproteinase and promote migration of endothelial cells [\u003ca href=\"#B51\"\u003e51\u003c/a\u003e]. Rac-1 may exert this activity through upregulate transcription factors such as NF-\u003ci\u003e\u003c/i\u003eB known to be involved in the expression of certain metalloproteinases including MMP-9. Our finding that EEAC concentration dependently decreased Rac-1 protein expression (Figure \u003ca href=\"fig6/\" target=\"_blank\"\u003e6\u003c/a\u003e), suggesting that EEAC may also inhibit the metastasis of CL1-5 cells through the PI3K/AktRac-1 and Rac-1MMP-9 pathways.\u003c/p\u003e\u003cp\u003eIn conclusion, we have demonstrated that EEAC inhibits the migration of human lung adenocarcinoma cancer CL1-5 cells. Mechanistically, we show that this effect of EEAC may occur through inactivation of the ERK1/2 signaling pathway, exerting inhibitory effects on FAK, p-FAK, and Rac-1 protein expressions and inhibiting PI3K, and phospho-Akt levels, thereby decreasing the activities of MMP-2, MMP-9 of CL1-5 cells (Figure \u003ca href=\"fig8/\" target=\"_blank\"\u003e8\u003c/a\u003e). Further preclinical and clinical studies are required to demonstrate the potential of EEAC as an anticancer agent.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig8\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig8\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"\" name=\"378415.fig.008\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/378415/figures/378415.fig.008.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 8\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig8/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eProposed signaling pathways for EEAC-mediated inhibition against migration of CL1-5 cells. The effect of EEAC is achieved likely through the inhibition of FAK, which regulates Rac-1/MMP-9 expression through MAPK and PI3K/AKT signaling pathways.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch4 id=\"abbreviations\"\u003eAbbreviations\u003c/h4\u003e\u003ctable class=\"gloss-abbr\"\u003e\u003ctr\u003e\u003ctd\u003eMMPs:\u003c/td\u003e\u003ctd\u003eMatrix metalloproteinases\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e uPA:\u003c/td\u003e\u003ctd\u003eUrokinase-type plasminogen activator\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e ECM:\u003c/td\u003e\u003ctd\u003eExtracellular matrix\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e MAPK:\u003c/td\u003e\u003ctd\u003eMitogen-activated protein kinase\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e ERK:\u003c/td\u003e\u003ctd\u003eExtracellular signaling-regulating kinase\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e JNK/SAPK:\u003c/td\u003e\u003ctd\u003ec-Jun N-terminal kinase/stress-activated protein kinase\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e PI3K:\u003c/td\u003e\u003ctd\u003ePhosphoinositide 3-kinase\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003eFAK:\u003c/td\u003e\u003ctd\u003eFocal adhesion kinase\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e RhoA:\u003c/td\u003e\u003ctd\u003eRas homologue gene family, member A.\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003ch4 id=\"acknowledgments\"\u003eAcknowledgments\u003c/h4\u003e\u003cp\u003eThe present study was partially supported by CMU98-S-08 and CMU99-TC-29 from China Medical University, Taichung, Taiwan. Also the support was from the National Science Council (NSC 1002320-B-039-014-). This study was supported in part by Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004 and DOH100-TD-B-111-005). W.-S. Chang provided the CL1-5 cells. All authors read and approved the final Paper. The authors have no conflict of interests to report. The authors would like to thank Dr. Jeffrey Conrad for critically reading the paper. They appreciate Dr. Lu Teh-Ling for her kindly provided us SB203580, a p38 inhibitor.\u003c/p\u003e\u003c/div\u003e\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"references\" id=\"references\"\u003eReferences\u003c/h4\u003e\u003col\u003e\u003cli id=\"B1\"\u003eA. Jemal, T. Murray, E. Ward et al., Cancer statistics, 2005, \u003ci\u003eCa-A Cancer Journal for Clinicians\u003c/i\u003e, vol. 55, no. 1, pp. 1030, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Cancer%20statistics,%202005\u0026author=A. Jemal\u0026author=T. Murray\u0026author=E. Ward et al.\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B3\"\u003eS. Man, W. Gao, Y. Zhang et al., Formosanin C-inhibited pulmonary metastasis through repression of matrix metalloproteinases on mouse lung adenocarcinoma, \u003ci\u003eCancer Biology and Therapy\u003c/i\u003e, vol. 11, no. 6, pp. 592598, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.4161/cbt.11.6.14668\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Formosanin%20C-inhibited%20pulmonary%20metastasis%20through%20repression%20of%20matrix%20metalloproteinases%20on%20mouse%20lung%20adenocarcinoma\u0026author=S. Man\u0026author=W. Gao\u0026author=Y. Zhang et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B4\"\u003eK. Lirdprapamongkol, J. P. Kramb, T. Suthiphongchai et al., Vanillin suppresses metastatic potential of human cancer cells through PI3K inhibition and decreases angiogenesis in Vivo, \u003ci\u003eJournal of Agricultural and Food Chemistry\u003c/i\u003e, vol. 57, no. 8, pp. 30553063, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1021/jf803366f\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Vanillin%20suppresses%20metastatic%20potential%20of%20human%20cancer%20cells%20through%20PI3K%20inhibition%20and%20decreases%20angiogenesis%20in%20Vivo\u0026author=K. Lirdprapamongkol\u0026author=J. P. Kramb\u0026author=T. Suthiphongchai et al.\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B2\"\u003eY. W. Chu, P. C. Yang, S. C. Yang et al., Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line, \u003ci\u003eAmerican Journal of Respiratory Cell and Molecular Biology\u003c/i\u003e, vol. 17, no. 3, pp. 353360, 1997. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Selection%20of%20invasive%20and%20metastatic%20subpopulations%20from%20a%20human%20lung%20adenocarcinoma%20cell%20line\u0026author=Y. W. Chu\u0026author=P. C. Yang\u0026author=S. C. Yang et al.\u0026publication_year=1997\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B5\"\u003eM. Kodate, T. Kasai, H. Hashimoto, K. Yasumoto, Y. Iwata, and H. Manabe, Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung, \u003ci\u003ePathology International\u003c/i\u003e, vol. 47, no. 7, pp. 461469, 1997. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Expression%20of%20matrix%20metalloproteinase%20(gelatinase)%20in%20T1%20adenocarcinoma%20of%20the%20lung\u0026author=M. Kodate\u0026author=T. Kasai\u0026author=H. Hashimoto\u0026author=K. Yasumoto\u0026author=Y. Iwata\u0026author=\u0026author=H. Manabe\u0026publication_year=1997\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B6\"\u003eC. J. Weng, C. F. Wu, H. W. Huang, C. H. Wu, C. T. Ho, and G. C. Yen, Evaluation of anti-invasion effect of resveratrol and related methoxy analogues on human hepatocarcinoma cells, \u003ci\u003eJournal of Agricultural and Food Chemistry\u003c/i\u003e, vol. 58, no. 5, pp. 28862894, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1021/jf904182y\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Evaluation%20of%20anti-invasion%20effect%20of%20resveratrol%20and%20related%20methoxy%20analogues%20on%20human%20hepatocarcinoma%20cells\u0026author=C. J. Weng\u0026author=C. F. Wu\u0026author=H. W. Huang\u0026author=C. H. Wu\u0026author=C. T. Ho\u0026author=\u0026author=G. C. Yen\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B7\"\u003eG. J. Huang, C. M. Yang, Y. S. Chang et al., Hispolon suppresses SK-Hep1 human hepatoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen activator through the PI3K/Akt and ERK signaling pathways, \u003ci\u003eJournal of Agricultural and Food Chemistry\u003c/i\u003e, vol. 58, no. 17, pp. 94689475, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1021/jf101508r\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Hispolon%20suppresses%20SK-Hep1%20human%20hepatoma%20cell%20metastasis%20by%20inhibiting%20matrix%20metalloproteinase-2/9%20and%20urokinase-plasminogen%20activator%20through%20the%20PI3K/Akt%20and%20ERK%20signaling%20pathways\u0026author=G. J. Huang\u0026author=C. M. Yang\u0026author=Y. S. Chang et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B8\"\u003eA. K. Gupta, D. E. Soto, M. D. Feldman et al., Signaling pathways in NSCLC as a predictor of outcome and response to therapy, \u003ci\u003eLung\u003c/i\u003e, vol. 182, no. 3, pp. 151162, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Signaling%20pathways%20in%20NSCLC%20as%20a%20predictor%20of%20outcome%20and%20response%20to%20therapy\u0026author=A. K. Gupta\u0026author=D. E. Soto\u0026author=M. D. Feldman et al.\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B9\"\u003eI. G. Campbell, S. E. Russell, D. Y. H. Choong et al., Mutation of the PIK3CA gene in ovarian and breast cancer, \u003ci\u003eCancer Research\u003c/i\u003e, vol. 64, no. 21, pp. 76787681, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1158/0008-5472.CAN-04-2933\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Mutation%20of%20the%20PIK3CA%20gene%20in%20ovarian%20and%20breast%20cancer\u0026author=I. G. Campbell\u0026author=S. E. Russell\u0026author=D. Y. H. Choong et al.\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B10\"\u003eY. W. Shih, P. S. Chen, C. H. Wu, Y. F. Jeng, and C. J. Wang, \u003ci\u003e\u003c/i\u003e-Chaconine-reduced metastasis involves a PI3K/Akt signaling pathway with downregulation of NF-\u003ci\u003e\u003c/i\u003eB in human lung adenocarcinoma A549 cells, \u003ci\u003eJournal of Agricultural and Food Chemistry\u003c/i\u003e, vol. 55, no. 26, pp. 1103511043, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1021/jf072423r\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=a-Chaconine-reduced%20metastasis%20involves%20a%20PI3K/Akt%20signaling%20pathway%20with%20downregulation%20of%20NF-?B%20in%20human%20lung%20adenocarcinoma%20A549%20cells\u0026author=Y. W. Shih\u0026author=P. S. Chen\u0026author=C. H. Wu\u0026author=Y. F. Jeng\u0026author=\u0026author=C. J. Wang\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B11\"\u003eZ. T. Tsai and S. L. Liaw, \u003ci\u003eThe Use and the Effect of Ganoderma\u003c/i\u003e, San Yun Press, Taichung, Taiwan, 1985. \u003cspan class=\"reflinks\"\u003e\u003c/span\u003e\u003cli id=\"B12\"\u003eZ. H. Ao, Z. H. Xu, Z. M. Lu, H. Y. Xu, X. M. Zhang, and W. F. Dou, Niuchangchih (\u003ci\u003eAntrodia camphorata\u003c/i\u003e) and its potential in treating liver diseases, \u003ci\u003eJournal of Ethnopharmacology\u003c/i\u003e, vol. 121, no. 2, pp. 194212, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.jep.2008.10.039\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Niuchangchih%20(Antrodia%20camphorata)%20and%20its%20potential%20in%20treating%20liver%20diseases\u0026author=Z. H. Ao\u0026author=Z. H. Xu\u0026author=Z. M. Lu\u0026author=H. Y. Xu\u0026author=X. M. Zhang\u0026author=\u0026author=W. F. Dou\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B13\"\u003eC. C. Chen, Y. W. Liu, Y. B. Ker et al., Chemical characterization and anti-inflammatory effect of polysaccharides fractionated from submerge-cultured \u003ci\u003eAntrodia camphorata\u003c/i\u003e mycelia, \u003ci\u003eJournal of Agricultural and Food Chemistry\u003c/i\u003e, vol. 55, no. 13, pp. 50075012, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1021/jf063484c\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Chemical%20characterization%20and%20anti-inflammatory%20effect%20of%20polysaccharides%20fractionated%20from%20submerge-cultured%20Antrodia%20camphorata%20mycelia\u0026author=C. C. Chen\u0026author=Y. W. Liu\u0026author=Y. B. Ker et al.\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B14\"\u003eH. L. Yang, Y. C. Hseu, J. Y. Chen et al., Antrodia camphorata in submerged culture protects low density lipoproteins against oxidative modification, \u003ci\u003eAmerican Journal of Chinese Medicine\u003c/i\u003e, vol. 34, no. 2, pp. 217231, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1142/S0192415X06003783\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Antrodia%20camphorata%20in%20submerged%20culture%20protects%20low%20density%20lipoproteins%20against%20oxidative%20modification\u0026author=H. L. Yang\u0026author=Y. C. Hseu\u0026author=J. Y. Chen et al.\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B15\"\u003eH. Wu, C. L. Pan, Y. C. Yao, S. S. Chang, S. L. Li, and T. F. Wu, Proteomic analysis of the effect of Antrodia camphorata extract on human lung cancer A549 cell, \u003ci\u003eProteomics\u003c/i\u003e, vol. 6, no. 3, pp. 826835, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1002/pmic.200401341\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Proteomic%20analysis%20of%20the%20effect%20of%20Antrodia%20camphorata%20extract%20on%20human%20lung%20cancer%20A549%20cell\u0026author=H. Wu\u0026author=C. L. Pan\u0026author=Y. C. Yao\u0026author=S. S. Chang\u0026author=S. L. Li\u0026author=\u0026author=T. F. Wu\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B16\"\u003eY. C. Hseu, S. C. Chen, H. C. Chen, J. W. Liao, and H. L. Yang, Antrodia camphorata inhibits proliferation of human breast cancer cells in vitro and in vivo, \u003ci\u003eFood and Chemical Toxicology\u003c/i\u003e, vol. 46, no. 8, pp. 26802688, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.fct.2008.04.036\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Antrodia%20camphorata%20inhibits%20proliferation%20of%20human%20breast%20cancer%20cells%20in%20vitro%20and%20in%20vivo\u0026author=Y. C. Hseu\u0026author=S. C. Chen\u0026author=H. C. Chen\u0026author=J. W. Liao\u0026author=\u0026author=H. L. Yang\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B17\"\u003eY. W. Lin, J. H. Pan, R. H. Liu, Y. H. Kuo, L. Y. Sheen, and B. H. Chiang, The 4-acetylantroquinonol B isolated from mycelium of Antrodia cinnamomea inhibits proliferation of hepatoma cells, \u003ci\u003eJournal of the Science of Food and Agriculture\u003c/i\u003e, vol. 90, no. 10, pp. 17391744, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1002/jsfa.4010\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%204-acetylantroquinonol%20B%20isolated%20from%20mycelium%20of%20Antrodia%20cinnamomea%20inhibits%20proliferation%20of%20hepatoma%20cells\u0026author=Y. W. Lin\u0026author=J. H. Pan\u0026author=R. H. Liu\u0026author=Y. H. Kuo\u0026author=L. Y. Sheen\u0026author=\u0026author=B. H. Chiang\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B18\"\u003eH. L. Yang, Y. H. Kuo, C. T. Tsai et al., Anti-metastatic activities of Antrodia camphorata against human breast cancer cells mediated through suppression of the MAPK signaling pathway, \u003ci\u003eFood and Chemical Toxicology\u003c/i\u003e, vol. 49, no. 1, pp. 290298, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.fct.2010.10.031\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Anti-metastatic%20activities%20of%20Antrodia%20camphorata%20against%20human%20breast%20cancer%20cells%20mediated%20through%20suppression%20of%20the%20MAPK%20signaling%20pathway\u0026author=H. L. Yang\u0026author=Y. H. Kuo\u0026author=C. T. Tsai et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B19\"\u003eM. H. Pan, C. C. Lin, J. K. Lin, and W. J. Chen, Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-\u003ci\u003e\u003c/i\u003e1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling, \u003ci\u003eJournal of Agricultural and Food Chemistry\u003c/i\u003e, vol. 55, no. 13, pp. 50305037, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1021/jf070316r\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Tea%20polyphenol%20(-)-epigallocatechin%203-gallate%20suppresses%20heregulin-1-induced%20fatty%20acid%20synthase%20expression%20in%20human%20breast%20cancer%20cells%20by%20inhibiting%20phosphatidylinositol%203-kinase/Akt%20and%20mitogen-activated%20protein%20kinase%20cascade%20signaling\u0026author=M. H. Pan\u0026author=C. C. Lin\u0026author=J. K. Lin\u0026author=\u0026author=W. J. Chen\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B20\"\u003eS. J. Lee, S. K. Kim, W. S. Choi, W. J. Kim, and S. K. Moon, Cordycepin causes p21WAF1-mediated G2/M cell-cycle arrest by regulating c-Jun N-terminal kinase activation in human bladder cancer cells, \u003ci\u003eArchives of Biochemistry and Biophysics\u003c/i\u003e, vol. 490, no. 2, pp. 103109, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.abb.2009.09.001\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Cordycepin%20causes%20p21WAF1-mediated%20G2/M%20cell-cycle%20arrest%20by%20regulating%20c-Jun%20N-terminal%20kinase%20activation%20in%20human%20bladder%20cancer%20cells\u0026author=S. J. Lee\u0026author=S. K. Kim\u0026author=W. S. Choi\u0026author=W. J. Kim\u0026author=\u0026author=S. K. Moon\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B21\"\u003eP. C. Chiang, S. C. Lin, S. L. Pan et al., Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: a crucial role of AMPK and mTOR pathways, \u003ci\u003eBiochemical Pharmacology\u003c/i\u003e, vol. 79, no. 2, pp. 162171, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.bcp.2009.08.022\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Antroquinonol%20displays%20anticancer%20potential%20against%20human%20hepatocellular%20carcinoma%20cells:%20a%20crucial%20role%20of%20AMPK%20and%20mTOR%20pathways\u0026author=P. C. Chiang\u0026author=S. C. Lin\u0026author=S. L. Pan et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B22\"\u003eY. W. Lin, J. H. Pan, R. H. Liu, Y. H. Kuo, L. Y. Sheen, and B. H. Chiang, The 4-acetylantroquinonol B isolated from mycelium of Antrodia cinnamomea inhibits proliferation of hepatoma cells, \u003ci\u003eJournal of the Science of Food and Agriculture\u003c/i\u003e, vol. 90, no. 10, pp. 17391744, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1002/jsfa.4010\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%204-acetylantroquinonol%20B%20isolated%20from%20mycelium%20of%20Antrodia%20cinnamomea%20inhibits%20proliferation%20of%20hepatoma%20cells\u0026author=Y. W. Lin\u0026author=J. H. Pan\u0026author=R. H. Liu\u0026author=Y. H. Kuo\u0026author=L. Y. Sheen\u0026author=\u0026author=B. H. Chiang\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B23\"\u003eC. T. Yeh, Y. K. Rao, C. J. Yao et al., Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells, \u003ci\u003eCancer Letters\u003c/i\u003e, vol. 285, no. 1, pp. 7379, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.canlet.2009.05.002\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Cytotoxic%20triterpenes%20from%20Antrodia%20camphorata%20and%20their%20mode%20of%20action%20in%20HT-29%20human%20colon%20cancer%20cells\u0026author=C. T. Yeh\u0026author=Y. K. Rao\u0026author=C. J. Yao et al.\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B24\"\u003eP. Fishman, S. Bar-Yehuda, G. Ohana et al., Adenosine acts as an inhibitor of lymphoma cell growtha major role for the A3 adenosine receptor, \u003ci\u003eEuropean Journal of Cancer\u003c/i\u003e, vol. 36, no. 11, pp. 14521458, 2000. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0959-8049(00)00130-1\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Adenosine%20acts%20as%20an%20inhibitor%20of%20lymphoma%20cell%20growtha%20major%20role%20for%20the%20A3%20adenosine%20receptor\u0026author=P. Fishman\u0026author=S. Bar-Yehuda\u0026author=G. Ohana et al.\u0026publication_year=2000\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B25\"\u003eB.-M. Huang, B.-S. Pan, and C.-Y. Lin, The effect of cordycepin on steroidogenesis and apoptosis in MA-10 mouse Leydig tumor cells, \u003ci\u003eEvidence-Based Complementary and Alternative Medicine\u003c/i\u003e, vol. 2011, Article ID 750468, 14 pages, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1155/2011/750468\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20effect%20of%20cordycepin%20on%20steroidogenesis%20and%20apoptosis%20in%20MA-10%20mouse%20Leydig%20tumor%20cells\u0026author=B.-M. Huang\u0026author=B.-S. Pan\u0026author=\u0026author=C.-Y. Lin\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B26\"\u003eW. C. Wu, J. R. Hsiao, Y. Y. Lian, C. Y. Lin, and B. M. Huang, The apoptotic effect of cordycepin on human OEC-M1 oral cancer cell line, \u003ci\u003eCancer Chemotherapy and Pharmacology\u003c/i\u003e, vol. 60, no. 1, pp. 103111, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1007/s00280-006-0354-y\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20apoptotic%20effect%20of%20cordycepin%20on%20human%20OEC-M1%20oral%20cancer%20cell%20line\u0026author=W. C. Wu\u0026author=J. R. Hsiao\u0026author=Y. Y. Lian\u0026author=C. Y. Lin\u0026author=\u0026author=B. M. Huang\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B27\"\u003eS. J. Lee, S. K. Kim, W. S. Choi, W. J. Kim, and S. K. Moon, Cordycepin causes p21WAF1-mediated G2/M cell-cycle arrest by regulating c-Jun N-terminal kinase activation in human bladder cancer cells, \u003ci\u003eArchives of Biochemistry and Biophysics\u003c/i\u003e, vol. 490, no. 2, pp. 103109, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.abb.2009.09.001\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Cordycepin%20causes%20p21WAF1-mediated%20G2/M%20cell-cycle%20arrest%20by%20regulating%20c-Jun%20N-terminal%20kinase%20activation%20in%20human%20bladder%20cancer%20cells\u0026author=S. J. Lee\u0026author=S. K. Kim\u0026author=W. S. Choi\u0026author=W. J. Kim\u0026author=\u0026author=S. K. Moon\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B28\"\u003eS. J. Lee, G. S. Moon, K. H. Jung, W. J. Kim, and S. K. Moon, c-Jun N-terminal kinase 1 is required for cordycepin-mediated induction of G2/M cell-cycle arrest via p21WAF1 expression in human colon cancer cells, \u003ci\u003eFood and Chemical Toxicology\u003c/i\u003e, vol. 48, no. 1, pp. 277283, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.fct.2009.09.042\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=c-Jun%20N-terminal%20kinase%201%20is%20required%20for%20cordycepin-mediated%20induction%20of%20G2/M%20cell-cycle%20arrest%20via%20p21WAF1%20expression%20in%20human%20colon%20cancer%20cells\u0026author=S. J. Lee\u0026author=G. S. Moon\u0026author=K. H. Jung\u0026author=W. J. Kim\u0026author=\u0026author=S. K. Moon\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B29\"\u003eY.-M. Tzeng and M. Geethangili, Review of pharmacological effects of antrodia camphorata and its bioactive compounds, \u003ci\u003eEvidence-Based Complementary and Alternative Medicine\u003c/i\u003e, vol. 2011, Article ID 212641, 17 pages, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1093/ecam/nep108\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Review%20of%20pharmacological%20effects%20of%20antrodia%20camphorata%20and%20its%20bioactive%20compounds\u0026author=Y.-M. Tzeng \u0026author=M. Geethangili\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B30\"\u003eJ. T. Parsons, Focal adhesion kinase: the first ten years, \u003ci\u003eJournal of Cell Science\u003c/i\u003e, vol. 116, no. 8, pp. 14091416, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1242/jcs.00373\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Focal%20adhesion%20kinase:%20the%20first%20ten%20years\u0026author=J. T. Parsons\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B31\"\u003eM. Canel, P. Secades, M. Garzn-Arango et al., Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression, \u003ci\u003eBritish Journal of Cancer\u003c/i\u003e, vol. 98, no. 7, pp. 12741284, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1038/sj.bjc.6604286\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Involvement%20of%20focal%20adhesion%20kinase%20in%20cellular%20invasion%20of%20head%20and%20neck%20squamous%20cell%20carcinomas%20via%20regulation%20of%20MMP-2%20expression\u0026author=M. Canel\u0026author=P. Secades\u0026author=M. Garzn-Arango et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B32\"\u003eC. Hwangbo, J. Kim, J. J. Lee, and J. H. Lee, Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase C\u003ci\u003e\u003c/i\u003e and the PDZ adapter protein mda-9/syntenin, \u003ci\u003eCancer Research\u003c/i\u003e, vol. 70, no. 4, pp. 16451655, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1158/0008-5472.CAN-09-2447\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Activation%20of%20the%20integrin%20effector%20kinase%20focal%20adhesion%20kinase%20in%20cancer%20cells%20is%20regulated%20by%20crosstalk%20between%20protein%20kinase%20Ca%20and%20the%20PDZ%20adapter%20protein%20mda-9/syntenin\u0026author=C. Hwangbo\u0026author=J. Kim\u0026author=J. J. Lee\u0026author=\u0026author=J. H. Lee\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B33\"\u003eX. N. Meng, Y. Jin, Y. Yu et al., Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion, \u003ci\u003eBritish Journal of Cancer\u003c/i\u003e, vol. 101, no. 2, pp. 327334, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1038/sj.bjc.6605154\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Characterisation%20of%20fibronectin-mediated%20FAK%20signalling%20pathways%20in%20lung%20cancer%20cell%20migration%20and%20invasion\u0026author=X. N. Meng\u0026author=Y. Jin\u0026author=Y. Yu et al.\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B34\"\u003eK. C. Lai, A. N. C. Huang, S. C. Hsu et al., Benzyl Lsothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway, \u003ci\u003eJournal of Agricultural and Food Chemistry\u003c/i\u003e, vol. 58, no. 5, pp. 29352942, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1021/jf9036694\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Benzyl%20Lsothiocyanate%20(BITC)%20inhibits%20migration%20and%20invasion%20of%20human%20colon%20cancer%20HT29%20cells%20by%20inhibiting%20matrix%20metalloproteinase-2/-9%20and%20urokinase%20plasminogen%20(uPA)%20through%20PKC%20and%20MAPK%20signaling%20pathway\u0026author=K. C. Lai\u0026author=A. N. C. Huang\u0026author=S. C. Hsu et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B35\"\u003eH. F. Liao, Y. Y. Chen, J. J. Liu et al., Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis, \u003ci\u003eJournal of Agricultural and Food Chemistry\u003c/i\u003e, vol. 51, no. 27, pp. 79077912, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1021/jf034729d\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Inhibitory%20effect%20of%20caffeic%20acid%20phenethyl%20ester%20on%20angiogenesis,%20tumor%20invasion,%20and%20metastasis\u0026author=H. F. Liao\u0026author=Y. Y. Chen\u0026author=J. J. Liu et al.\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B36\"\u003eP. T. Kuo, T. P. Lin, L. C. Liu et al., Penta-O-galloyl-\u003ci\u003e\u003c/i\u003e-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression, \u003ci\u003eJournal of Agricultural and Food Chemistry\u003c/i\u003e, vol. 57, no. 8, pp. 33313339, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1021/jf803725h\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Penta-O-galloyl--D-glucose%20suppresses%20prostate%20cancer%20bone%20metastasis%20by%20transcriptionally%20repressing%20EGF-induced%20MMP-9%20expression\u0026author=P. T. Kuo\u0026author=T. P. Lin\u0026author=L. C. Liu et al.\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B37\"\u003eY. Zhang, A. A. Thant, Y. Hiraiwa et al., A role for focal adhesion kinase in hyluronan-dependent MMP-2 secretion in a human small-cell lung carcinoma cell line, QG90, \u003ci\u003eBiochemical and Biophysical Research Communications\u003c/i\u003e, vol. 290, no. 3, pp. 11231127, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1006/bbrc.2001.6321\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=A%20role%20for%20focal%20adhesion%20kinase%20in%20hyluronan-dependent%20MMP-2%20secretion%20in%20a%20human%20small-cell%20lung%20carcinoma%20cell%20line,%20QG90\u0026author=Y. Zhang\u0026author=A. A. Thant\u0026author=Y. Hiraiwa et al.\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B38\"\u003eC.-Y. Huang, Y.-M. Chang, Y.-T. Shih et al., Schwann cell migration induced by earthworm extract via activation of PAs and MMP2/9 mediated through ERK1/2 and p38, \u003ci\u003eEvidence-based Complementary and Alternative Medicine\u003c/i\u003e, vol. 2011, Article ID 395458, 12 pages, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1093/ecam/nep131\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Schwann%20cell%20migration%20induced%20by%20earthworm%20extract%20via%20activation%20of%20PAs%20and%20MMP2/9%20mediated%20through%20ERK1/2%20and%20p38\u0026author=C.-Y. Huang\u0026author=Y.-M. Chang\u0026author=Y.-T. Shih et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B39\"\u003eB. Kumar, S. Koul, J. Petersen et al., p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity, \u003ci\u003eCancer Research\u003c/i\u003e, vol. 70, no. 2, pp. 832841, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1158/0008-5472.CAN-09-2918\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=p38%20mitogen-activated%20protein%20kinase-driven%20MAPKAPK2%20regulates%20invasion%20of%20bladder%20cancer%20by%20modulation%20of%20MMP-2%20and%20MMP-9%20activity\u0026author=B. Kumar\u0026author=S. Koul\u0026author=J. Petersen et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B40\"\u003eM. Loesch, H. Y. Zhi, S. W. Hou et al., p38\u003ci\u003e\u003c/i\u003e MAPK cooperates with c-Jun in trans-activating matrix metalloproteinase 9, \u003ci\u003eJournal of Biological Chemistry\u003c/i\u003e, vol. 285, no. 20, pp. 1514915158, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1074/jbc.M110.105429\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=p38?%20MAPK%20cooperates%20with%20c-Jun%20in%20trans-activating%20matrix%20metalloproteinase%209\u0026author=M. Loesch\u0026author=H. Y. Zhi\u0026author=S. W. Hou et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B41\"\u003eK. C. Chan, H. H. Ho, C. N. Huang, M. C. Lin, H. M. Chen, and C. J. Wang, Mulberry leaf extract inhibits vascular smooth muscle cell migration involving a block of small GTPase and Akt/NF-kB signals, \u003ci\u003eJournal of Agricultural and Food Chemistry\u003c/i\u003e, vol. 57, no. 19, pp. 91479153, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1021/jf902507k\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Mulberry%20leaf%20extract%20inhibits%20vascular%20smooth%20muscle%20cell%20migration%20involving%20a%20block%20of%20small%20GTPase%20and%20Akt/NF-kB%20signals\u0026author=K. C. Chan\u0026author=H. H. Ho\u0026author=C. N. Huang\u0026author=M. C. Lin\u0026author=H. M. Chen\u0026author=\u0026author=C. J. Wang\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B42\"\u003eK. Shibata, F. Kikkawa, A. Nawa et al., Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells, \u003ci\u003eCancer Research\u003c/i\u003e, vol. 58, no. 5, pp. 900903, 1998. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Both%20focal%20adhesion%20kinase%20and%20c-Ras%20are%20required%20for%20the%20enhanced%20matrix%20metalloproteinase%209%20secretion%20by%20fibronectin%20in%20ovarian%20cancer%20cells\u0026author=K. Shibata\u0026author=F. Kikkawa\u0026author=A. Nawa et al.\u0026publication_year=1998\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B43\"\u003eZ. Z. Zeng, Y. Jia, N. J. Hahn, S. M. Markwart, K. F. Rockwood, and D. L. Livant, Role of focal adhesion kinase and phosphatidylinositol 3-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells, \u003ci\u003eCancer Research\u003c/i\u003e, vol. 66, no. 16, pp. 80918099, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1158/0008-5472.CAN-05-4400\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Role%20of%20focal%20adhesion%20kinase%20and%20phosphatidylinositol%203'-kinase%20in%20integrin%20fibronectin%20receptor-mediated,%20matrix%20metalloproteinase-1-dependent%20invasion%20by%20metastatic%20prostate%20cancer%20cells\u0026author=Z. Z. Zeng\u0026author=Y. Jia\u0026author=N. J. Hahn\u0026author=S. M. Markwart\u0026author=K. F. Rockwood\u0026author=\u0026author=D. L. Livant\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B44\"\u003eY. A. Choi, H. K. Lim, J. R. Kim et al., Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway, \u003ci\u003eJournal of Biological Chemistry\u003c/i\u003e, vol. 279, no. 35, pp. 3657936585, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1074/jbc.M314235200\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Group%20IB%20secretory%20phospholipase%20A2%20promotes%20matrix%20metalloproteinase-2-mediated%20cell%20migration%20via%20the%20phosphatidylinositol%203-kinase%20and%20Akt%20pathway\u0026author=Y. A. Choi\u0026author=H. K. Lim\u0026author=J. R. Kim et al.\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B45\"\u003eK. Wennerberg and C. J. Der, Rho-family GTPases: it's not only Rac and Rho (and i like it), \u003ci\u003eJournal of Cell Science\u003c/i\u003e, vol. 117, no. 8, pp. 13011312, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1242/jcs.01118\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Rho-family%20GTPases:%20it's%20not%20only%20Rac%20and%20Rho%20(and%20i%20like%20it)\u0026author=K. Wennerberg \u0026author=C. J. Der\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B46\"\u003eS. C. Hubchak, E. E. Sparks, T. Hayashida, and H. W. Schnaper, Rac1 promotes TGF-\u003ci\u003e\u003c/i\u003e-stimulated mesangial cell type I collagen expression through a PI3K/Akt-dependent mechanism, \u003ci\u003eAmerican Journal of Physiology\u003c/i\u003e, vol. 297, no. 5, pp. F1316F1323, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1152/ajprenal.00345.2009\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Rac1%20promotes%20TGF--stimulated%20mesangial%20cell%20type%20I%20collagen%20expression%20through%20a%20PI3K/Akt-dependent%20mechanism\u0026author=S. C. Hubchak\u0026author=E. E. Sparks\u0026author=T. Hayashida\u0026author=\u0026author=H. W. Schnaper\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B47\"\u003eM. Higuchi, N. Masuyama, Y. Fukui, A. Suzuki, and Y. Gotoh, Akt mediates Rac/Cdc42-regulated cell motility in growth factor-stimulated cells and in invasive PTEN knockout cells, \u003ci\u003eCurrent Biology\u003c/i\u003e, vol. 11, no. 24, pp. 19581962, 2001. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0960-9822(01)00599-1\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Akt%20mediates%20Rac/Cdc42-regulated%20cell%20motility%20in%20growth%20factor-stimulated%20cells%20and%20in%20invasive%20PTEN%20knockout%20cells\u0026author=M. Higuchi\u0026author=N. Masuyama\u0026author=Y. Fukui\u0026author=A. Suzuki\u0026author=\u0026author=Y. Gotoh\u0026publication_year=2001\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B48\"\u003eL. S. Price and J. G. Collard, Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion, \u003ci\u003eSeminars in Cancer Biology\u003c/i\u003e, vol. 11, no. 2, pp. 167173, 2001. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1006/scbi.2000.0367\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Regulation%20of%20the%20cytoskeleton%20by%20Rho-family%20GTPases:%20implications%20for%20tumour%20cell%20invasion\u0026author=L. S. Price \u0026author=J. G. Collard\u0026publication_year=2001\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B49\"\u003eJ. C. Stam, F. Michiels, R. A. Van Der Kammen, W. H. Moolenaar, and J. G. Collard, Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling, \u003ci\u003eEMBO Journal\u003c/i\u003e, vol. 17, no. 14, pp. 40664074, 1998. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1093/emboj/17.14.4066\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Invasion%20of%20T-lymphoma%20cells:%20cooperation%20between%20Rho%20family%20GTPases%20and%20lysophospholipid%20receptor%20signaling\u0026author=J. C. Stam\u0026author=F. Michiels\u0026author=R. A. Van Der Kammen\u0026author=W. H. Moolenaar\u0026author=\u0026author=J. G. Collard\u0026publication_year=1998\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B50\"\u003eY. C. Lee, T. H. Cheng, J. S. Lee et al., Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells, \u003ci\u003eMolecular and Cellular Biochemistry\u003c/i\u003e, pp. 113, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1007/s11010-010-0618-z\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Nobiletin,%20a%20citrus%20flavonoid,%20suppresses%20invasion%20and%20migration%20involving%20FAK/PI3K/Akt%20and%20small%20GTPase%20signals%20in%20human%20gastric%20adenocarcinoma%20AGS%20cells\u0026author=Y. C. Lee\u0026author=T. H. Cheng\u0026author=J. S. Lee et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B51\"\u003eN. Shirvaikar, L. A. Marquez-Curtis, M. Z. Ratajczak, and A. Janowska-Wieczorek, Hyaluronic acid and thrombin upregulate MT1-MMP through PI3K and Rac-1 signaling and prime the homing-related responses of cord blood hematopoietic stem/progenitor cells, \u003ci\u003eStem Cells and Development\u003c/i\u003e, vol. 20, no. 1, pp. 1930, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1089/scd.2010.0118\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Hyaluronic%20acid%20and%20thrombin%20upregulate%20MT1-MMP%20through%20PI3K%20and%20Rac-1%20signaling%20and%20prime%20the%20homing-related%20responses%20of%20cord%20blood%20hematopoietic%20stem/progenitor%20cells\u0026author=N. Shirvaikar\u0026author=L. A. Marquez-Curtis\u0026author=M. Z. Ratajczak\u0026author=\u0026author=A. Janowska-Wieczorek\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e\u003c/div\u003e\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"copyright\" id=\"copyright\"\u003eCopyright\u003c/h4\u003e\u003cp\u003eCopyright  2012 Ying-Yi Chen et al. This is an open access article distributed under the \u003ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/3.0/\"\u003e  Creative Commons Attribution License\u003c/a\u003e, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.\u003c/p\u003e\u003c/div\u003e","section_links":[{"hash":"abstract","title":"Abstract"},{"hash":"introduction","title":"Introduction"},{"hash":"materials-and-methods","title":"Materials and Methods"},{"hash":"results","title":"Results"},{"hash":"discussions","title":"Discussions"},{"hash":"abbreviations","title":"Abbreviations"},{"hash":"acknowledgments","title":"Acknowledgments"},{"hash":"references","title":"References"},{"hash":"copyright","title":"Copyright"}],"style":"","block_links":[{"title":"PDF","type":"PDF","url":"downloads.hindawi.com/journals/ecam/2012/378415.pdf","childrens":[]},{"title":"Download Reference","type":"RIS","url":"/journals/ecam/2012/378415.ris","childrens":[]},{"title":"Download other formats","type":"","url":"","childrens":[{"title":"ePub","type":"ePUB","url":"downloads.hindawi.com/journals/ecam/2012/378415.epub"},{"title":"XML","type":"XML","url":"downloads.hindawi.com/journals/ecam/2012/378415.xml"}]}],"articleStats":{"no_of_views":4174,"no_of_downloads":1634,"no_of_citations":38},"relatedArticleChildren":{"articles":[]},"alertMessage":{"HIGH":[],"MODERATE":[],"LOW":["A \u003cb\u003eErratum\u003c/b\u003e for this article has been published.\n  To view the article details, please click the Erratum tab above."]}},"year":"2012","statusCode":false},"currentUrl":"https://www.hindawi.com/journals/ecam/2012/378415/","siteUrl":"https://www.hindawi.com","currentPath":"/journals/ecam/2012/378415/","host":"www.hindawi.com"},"page":"/journal_article","query":{},"buildId":"cpr9K8AjZYaP4CWVbtn5c","dynamicBuildId":false,"assetPrefix":"https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c"}</script><script async="" id="__NEXT_PAGE__/journal_article" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/journal_article.js"></script><script async="" id="__NEXT_PAGE__/_app" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js"></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/webpack-8ed9452df514b4d17d80.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/common.833c76e043bbff9f1f05.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_error.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/basic_page.j~be281a1b.25833a967f60c50378e5.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/main-87fc3e527b54e364ead2.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/login.js~stati~9d879864.8fb864f66b07cdcdf10f.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/content_alerts~fb8dc725.93e0b4fc708693fdbfaa.js" async=""></script><script src="https://www.hindawi.com/static/themes/hindawi/base.js"></script></body></html>